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High utilization of the emergency department (ED) by patients with anxiety symptoms 
has brought attention to mental health access disparities among low-income 
racially/ethnically diverse populations. The health system in this study attempted to 
increase access to mental health care with integrative group medical visits (IGMVs), a 
nonpharmacological intervention with biomedical care consultation, health education, 
and peer support. The purpose of this retrospective comparative analysis, guided by an 
integrative health equity in primary care framework, was to determine whether patients 
with diagnoses of anxiety who attended four or more IGMVs had reduced nonemergent 
ED utilization, reduced prescribed doses of benzodiazepine (BZD), and reduced severity 
of anxiety symptoms compared to usual care (no IGMV attendance). The 2017-2018 
records of a sample of 85 patients (43 IGMVs, 42 usual care) with anxiety diagnoses 
were reviewed from one U.S. racially/ethnically diverse health system database. 
Nonemergent ED utilization, BZD use, and anxiety symptom severity data were analyzed 
using repeated-measures analysis of variance. Results demonstrated that the IGMV group 
had no statistically significant difference in ED utilization (p = 0.82), BZD use (p = 0.67), 
and anxiety symptom severity (p = 0.89) compared to usual care. Future research could 
focus on cost-effectiveness studies of allopathic versus nonallopathic practitioners 
facilitating IGMVs for integrated behavioral health in the primary care home for low-
income diverse populations. This study contributes to social change by adding to the 
literature on the effect of IGMV access on behavioral health and health outcomes for 
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I dedicate this dissertation project, and labor of love, to the patients whom I serve, 
especially those whom I served in an integrative group medical visit setting. The majority 
of the primary care patients whom I serve are underserved Latino, Spanish-only speaking 
adults in Southeast Florida. While this inquiry is not about them directly, they inspired 
me to look into the subject of anxiety and access to mental health services in a different 
part of the United States with a more robust program of integrative group visits.  
Listening to their stories of separation, partner or other family deportation, poor 
access, discrimination, and misinformation over their lifetime of care spurred this 
investigation into their mental health. While not all their stories were negative and they 
did highlight positive experiences also, the negative certainly outweighed the positive, 
and I noticed that the positive experiences were with minority practitioners. As we have 
seen over time in research, racially/ethnically diverse persons experience suboptimal care 
while less often, even from other racially/ethnically diverse practitioners. This is 
concerning and points to a need for increased vigilance and perhaps more implicit bias 
and other diversity and inclusion training. It also points to the need for equitable 
healthcare, increased focus on mental health for all to reduce opportunities to be treated 
differently, and improved access to mental health integrated with primary care to reduce 
transportation costs and time.  
I heard my patients share with me their consumption of nonprescribed 
benzodiazepines (BZDs), getting BZDs over the counter in other countries, abuse of 
BZDs over decades, carrying BZDs into the United States, or getting supplies from 
 
 
friends or family. This prompted me to realize that perhaps the standard notion of BZD 
abuse as a “White problem” was not accurate and led to this doctoral project inquiry.   
I also dedicate this to all disadvantaged persons nationally and internationally, as 
inspired by the integrative health practitioner community, Integrative Medicine for the 
Underserved (IM4US), and my previous international public health work, to honor all 
indigenous communities and practices in their wealth of knowledge and practices over 
thousands of years that help to inform our work on blending allopathic with natural 
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Part 1: Overview 
Introduction 
Equitable access to appropriate, evidence-based, affordable, and integrated 
behavioral health care in primary care for low-income patients is lacking (Farber et al., 
2017). Researchers and the U.S. government have recommended the integration of 
behavioral health in primary care, but integration has been limited (Linman et al., 2019). 
Group treatment models have been successful in behavioral health settings, but access to 
behavioral care is often delayed (Dark et al., 2017).  
The purpose of this retrospective, quantitative comparative analysis study was to 
investigate whether an integrative medicine model of care increased behavioral health 
access and improved health outcomes for low-income patients with anxiety within the 
context of their primary care medical home (PCMH). The research questions were as 
follows:  
1. What effect does integrative group medical visits (IGMVs) have on the 
number of nonemergent visits to the emergency department (ED) in 1 year in 
low-income adult patients with anxiety disorders versus low-income adult 
patients with anxiety disorders receiving usual care? 
2. What is the effect of IGMVs on the benzodiazepine (BZD) prescription dose 
in 1 year in low-income adult patients with anxiety disorders compared to 
low-income adult patients with anxiety disorders receiving usual care? 
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3. What is the effect of IGMVs on anxiety disorder symptom severity reduction 
in 1 year compared to usual care groups in low-income adult patients with 
anxiety disorders? 
Using secondary data from 2017-2018 from a U.S. health system with an established 
integrated behavioral health (IBH) and IGMV program, I hypothesized that ED visits, 
benzodiazepine use, and anxiety symptom severity would be different in the IGMV group 
compared to a group of low-income adults who received usual care without IGMVs. 
One in every five Americans has a mood disorder (NIH, 2017). Mood disorders 
rank as the second highest reason for ED utilization among safety-net institutions versus 
sixth in non-safety-net institutions (Sutton et al., 2016). In the United States, safety-net 
institutions are organizations that provide patient care to those who are uninsured and 
underserved (Altman & Lewin, 2000). Anxiety disorders, often comorbid with mood 
disorders, have the highest global burden of disease, currently at about 7% both 
nationally and globally with a 3-month prevalence of up to 10% and one third of 
Americans experiencing an anxiety disorder in their lifetime (Alonso et al., 2018; 
Chisholm et al., 2016; National Institutes of Health [NIH], 2017).  
While safety-net institutions may serve patients at all income levels, the majority 
of racially/ethnically diverse low-income patients receive care within safety-net 
institutions (Sutton et al., 2016). Unlike patients with psychiatric disorders who are 
hospitalized, those with anxiety disorders who are not hospitalized are discharged back to 
the community (Simpson et al., 2014). With delays into primary care, patients who have 
not had their mental health needs met often end up back in the ED with the likelihood of 
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being given BZDs to relieve their anxiety (Dark et al., 2017). For many patients, the ED 
has become the provider for unmet mental health care needs. The ED as a mental health 
provider illuminates the first entry to a larger systemic problem (Stone et al., 2012) of 
healthcare segregation, making available healthcare separate and not equal. 
Systemic Concerns of Inequality 
EDs are not routinely equipped or skilled for mental health care services that may 
be required by the patients who seek care in the ED. The diverse population with a wide 
range of presenting mental ailments sets the stage for a systemic problem that goes 
beyond the ED scope of patient care. Additionally, high utilization increases the 
economic burden on the health system (Dark et al., 2017) or the patients and families that 
utilize them.  
Secondly, regularly prescribed BZDs for anxiety contribute to drug use, misuse, 
and an increase in morbidity and mortality alone or with opioid use. Disparities in access 
to mental health assessment and treatment have been documented in lower 
socioeconomic status patients and racially/ethnically diverse patients. Specifically, the 
standard of initiation of treatment within 14 days and engagement within 30 days is lower 
for African Americans, Native Americans, and Latinos (Acevedo, 2015).  
Complementary and integrative health (CIH) models of care in primary care, 
while not novel, are not the standard of care, despite evidence of a variety of integrative 
treatment modalities improving health outcomes, primarily pain and mental health (Hull 
et al., 2019). Specific to this study, the benefits of mindfulness meditation have been 
widely studied and published (Goyal et al., 2014; Kabat-Zinn et al., 1985; Miller et al., 
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1995). Goyal et al.’s (2014) systematic review covered 47 trials, finding moderate 
evidence for mindfulness meditation as a means of anxiety reduction. While models of 
clinical practice have been disseminated, a framework for the healthcare system and 
educational system to incorporate CIH has not been realized. More recently, research has 
shown that low-income racially/ethnically diverse populations respond well to 
incorporation of mindfulness meditation practices (Bowen et al., 2014; Charlot et al., 
2018).  
Treatment for Low-Income or Racially/Ethnically Diverse Patients 
Low-income racially/ethnically diverse patients have increased barriers to care, 
experience inequities in care provided, and experience longer wait times for post ED 
follow-up appointments (James et al., 2010; Saluja et al., 2019). Compared to non-safety-
net ED utilization, higher utilization of the ED for mental health care by the underserved 
brings attention to the problem of mental health access disparity among low-income 
racially/ethnically diverse populations (Cook et al., 2017; Richardson et al., 2003) 
compared to middle- and high-income individuals who do not return or access mental 
health services from an ED. Iturralde et al. (2019) found that patients with anxiety were 
independently associated with more ED utilization and reported them to be 
disproportionately found among the highest cost patients in a large, diverse sample of 
health system users. 
Treatment for Opioid or Benzodiazepine Misuse or Abuse 
Singularly or concurrently with opioids, BZD use and misuse are a population 
health and systemic concern. In a retrospective study of medical expenditure data from 
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2011, 2013, and 2015, persons with anxiety had an almost 10-fold odds ratio for opioid 
BZD concurrent use (Vadiei & Bhattacharjee, 2020). As with opioids, efforts have also 
been underway to curb the use of BZDs, which are often used concurrently with opioids 
and increase morbidity and mortality from overdose (Vadiei & Bhattacharjee, 2020). 
BZDs are modulators of the neurotransmitter gamma-aminobutyric acid and act as 
tranquilizers and sedatives (Fluyau et al., 2018). BZDs were designed as a rescue 
medication primarily for panic attacks and sleep or preprocedural sedation, respectively 
(Fluyau et al., 2018). However, due to the highly effective short-term results and 
addictive properties of BZDs, these substances have become misused and abused. 
According to the 2018 National Survey on Drug Use and Health, an estimated 5 
million adults aged 18 and over misused BZDs (Substance Abuse and Mental Health 
Services Administration [SAMHSA], 2019). In countries of origin (of many 
racially/ethnically diverse persons), BZDs are available over the counter without a 
prescription from a licensed practitioner (Moreno et al., 2018). This challenges the 
current evidence that BZD use is more prevalent in non-Hispanic Whites, as those data 
come from medical expenditure reviews. Resident immigrants while traveling purchase 
BZDs (or receive BZDs from contacts that have traveled abroad) that their U.S. primary 
care provider (PCP) may not have prescribed for them. Since the recognition of the 
opioid epidemic, many PCPs no longer prescribe controlled substances. If BZDs are used 
longer than 1 month routinely, stopping abruptly may produce seizures or life-threatening 
delirium (Fluyau et al., 2018). 
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Addiction to BZD is a factor in high-cost utilization when supplies run out or 
alternatives to addressing anxiety are not available (Dark et al., 2017). In prescriptions 
alone, BZD are the most misused and abused medications (Fluyau et al., 2018) leading to 
a substance use disorder. Cryptomarkets, otherwise known as the hidden or dark web 
online, represent another portal for access to BZDs that is difficult to investigate; such 
markets were not included in this study but are a known source contributing to ongoing 
abuse of BZDs (Van Hout & Hearne, 2017). Therefore, the aforementioned SAMHSA 
(2019) estimate was the only calculable figure.  
BZDs are not a recommended first-line intervention for anxiety. However, 
practitioners often prescribe BZDs prior to any of the recommended first-line agents such 
as selective serotonin reuptake inhibitors (SSRIs) or serotonin and norepinephrine 
reuptake inhibitors (SNRIs; Blackwelder & Bragg, 2016). While BZDs are considered a 
short-term method, early initiation and the propensity for addiction have led to 
inappropriate long-term use and subsequently substance use disorders (Bouvier et al., 
2018).  
Complementary or Alternative Treatment Options 
In efforts to improve their mental health or due to wait times for a consultation, 
many patients may, alone or in conjunction with prescribed medications, self-medicate 
with home remedies, teas, herbs, and nutritional supplements that they may not discuss 
with their practitioner. More than half report that their practitioner has never asked them 
about their herb or supplement use (Pruitt et al., 2018). While many are relatively safe, 
others have potentiating effects, interactions, or alternatively no evidence-based effect 
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(Pruitt et al., 2018). Self-medicating with both allopathic and nonallopathic substances 
may result and has resulted in serious and/or fatal consequences (Alford et al., 2016; 
Fluyau et al., 2018).  
Healthcare practitioners receive little education on herbs, supplements, and 
integrative approaches (Pruitt et al., 2018). Creating a practice environment for patients 
with support from their peers that increases options and trust (Lavoie et al., 2013; 
Thompson-Lastad, 2018) to disclose self-treatments aids in the discovery of alternative 
coping mechanisms that are critical in addressing this mental health access problem.   
Mental Health Access 
Access to mental health care that provides appropriate, evidence-based, step-wise 
care for anxiety disorders may address this systemic problem. The ED provider provides 
rescue medication and in some cases a navigator to find an appropriate medical home. 
However, the wait time to see a psychiatric practitioner or even a PCP is conducive to 
repeat ED visits until care is established.   
In many cases, patients prefer that their PCP manage their mental health care 
(Buche et al, 2017). The integration of primary care and behavioral health (via a team-
based care model) as IBH has been established as a strategy for social change to improve 
health outcomes and reduce high-cost utilization (Buche et al., 2017). Once care is 
established, group medical visits (GMV) with a PCP are spaces, whether virtual or in 
person, that have been created in some health systems to allow patients increased access 




Anxiety disorders are a growing population health concern, the prevalence of 
which has surpassed that of depression disorders, with women having twice the rate of 
men (NIH, 2017). Of note, according to the fifth edition of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-5), posttraumatic stress disorder (PTSD) has been 
removed from anxiety disorders classification and is now classified under trauma-related 
disorders (American Psychiatric Association [APA], 2013). In the DSM-5, anxiety 
disorders include primarily childhood separation anxiety disorder, selective mutism, and 
specific phobias, whereas in adulthood there are higher percentages of panic disorder, 
agoraphobia, social anxiety disorder (SAD), general anxiety disorder (GAD), 
substance/medication-induced anxiety disorder, anxiety disorder due to a medical 
concern, and anxiety disorder unspecified (Alonso et al., 2018; APA, 2013; Bandelow et 
al., 2017).  
In practice, PCPs commonly use GAD-7 and additional questions to diagnose 
anxiety. If the diagnosis is unclear, the diagnosis “unspecified anxiety disorder” is often 
utilized. In research, common instruments for measuring anxiety in participants include 
the Hamilton Anxiety Scale and GAD-7 (Sampaio et al., 2016; Spitzer et al., 2006; 
Webster et al., 2017). The current study’s sample of patients was low-income adults 
already diagnosed by the PCP with any of the aforementioned adult anxiety disorders. 
After the age of 50, GAD is the most common anxiety disorder (Bandelow et al., 
2017). Anxiety often presents in somatic forms, such as palpitations, tremors, dizziness, 
nausea, muscle tension, shortness of breath, headaches, chest pain, digestive complaints, 
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and sweating (Bandelow et al., 2017; Gates et al., 2016). Investigating the somatic 
complaints often delays recognition and hence appropriate mental health care for anxiety 
disorders. Patients’ awareness of their own somatic symptoms related to anxiety, such as 
shortness of breath or pain and an inability to manage those symptoms, often results in 
overutilization of emergency services for acute relief (Dark et al., 2017).  
Group Medical Visits 
The Agency for Healthcare Research Quality (AHRQ) has recommended GMV to 
address patient access to care, increase patient and practitioner satisfaction in care 
delivered, and decrease high-cost health care utilization, including ED and specialty visits 
(AHRQ, 2018; Shaw et al., 2014). GMV are shared medical appointments (SMA) with a 
group of patients being seen simultaneously, lasting from 1-2 hours with a range in 
attendance from five to 16 patients with some common diagnoses and/or common interest 
in receiving an intervention (AHRQ, 2018).  
There are various GMV types, which include drop-in, diagnosis-based, 
transdiagnostic, and intervention-based group visits (AHRQ, 2018), all of which are done 
either in person or virtually. GMV combine biomedical care and consultation with health 
education and peer support. For example, a group of patients may be coming to the group 
because they all have chronic pain and simultaneously would like to receive acupuncture 
for their chronic pain condition. Other chronic pain groups may focus on acceptance of 
pain or mindfulness techniques to cope with pain and participate in activities to uncover 
their source of pain (i.e., contributors of pain via nutrition, work, or home life activities) 
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and share experiences and community resources (Gardiner et al., 2014) and are referred 
to as an integrative group medical visit (IGMV).  
Significant positive health outcomes that have been documented in systematic 
reviews include increased patient satisfaction, increased patient knowledge, reduction in 
symptom severity, weight reduction, and increased healthy eating habits (Parikh et al., 
2019). There is evidence that GMV participants (diabetes patients and elders) have lower 
ED utilization and hospitalizations while active in groups (Edelman et al., 2012; Gardiner 
et al., 2019; Shaw et al., 2014).  
While there is little counterevidence of the benefits of GMV, Canadian 
researchers surveyed 111 patients and found that patients reported both individual visits 
and GMV to be positive (Remick & Remick, 2014). There was only a slightly higher 
preference for GMV, and using repeated measure analysis of variance (ANOVA) for 
analysis resulted in no difference (Remick & Remick, 2014).  However, it should be 
noted that all of the patients were patients of the same psychiatrist who were having their 
follow-up appointments in groups versus individually to reduce the wait time to see the 
psychiatrist, and this was not in the context of a PCMH or IBH setting.  
While not in the context of IGMVs, in an earlier systematic review and meta-
analysis, Goyal et al. (2014) found moderate evidence of meditation improving anxiety, 
depression, and pain. There was no significant evidence for substance use, positivity, 
eating habits, and weight reduction. Goyal et al. did recommend that stronger study 
designs were needed for clinicians to give stronger recommendations to patients on the 
benefits of meditation.  
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Context Within Patient-Centered Medical Homes 
In the past 20 years, practitioners serving the underserved have offered GMV in 
the context of primary care that is deemed a PCMH. PCMHs include private and 
government community clinics, national health service, and federally qualified health 
centers (FQHCs; Wadsworth et al., 2019). PCMH certification requires that there is a 
health care team for each patient coordinating care to ensure that there are no care gaps 
and addressing different aspects of their health, including social determinants of health 
(Linman et al., 2019).  
With the utilization of GMV in PCMH, researchers have noted that the efficiency 
of care increases as care team members work together with multiple patients at a time, 
creating access and peer support simultaneously (Parikh et al., 2019). Earlier GMVs 
focused on diabetes, pregnancy and parenting, and cancer. Since 1990, different models, 
including transdiagnostic groups (focused on stress reduction), teaching kitchen groups 
(preparing low-cost, nutritious meals), and integrative pain management groups have 
burgeoned. Research on the effectiveness of these and other groups has also been 
employed, with a surge noted after 2014 (Parikh et al., 2019). 
Integrated Behavioral Health 
A survey of PCMH found that less than half of the patients have onsite access to a 
behaviorist, social worker, or psychologist on the care team (Kessler et al., 2014). For 
those who have IBH at the PCMH, there is improved adherence to treatment plans and 
improved health outcomes. Zeiss and Karlin (2008) found that patients preferred IBH at 
the location where they received their primary care (colocated care). From their study on 
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anxiety-related ED use, Dark et al. (2017) concluded that an IBH approach would reduce 
ED visits. Access to GMV has increased IBH in primary care and allowed patients the 
convenience of having their primary and mental health care in one location (colocation). 
In addition, in a U.S. national health statistics report on over 88,000 adults, patients 
reported more interest in CIH practices to manage their health, with yoga being the most 
prevalent CIH practice (Clarke et al., 2015).  
Integrative Group Medical Visits 
IGMVs build on the growing use of GMVs for chronic care. While IGMVs have 
the same basic components of GMVs, they include one or more nonpharmacological 
interventions. Two-thirds of the IGMVs studied included a mindfulness meditation 
component (Thompson-Lastad, 2019). Hence, in the current study, IGMVs with 
mindfulness meditation were compared to usual care. IGMVs have been implemented in 
response to interest in CIH, which remains inaccessible to many people due to limited 
insurance coverage and high out-of-pocket costs. While elements such as awareness, 
deep breathing, focused attention, meditation, and mindful movement are essentially free 
to do and require no literacy, access to learning the steps and the benefits is typically 
expensive and not included in mainstream healthcare. Utilizing a patient’s diagnosis to 
offer them mindfulness meditation in the IGMV setting creates a scenario in which both 
the care team and the patients benefit and the PCP may bill insurance.  
Results of multiple studies have indicated that IGMVs may contribute to 
improving patient experience, improving population health, reducing costs, and 
increasing practitioner satisfaction (Chao et al., 2019; Cornelio-Flores et al., 2018; 
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Dresner et al., 2016; Gardiner et al., 2017, Gardiner et al., 2019; Gareau et al., 2016; 
Geller et al., 2015; Mehl-Madrona et al., 2016; Rowley et al., 2016; Shaw et al., 2014; 
Strickland et al., 2016).  
Synthesizing the Literature 
The relevant literature for the field of IBH in primary care draws from various 
disciplines, which highlights the interdisciplinary nature of this inquiry. Some of the key 
literature for this inquiry, from the pioneers of infusing integrative health into GMV, was 
published between 2011 and 2014, while the majority of the literature synthesized was 
primarily published within the last 5 years. Hence, I have included some key literature 
from previous years to explain the progression of this research. The fields of nursing, 
health psychology, primary care, CIH, behavioral medicine, behavioral economics, health 
care utilization, and public health were explored for relevant scholarship on the IBH in 
primary care by way of IGMV to address anxiety disorders and improve health outcomes 
in predominantly low-income racially/ethnically diverse adults.  
In a qualitative review of earlier group visit research (1974-2004), Jaber et al. 
(2006), along with other findings, reported a decrease in high-cost utilization, including 
specialty care, urgent care, and ED utilization, illuminating improved management by 
both the team and the patient. These were statistically significant primarily on elders, 
those with headaches and diabetes, but not specifically low-income patients. In the past 
10 years, there has been a surge of research in GMV, including IGMV research on 
racially/ethnically diverse low-income populations. Gardiner et al. (2019) focused on 
chronic pain and depression, which highlighted outcomes related to utilization, patient 
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satisfaction, and health outcomes in low-income racially/ethnically diverse patients in the 
primary care/PCMH context.  
ED utilization has been the primary reported cost measure because it is the most 
expensive (Ernst et al., 2015) and it is a patient-driven versus provider-driven cost. ED 
utilization in patients with chronic pain and depression utilizing IMGV mindfulness-
based stress reduction (MBSR) based IGMV was reduced and was statistically significant 
at 9 weeks compared to the control but not at 21 weeks (Gardiner et al., 2019). While 
Gardiner et al. (2019) mentioned the cost savings via decreased opioid use and reduced 
ED utilization, the cost savings was not quantified. Gardiner et al. (2019) and Mehl-
Madrona et al. (2016) specifically recommended more emphasis on cost reduction 
research.  
While there have been a variety of programmatic types of IGMV in practice 
(Thompson-Lastad, 2019), the majority of published IGMV research has been on 
depression and chronic pain, inclusive of emphasis on opioid use. Reducing opioid 
consumption, considering the opioid crisis, has been shown to be associated with IGMV 
in a recent randomized controlled trial (RCT; Gardiner et al., 2019). While anxiety 
disorders have been listed as comorbidities (Chao et al., 2019; Gardiner et al., 2019), 
there has not been a focus on people with anxiety disorders. However, while not 
discussed or analyzed, there was a significant reduction in anxiety symptoms post 3 
months of IGMV (Chao, 2019). While opioid reduction was tracked, BZD reduction was 
not tracked (M. Chao, personal communication, May 7, 2020). 
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Some patients with anxiety disorders respond well to SSRIs and SNRIs alone or 
along with nonpharmacological interventions. Multiple studies have been completed to 
investigate the best taper method for discontinuation of BZDs. Unfortunately, the 
researchers who completed a meta-analysis of these studies found very little evidence that 
anything is better than placebo (Welsh et al., 2018); however, nonpharmacological 
methods were not included in this meta-analysis. Welsh et al. (2018) pointed most 
favorably to paroxetine and imipramine, which were both found to be helpful in tapering.  
While mixed reviews, Welsh et al. (2018) also suggest the use of melatonin for 
difficulty sleeping because insomnia is a frequently co-occurring diagnosis and has a low 
side effect profile. The use of propranolol had mixed outcomes as well, but investigators 
reported that it could be used on a trial basis because the options are limited. Lastly, 
buspirone had a worse taper outcome than placebo (Welsh et al., 2018). Yoga, with an 
emphasis on meditation and controlled breath, was the only intervention better than 
placebo with greater outcomes with increased frequency (Saeed et al., 2019).  
GAD may be classified as minimal, mild, moderate, or severe via the GAD-7 
scale (Spitzer et al., 2006), which is the most common instrument utilized by PCPs for 
diagnosing patients. It consists of seven questions, and the highest score is 21. The 
threshold for mild anxiety is greater than or equal to 5, moderate is 10-14, and severe is 
above 15 (Spitzer et al., 2006). In research, common instruments for measuring anxiety 
of participants include the Hamilton Anxiety Scale and GAD-7 (Sampaio et al., 2016; 
Webster et al., 2017).  
16 
 
GAD is often diagnosed first in the primary care setting but often goes 
unrecognized and untreated (Bandelow et al., 2017). When the PCP, team, and patient are 
unable to manage anxiety and the symptoms worsen, a referral to psychiatry is the 
standard practice. While not an exact proxy, symptom severity may be tied closely to the 
number of BZD doses that a patient requires. Additionally, recording BZD reductions 
post mindfulness meditation is an important consideration because there is a dearth of 
information in the literature. Therefore, the third area that was investigated in this study 
was symptom severity changes for those who attended IGMV compared to those in usual 
primary care in the PCMH setting to report something meaningful about levels of anxiety 
pre and post exposure to IGMV.  
Aside from psychiatric medication use, other aspects of mental and emotional 
health have been documented in IGMV research with statistically significant 
improvements in mental health quality of life measured by the SF-36 with reductions in 
depression and loneliness (Gardiner et al., 2019; Geller et al., 2011) and a decrease in 
pain medication usage (Gardiner et al., 2019). IGMVs have taken on favorable roles in 
creating more access to CIH in the mainstream primary care setting.  
Several studies have demonstrated a reduction in anxiety with the utilization of 
yoga (Adams et al., 2015; Bukar et al., 2019; Kuppusamy et al., 2020). Bukar et al. 
(2019) also found similar results in an inpatient psychiatric setting with significant 
reductions in anxiety lasting up to 1 day, which resulted in the hiring of a yoga instructor 
as a staff member. Bukar et al. noted that BZD use was reduced, but because it was not 
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measured directly, they suggested that further research be conducted on how yoga and 
meditation affect the reduction of BZD use.  
Components of yoga practice such as mindfulness meditation and meditative 
movements are often included in IGMVs and IGMV research (Chao et al., 2015; Chao et 
al., 2019; Gardiner et al., 2019; Saper et al., 2017; Thompson-Lastad, 2019). The ancient 
practice of yoga began approximately 5,000 years ago in India with meditation and breath 
work or pranayama (Wimberly et al., 2018), but over time, the postures (asanas) were 
added. Meditative breath work has been observed to increase parasympathetic activity 
while reducing sympathetic activity (Kuppusamy et al., 2020). Researchers have also 
reported significant increases with meditation practice over time. Modern yoga is the 
union of breath work with an intentional sequence of meditative movements.  
The progression of both qualitative and quantitative research has illuminated a 
need for describing the phenomenon of groups in primary care, the inclusion effect 
(Geller, 2019), or the access to integrative health with the guidance of the PCP and peers. 
In a sentinel study conducted in Canada, Lavoie et al. (2013) reported that both 
practitioners and patients expressed the benefits of having GMV in a PCMH. Themes 
extracted from the interviews were increased self-management, improved information 
sharing, increased trust of providers, less isolation, and peer support. More recently, 
Thompson-Lastad (2018) found with both practitioners and patients that the peer 
interaction and support changed the power dynamics to allow for cocreating health plans, 
which resulted in revelations of health determinants, equity issues, community resources, 
and what motivates or hinders patients in behavioral change.  
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Research has already been strongly in favor of the increase in patient satisfaction 
with the use of IGMV, exposing patients to other community members, increasing coping 
and empowerment, reducing loneliness, and having an opportunity to share experiences 
and community resources with each other (Dresner et al., 2016, Geller et al., 2011, 2015; 
Housden et al., 2017; Lestoquoy et al., 2017; Thompson-Lastad, 2018). Housden et al. 
(2017) found that nurse practitioner (NP)-led GMVs encouraged interprofessional 
practice and served to deconstruct, as Thompson-Lastad (2018) also noted, some of the 
traditional primary care hierarchies between practitioners and patients. Orzechowski 
(2016) also found that there were decreased wait times for appointments from 3 months 
to 1 month in a feasibility study examining mindfulness groups for patients with 
fibromyalgia.  
This retrospective study examined three aspects of the problem of behavioral 
health access in one health system in the United States (also included in Thompson-
Lastad’s [2019] national survey of locatable IGMVs), which utilized IGMVs to provide 
greater behavioral health access to their safety net patients. These three aspects may be 
viewed in terms of how these dependent variables, ED utilization, BZD dose, and 
patients’ level of anxiety symptoms, responded to the independent variable, IGMV, in a 
purposeful sampling of patient data from their 2017-2018 historical electronic health 
records of IGMV practice from a safety-net health system that has had both IBH in 




The key variables for this study were bridged over the three manuscripts, while 
the independent variable remained constant. The independent variable was the type of 
mental health service (IGMV or usual care) for patients with an anxiety diagnosis who 
received mental health services at the safety net with IBH in primary care/PCMH.  
The first dependent variable was ED utilization the year prior and after a year of 
participation in the IGMV. ED utilization was defined as nonemergent visits to the ED 
that did not require hospitalization. The second dependent variable was reported 
prescription dose of BZD just prior to the year and after participation in IGMV sessions. 
The third variable was the composite score of the four anxiety-related questions on the 
annual health-screening tool prior to IGMV sessions and post IGMV sessions. The health 
screening tool was a merging of the Staying Healthy/Screening, Brief Intervention, and 
Referral to Treatment screening tool, and all patients are given the screening on an annual 
basis. Questions 2, 7, 8, and 9 are related to anxiety (Appendix A). The time frames for 
the usual care group’s ED utilization, BZD use, and anxiety symptom severity scores 
mirrored those of the IGMV group. 
Construct 
Mindfulness meditation was the constant integrative modality that was threaded 
throughout the IGMV sessions and was defined as observing thoughts in a nonjudgmental 
and nonreactive way to bring a sense of heightened awareness to the present state of 
emotions and sensations (Barnby et al., 2015; Jayatilake, 2017; Kabat-Zinn et al., 1985). 
Kabat-Zinn et al. (1985) noted reductions in anxiety symptoms in 20 of 22 patients who 
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were referred into an 8-week MBSR program by their physicians at both postintervention 
and a 3-month follow up.  
Barnby et al. (2015) found that mindfulness meditation, through neuroimaging, 
reduces both anxiety and ruminating thoughts by inhibiting activity in the posterior 
regions and increasing activity and connectivity in the prefrontal and frontal regions of 
the brain. In addition to the aforementioned evidence of neuroplasticity, neuroimaging of 
experienced meditators demonstrated an increased thickness of the prefrontal cortex with 
more practice over time and a resultant delay in cortical thinning that comes with the 
typical aging process (Brandmeyer & Delorme, 2020).  
Evidence supports that mindfulness meditation modulates reactivity to inner 
thoughts, perceptions, and the wandering mind (Brandmeyer & Delorme, 2020). In as 
little as 3 months, Lutz et al. (2018) found that subjects had increased focus and 
decreased emotional reactivity (Lutz et al., 2018), whereas Brandmeyer and Delorme 
(2017) found similar results within eight sessions.  
Slowing down emotional reactivity is a critical outcome for those with acute or 
chronic anxiety symptoms (Tolin et al., 2021). Travis et al. (2018) reported that an RCT 
on meditation showed an increase in brain integration and reduced distress. Likewise, 
reducing distress and stress reduces cortisol release, glucose, and blood pressure. Similar 
to other chronic diseases, with anxiety, if root causes and alternative coping skills are not 
brought to awareness and addressed, the stress on the mind and body may result in other 
health-related consequences such as shorter telomeres (Wang et al., 2017), loss of 
memory, high blood pressure, elevated glucose, and organ damage. Apart from chronic 
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pain and depression, anxiety is also often found as a comorbid condition with diabetes 
and hypertension (Ogle et al., 2018).  
Conceptual Framework and Theory 
From the inception of the GMV model, the majority of the GMV research has 
been void of theory or frameworks, with one exception being the mention of diffusion of 
innovations theory (Housden et al., 2017). Rather, the focus has been on the pragmatic 
models of the groups themselves. For example, Ornish and colleagues utilized a cardiac 
rehab model that demonstrated signs of reversing heart disease with a vegetarian diet, 
exercise, and group support (Ornish et al., 1990). Noffsinger (2012) outlined different 
practice models that may incorporate GMV as an ongoing manner of managing patient 
panels, reducing wait times, and utilizing multiple team members to operationalize 
increased access, improved quality, and reduced costs compared to the typical individual 
office visit model.  
Ornish et al. (1990), Noffsinger (2012), and others have laid the groundwork for 
building practice models that incorporate drop-in group medical visits to assist the 
individual provider to manage their panel more effectively or alternative monthly chronic 
care group visits that group patients by diagnosis or utilization behavior (Noffsinger, 
2012). As GMV have been incorporated into primary care and specialty care for the past 
20 years, more developments have arisen utilizing the aforementioned practice models 
while infusing integrative medicine and health modalities like Gardiner et al (2019) 
infusion of MBSR and virtual assistant and Geller’s (2011) empowerment model, 
allowing patients to decide what activities or modalities they would like to improve their 
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health and well-being. Reflecting on these practice models, I suggested a framework and 
theory to encapsulate this evolution and propel forward into sustainable and 
transformative practice possibilities for improving both mental health and population 
health in an exceedingly diverse patient population.  
Premise for a New Framework 
The framework that I proposed was a combination of one conceptual framework 
and two theories. The first looked at the system from a population health level 
(Quadruple Aim), the second provided a critical explanation of the context and social 
determinants of health that intersect at the community level (intersectionality theory), and 
the third focused on the mental accounting that happens at the person level (mental 
accounting theory). Together, they provided an interdisciplinary explanation to describe 
structural priorities of the mainstream system and the outcomes that occur. Within this 
new framework, different interventions can be inserted, such as IGMV, to explore how 
the intervention fits within the context of structural inequities and healthcare system 
priorities.  
The Quadruple Aim Framework 
The Quadruple Aim Framework (QAF) is an expansion of the Triple Aim 
developed by leaders at the Institute of Healthcare Improvement. The Quadruple Aim 
suggested a focus on the Triple Aim, which is improved patient experience, improved 
health outcomes, and reduced costs (Berwick et al., 2008), and then added higher 
practitioner satisfaction or care team well-being. The final aim was first described by 
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William Spinelli (2013) as the “phantom limb” and later formalized as an important 
consideration in reducing burnout of practitioners (Bodenheimer & Sinsky, 2013).  
While all four aims of IGMVs have been researched, the aims of focus in this 
study may be categorized under the right side of Figure 1, improved health outcomes and 
reduced costs, but should still be seen in the context of the four aims of the QAF, as 
patient experience and care team well-being also affect the other aims indirectly or 
directly. In addition, the use of CIH modalities in the context of this framework 
influences the whole in delivering whole-person integrated care.  
Figure 1 
Quadruple Aim Framework 
 
Note. Quadruple Aim (n.d.). 
The theoretical basis for understanding the phenomena occurring with low-
income racially/ethnically diverse patients (otherwise known as the underserved) in the 
context of the current health system is intersectionality theory. Intersectionality theory 
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provided a lens with which to look at the QAF, keeping in mind that safety-net hospital 
patients have different outcomes—for this study, specifically those who are underserved 
and have an anxiety diagnosis. The QAF frames the health care context in which people 
receive care; intersectionality theory provided a lens to view how some of the outcomes 
of how people receive care are explained, while mental accounting theory takes into 
consideration the ultimate choices that low-income patients are able to make when facing 
the structural challenges of their communities and their interactions with their local health 
care system. 
Intersectionality Theory 
Crenshaw coined the concept of intersectionality to view the intersection of race 
and gender as it relates to the marginalization of Black women (Crenshaw, 1989). 
Intersectionality theory has been adopted in the health professions to explain the complex 
way in which the social determinants of health such as economic stability, education 
level, environment, access to food and health care, and social networks (or lack thereof) 
interact with different aspects of a person’s identity. The intersection of the social 
determinants of health with the multiple categories of labels placed on individuals shape 
the discriminatory experiences that some marginalized groups may face within health 
systems (Gkiouleka et al., 2018). Institutions have a significant and powerful role in their 
communities’ population health outcomes.   
Population health outcomes are not only determined by the care received, but also 
by the context, access to the appropriate care for the diagnosis in question, and the cost to 
the person, community, and society, which drives the cost of health care either up or 
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down. Patients have on average 10 visits before they receive an anxiety diagnosis 
(Alonso et al., 2018), resulting in a delay in appropriate treatment. Diagnosis is further 
delayed because most appointments are 1-3 months apart, which may contribute to 
interim increases in high-cost utilization.   
Mental Accounting Theory 
Another area which enlightens this conceptual framework, is that of behavioral 
economics. Elbel et al. (2014) concluded that low-income patients are particularly 
understudied when it comes to their health care choices and that vulnerable populations 
would benefit from assistance in making better health care choices. They drew on 
Thaler’s (2016) notion of nudges to suggest that nudges are key in assisting patients in 
making better choices.  
Thaler (2016) reinserted human psychology and behavior into the field of 
economics, reemphasizing the work of 18th century economist Smith to bring back the 
notion of the human drivers of economic choices (Barberis, 2018). The reasons that more 
low-income patients than middle to higher income patients go to the ED for nonemergent 
reasons that include mental health care may include factors such as transportation issues, 
a custom of going to hospitals versus outpatient facilities in their countries of origin, the 
proximity of the ED versus a primary care office, and/or lack of a PCP or insurance. 
Thaler’s theory of mental accounting helps to explain why people make some of the 
choices that they make, some of which may be rational, but more often are not rational 
but reactive and based on emotion, pain, anxiety level, and what is important at the 
present moment, not long term. He recommended that health care practitioners provide 
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choice architecture to patients so that they may make more informed and better choices 
for their health.  
Utilizing the theories of intersectionality and mental accounting to frame the 
research questions provided insight into the interaction of these concepts together as they 
relate to the two aims of health outcomes and cost reduction. These are concepts and 
theories steeped in the context of the capitalist system, which, by definition, do not 
support underserved, low-income racially/ethnically diverse patients. However, the 
accessibility of the expensive and expansive hospital systems and their EDs allow anyone 
to choose this location for their care (Stone et al., 2012), regardless of its utility to meet 
the needs presented.  
Combining these lenses together opened a new way of viewing the current health 
care system and imagining addressing more holistic care within this context. Choice 
architecture combined with integrative and appropriate care may be communicated with 
nudges and in culturally diverse spaces where patients may feel safety, trust, and access 
to the care that is needed to address access and equity. Integration of the IGMV as a 
space that promotes choices frames the utility of IGMV for increasing mental health 
access and health equity for low-income racially/ethnically diverse patients. The new 
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The Gap  
Recent literature revealed that there is lower ED utilization with IBH in the 
PCMH model (Gardiner et al, 2019; Serrano et al., 2018). Peterson and la Cour (2016) 
hypothesized that lower socioeconomic status would make a difference in participants’ 
ability to take part in mindfulness meditation and breath work, but the results of their 
research did not support their assumptions. Further, the literature supported the IGMV 
format for increasing access and support for patients along with a reduction in ED 
utilization (AHRQ, 2018; Shaw et al., 2014).  
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What is unknown is whether statistically significant numbers of established 
patients with anxiety disorders attending IGMVs in the context of the IBH in PCMH had 
significantly lower ED utilization rates, significantly reduced BZD dose, and significantly 
reduced severity in symptoms compared to patients in the same healthcare system who 
had not attended IGMV and were receiving usual care. These are critical statistics for 
creating the evidence base needed for wider uptake of this model, if it indeed saved 
money, reduced medication usage, and improved lives at the population health level.  
If IGMV demonstrated a reduction of ED utilization for those with anxiety 
disorders, the result could be a significant cost savings to safety-net institutions. The 
potential diffusion of IGMV by safety-net institutions could influence access to 
integrative mental health care. Whether in person or via telehealth groups, IGMVs are 
being integrated in primary care. The potential positive social change impact is greater 
access to integrative mental health care for the underserved, improved mental health 
outcomes, and reduction of nonemergent use of the ED.   
Overview of the Manuscripts 
The purpose of this retrospective quantitative comparative analysis was to 
determine whether patients with diagnoses of anxiety who have participated in IGMV, in 
the context of the PCMH, have reduced ED utilization for nonemergent care, reduced 
prescription dose of BZD, and reduced severity of symptoms compared to patients 
receiving usual care who did not participate in IGMV. 
The interconnection between the three related research questions contributed to 
the discovery of how IBH in primary care via IGMV affected adult patients with anxiety 
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diagnoses in different aspects of how and where they receive their care. Usual care was 
defined as patients who were having their anxiety managed by their PCP only, as 
participation in psychotherapy groups was controlled for. Utilizing the right side aims 
(improved health outcomes and reduction of costs) of the QAF provided a context to 
visualize how these constructs and questions were interrelated.  
The chosen research site has reported implementation of the tool Stay 
Healthy/Screening, Brief Intervention and Referral to Treatment, which is a combination 
of two validated tools that have been merged into one screening system (Department of 
Health Care Services [DHCS], 2019). The Screening, Brief Intervention and Referral to 
Treatment tool is used in primary care to identify patients needing timely interventions 
and referrals to relevant resources for substance use disorder and psychiatric disorders 
(Hargraves et al., 2017). Both tools have been through interrater and interscreener 
reliability checks. Internal testing and survey fatigue in combining the tools was also 
completed between 2016-2017, and all patients are mandated by the state to take the 
assessment annually (M. Changaris, personal communication, August 2, 2020).  
The Stay Healthy Assessment is an individual health education and behavioral 
assessment that was developed by the DHCS in 1999 and updated in 2013 and is 
available in 10 languages (DHCS, 2019). All patients complete the combined Stay 
Healthy/Screening, Brief Intervention and Referral to Treatment tool annually. The 
questions related to anxiety were analyzed for the anxiety status of the participants before 
and after participation in IGMV groups (Appendix A). Given that this study was a 
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retrospective review and not a prospective study, collecting pre and post GAD-7 scores 
was not relevant, as patients had already been diagnosed with an anxiety disorder.  
Through these three related inquiries, I investigated three aspects of anxiety care 
at two time points before and at the end of the year. First, nonemergent ED utilization 
related to anxiety concerns represented the degree of high-cost anxiety care at the tertiary 
level. Second, BZD prescribed dose related to provider-initiated and patient-felt need for 
controlled substance management of anxiety symptoms at the primary level. Lastly, 
anxiety symptom severity related to patient-felt level of wellness at the individual level.  
Manuscript 1 
Specific Problem 
The problem of overutilization of ED for nonemergent care for those with anxiety 
diagnoses is a proxy for the search for mental health care for those with anxiety that is 
not available or accessible to low-income, racially/ethnically diverse populations in a 
safety-net community. Additionally, low-income racially/ethnically diverse patients have 
increased barriers to care, experience inequities in care provided, and experience longer 
wait times for post ED follow-up appointments (James et al., 2010). Compared to non-
safety net ED utilization, higher utilization of the ED for mental health care by the 
underserved brings attention to the problem of mental health access disparity among low-
income racially/ethnically diverse populations (Cook et al., 2017; Richardson et al., 
2003) compared to middle- and high-income individuals who do not return or access 




What effect does IGMV have on the number of nonemergent visits to the ED in 1 
year in low-income adult patients with anxiety disorders versus low-income adult patients 
with anxiety disorders receiving usual care?  
Nature of the Study and Design 
I conducted a quantitative retrospective, comparative analysis of retrospective 
data purposively sampled from 2017-2018 to compare care for adult low-income patients 
with anxiety disorders who received IGMV and adult low-income patients with anxiety 
disorders who received usual care. I used single stage sampling because the qualifying 
data were sent to me from the specified time frame between 2017 and 2018. Patients 
spend on average 6 to 9 months in a group cohort (Balasubramanian et al., 2017), and 
patients also completed annual surveys; therefore, pre and post years were selected for 
review. 
Sources of Data 
I received patient sociodemographics (Appendix B), patients’ psychiatric disorder 
diagnoses, IGMV attendance over the year, and number of nonemergent visits to the ED 
for anxiety disorders from 2017-2018 for both the IGMV participants and the control 
group (usual care). The sources of the data were deidentified safety-net hospital records 
and associated outpatient records on number of nonemergent visits by those with anxiety 
diagnosis from the IGMV group and usual care group. Health center staff filtered by 
inclusion criteria and downloaded the data into Excel spreadsheets, which were then sent 





The problem was use of BZD for anxiety versus access to nonpharmacological 
interventions that could potentially reduce the use of BZD in low-income populations in a 
safety-net community. In a U.S. national health statistics report of over 88,000 adults, 
patients reported more interest in CIH practices to manage their health, with yoga being 
the most prevalent CIH practice (Clarke et al., 2015).  
However, nonpharmacological interventions in primary care are rarely accessible 
outside of the IGMV context. Patients are referred out to interventions that they are 
unable to afford or resort to medications from their PCP that are cheaper alternatives 
rather than accessing complementary and alternative care in the community.  
Research Question 
What is the effect of IGMV on the BZD prescription dose in 1 year in low-income 
adult patients with anxiety disorders compared to low-income adult patients with anxiety 
disorders receiving usual care? 
Nature of the Study and Design 
I conducted a quantitative retrospective, comparative analysis of retrospective 
data purposively sampled from 2017-2018 to compare care for adult low-income patients 
with anxiety disorders who received IGMV and adult low-income patients with anxiety 
disorders who received usual care. I used single stage sampling because the qualifying 
data were sent to me from the specified time frame between 2017 and 2018. Patients 
spend on average 6 to 9 months in a group cohort (Balasubramanian et al., 2017), and 
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patients also complete annual surveys; therefore, pre and post years were selected for 
review. 
Sources of Data 
I received sociodemographic data (Appendix B), patients’ psychiatric disorder 
diagnoses, IGMV attendance over 1 year, and BZD prescription dose just prior to and 
post IGMV for the same time frames for both the IGMV participants and the control 
group (usual care). The sources of the data were deidentified safety-net hospital records 
and associated outpatient records, as well as pharmacy records on BZD dose by both the 
ED and PCP. Health center staff filtered the data by inclusion criteria and downloaded 
the data into Excel spreadsheets, which were sent to me. 
Manuscript 3 
Specific Problem 
The problem is chronic uncontrolled anxiety in low-income adults who live in a 
safety-net community. Like depression, anxiety is a chronic disease. Anxiety disorders 
have the highest global burden of disease, currently at about 7% both nationally and 
globally with a 3-month prevalence of up to 10% and one third of Americans 
experiencing an anxiety disorder in their lifetime (Alonso et al., 2018; Chisholm et al., 
2016; NIH, 2017). Patients have on average 10 visits before they receive an anxiety 
diagnosis (Alonso et al., 2018), resulting in delays in appropriate mental health treatment. 
Symptom severity refers to the presence and degree of anxiety symptoms as measured by 
Questions 2, 7, 8, and 9 on Adult Part 1 of the standard tool used at the practice site 




What is the effect of IGMV on anxiety disorder symptom severity reduction in 1 
year compared to usual care groups in low-income adult patients with anxiety disorders? 
Nature of the Study and Design 
I conducted a quantitative retrospective, comparative analysis of retrospective 
data purposively sampled from 2017-2018 to compare care for adult low-income patients 
with anxiety disorders who received IGMV and adult low-income patients with anxiety 
disorders who received usual care. I used single stage sampling because the qualifying 
data were sent to me from the specified time frame between 2017 and 2018. Patients 
spend on average 6 to 9 months in a group cohort (Balasubramanian et al., 2017), and 
patients also complete annual surveys; therefore, pre and post years were selected for 
review. 
Sources of Data 
I gathered patient sociodemographics (Appendix B), patients’ psychiatric disorder 
diagnoses, IGMV attendance, and pre and post assessment of symptoms that were 
collected on each separate participant for the same time frames for both the IGMV 
participants and the control group (usual care). The sources of the data were deidentified 
safety-net hospital records and associated outpatient records of patients’ survey results. 
Health center staff downloaded the survey data and sent them to me. 
Significance 
High-income countries such as the United States spend on average $50 per person 
per year on mental health prevention and treatment (Chisholm et al., 2016). However, the 
35 
 
global and national burden of disease for depression and anxiety are higher than for any 
other mental or neurological disorder, with females having a disproportionate prevalence 
of either depression or anxiety and the highest disability-adjusted life years (DALYs) rate 
(Whiteford et al., 2015).  
Chisholm et al. (2016) purported that the limited focus on public mental health 
demonstrates a substantial gap between the need for prevention and treatment and the 
actual investment made. With 2015 baseline data, they extrapolated out to the year 2030 
to see if the return on investment (ROI) would be worth investing more on those with 
both depression and anxiety (Chisholm et al., 2016). They found that the ROI for those 
with depression and/or anxiety would not only benefit with improved mental health 
status, but the improvements would translate into individual and population-level 
outcomes: increases in health life-years of work for the economy and large economic 
productivity (Chisholm et al., 2016).  
The potential economic output and lives saved need to be taken into 
consideration. A recent RCT in Sweden also reported on the quality-adjusted life years 
and found that the mindfulness group was more cost effective on all measurements of 
their study, including but not limited to medication costs and costs of the visits (Saha et 
al., 2020). Chisholm et al.’s (2016) global systematic review reported an 80% gap in 
anxiety treatment and prevention in high-income countries. Chisholm et al. and Saha et 
al. (2020) both reported on the societal perspective of costs saved from sick leave and 
income gained from increased productivity. Chisholm et al. reported use of conservative 
projection models from 2016-2030 at only 5% increase in work productivity and 
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estimated that an average cost of $2 per person investment on anxiety prevention and 
treatment annually would result in a return on health value benefit at $50 billion.  
The majority of adult GMV research has focused on diabetes (Vaughan et al., 
2019). The majority of IGMV adult mental health research has focused on chronic pain 
and depression (Parikh et al., 2019), but the effect of these interventions on those with the 
comorbid diagnosis of anxiety has not been analyzed. However, more than half of 
persons with depression have the comorbidity of anxiety affecting approximately 40 
million people in the United States (Anxiety and Depression Association of America 
[ADAA], 2020). 
Research on racially/ethnically diverse populations participating in mindfulness 
meditation and IGMV is nascent. Given the rapid increase of racial/ethnic groups and 
their ever-growing mental health concerns, more research is needed in racially/ethnically 
diverse populations in the United States (Bucay-Harari et al., 2020; Guo et al., 2015). 
Additionally, while there is a plethora of literature on mindfulness practices for mental 
health for White persons, more research was needed on the use of mindfulness practices 
in low-income racially/ethnically diverse persons (Burnett-Zeigler et al., 2016; Ryan et 
al., 2018) with anxiety. The diversity of those who are categorized as Latinos or Asians 
has also grown, and hence more inclusion in research is needed (Bucay-Harari et al., 
2020). The Hispanic Community Health Study/Study of Latinos is one example of a 
multicity trial that captured the diversity of anxiety-depression symptomatology within 
Latinos (Camacho et al., 2015). 
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Given the cost of high utilization and specialty mental health care, research was 
needed to identify which treatment interventions were effective in both improving health 
outcomes and containing costs, especially in those who are uninsured and underinsured. 
Currently, ineffective treatments are costing individuals their mental stability and society 
millions of dollars annually in lost economic output (Chisholm et al., 2016). The addition 
of mindfulness meditation practices as an adjunct or replacement in some cases to usual 
care (a control) needed to be investigated in larger sample sizes of low-income 
racially/ethnically diverse adult patients (Burnett-Zeigler et al., 2016).  
Addressing and supporting people with anxiety disorders through an 
interdisciplinary approach in the community and integrating nonpharmacological 
methods fosters greater trust between racially/diverse populations and their practitioners 
and effects positive social change. Because there is already existing information on 
patients in different health systems, I reviewed retrospectively how a subset of patients 
may have benefited from such interventions over time, which not only contributed to 
addressing the gap in the literature, but also offered recommendations based on the 
findings for coordinated and cost-effective community care of those with anxiety 
disorders. I chose the research site where I collected my data because there were data on 
IGMV and sufficient patients with an anxiety disorder. Furthermore, this healthcare 
facility utilized IBH within a PCMH model and nurse practitioners and psychologists 
were coleads for the IGMV. Additionally, the site reported a racially/ethnically diverse 





The purposes of this retrospective quantitative comparative analysis were to 
determine whether patients with diagnoses of anxiety who had participated in an IGMV, 
in the context of the PCMH, had reduced ED utilization for nonemergent care, reduced 
doses of BZD, and reduced severity of symptoms after participation in IGMV compared 
to those in the same safety-net PCMH who did not participate in IGMV and were 
managed by their PCP with access to standard IBH (usual care). 
The interconnection between the three related questions contributed to the 
discovery of how IBH in primary care with an infusion of the ancient practice of 
mindfulness meditation may or may not affect adult patients with anxiety diagnoses in 
different aspects of how and where they receive their care. This study falls under the 
QAF aims of addressing population (behavioral) health outcomes and reducing costs. 
Utilizing the right side aims (reduction of costs and improved health outcomes) of the 
QAF allowed viewing how these constructs and questions were interrelated. While some 
GMVs and IGMVs are being added to health systems, other health systems are slow to 
adopt this innovation or have discontinued this innovation from their practices for lack of 
quantitative evidence. The findings from this study could partially contribute to the 
quantitative research needed for evidence-based decision making on the continuation or 
discontinuation of IGMV at the current clinical site for the study because they only had 
one qualitative study of these groups. 
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The purpose of this retrospective comparative analysis was to determine what effect 
integrative group medical visits (IGMVs) had on the number of nonemergent visits to the 
emergency department (ED) in 1 year in low-income adult patients with anxiety disorders 
compared to low-income adult patients with anxiety disorders receiving usual care. A 
purposive sample of 85 low-income adult patients’ (43 IGMV, 42 usual care) 
nonemergent ED visits were analyzed, which showed a significant difference within 
subjects (p = 0.02), but no significant difference between groups’ ED utilization (p = 
0.82). These results showed that utilization of the ED continues to occur because it is 
difficult for patients to distinguish somatic feelings of anxiety from an organic crisis, 
which results in overutilization of emergency services. A multisite investigation of IGMV 
utilization in primary care compared to psychotherapy groups in diverse populations may 




Equitable access to appropriate, evidence-based, affordable, and integrated 
behavioral health care in primary care for low-income patients is lacking (Farber et al., 
2017). Researchers and the U.S. government have recommended the integration of 
behavioral health in primary care, but integration has been limited (Linman et al., 2019). 
Group treatment models have been successful in behavioral health settings, but access to 
behavioral care is often delayed (Dark et al., 2017).  
The purpose of this retrospective, quantitative comparative analysis study was to 
investigate whether an integrative medicine model of care increased behavioral health 
access and improved health outcomes for low-income patients with anxiety within the 
context of their primary care medical home (PCMH). The research question was the 
following: What effect does IGMV have on the number of nonemergent visits to the ED 
in 1 year in low-income adult patients with anxiety disorders versus low-income adult 
patients with anxiety disorders receiving usual care?. Using secondary data from 2017-
2018 from a U.S. health system with an established IBH and IGMV program, I 
hypothesized that the ED visits would be different in the IGMV group compared to a 
group of low-income adults who received usual care without IGMV. 
One in every five Americans has been diagnosed with a mood disorder (NIH, 
2017). Mood disorders rank as the second highest reason for ED utilization among safety-
net institutions versus sixth in non-safety-net institutions (Sutton et al., 2016). In the 
United States, safety-net institutions are organizations that provide patient care to those 
who are uninsured (Altman & Lewin, 2000). Anxiety disorders, often comorbid with 
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mood disorders, have the highest global burden of disease, currently at about 7% both 
nationally and globally with a 3-month prevalence of up to 10% and one third of 
Americans experiencing an anxiety disorder in their lifetime (Alonso et al., 2018; 
Chisholm et al., 2016; NIH, 2017).  
While safety-net institutions may serve patients at all income levels, the majority 
of low-income patients receive care within safety-net institutions (Sutton et al., 2016). 
Unlike patients with psychiatric disorders who are hospitalized, those with anxiety 
disorders who are not hospitalized are discharged back to the community (Simpson et al., 
2014). For many patients, the ED has become the provider for unmet mental health care 
needs (Stone et al., 2012). The ED as a mental health provider illuminates the first entry 
to a larger, systemic problem (Stone et al., 2012) of healthcare segregation, making 
available healthcare separate and not equal.  
Low-income racially/ethnically diverse patients have increased barriers to care, 
experience inequities in care provided, and experience longer wait times for post ED 
follow-up appointments (James et al., 2010; Saluja et al., 2019). Compared to non-safety-
net ED utilization, higher utilization of the ED for mental health care by the underserved 
brings attention to the problem of mental health access disparity among low-income 
racially/ethnically diverse populations (Cook et al., 2017; Richardson et al., 2003) 
compared to middle- and high-income individuals who do not return or access care for 
their mental health needs from an ED. Iturralde et al. (2019) found that patients with 
anxiety were independently associated with more ED utilization and reported them to be 
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disproportionately found among the highest cost patients in a large, diverse sample of 
health system users. 
In a multisite study, researchers reported patients with depression to have 
improved health outcomes in integrated settings where behavioral health care providers 
collaborated with the primary care provider (PCP) in the same location (Balasubramanian 
et al., 2017). Serrano et al. (2018) also reported that some IBH colocated with PCPs in a 
PCMH demonstrated a trend toward lower ED utilization, but that the differences 
between sites were difficult to determine. They noted that the sites were federally 
qualified health centers (FQHCs) serving low-income patients, and other factors may be 
responsible for the differences (Serrano et al., 2018). The problem of overutilization of 
ED for nonemergent care for those with anxiety diagnoses is a proxy for the search for 
behavioral health care for those with anxiety that is not available or accessible to low-
income, diverse populations in a safety-net community.  
Significance/Importance 
High-income countries like the United States spend, on average, $50 per person 
per year on behavioral health prevention and treatment (Chisholm et al., 2016). However, 
the global and national burden of disease for depression and anxiety are higher than any 
other mental or neurological disorder, with females having a disproportionate prevalence 
of either depression or anxiety and the highest disability-adjusted life years (DALYs) rate 
(Whiteford et al., 2015).  
Chisholm et al. (2016) purported that the limited focus on public mental health 
demonstrates a substantial gap between the need for prevention and treatment and the 
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actual investment made. With 2015 baseline data, they extrapolated out to the year 2030 
to see if the return on investment (ROI) would be worth investing more on those with 
both depression and anxiety (Chisholm et al., 2016). They found that the ROI for those 
with depression and/or anxiety would not only benefit with improved mental health 
status, but the improvements would translate into individual and population-level 
outcomes: increases in health life-years of work for the economy and large economic 
productivity (Chisholm et al., 2016).  
The potential economic output and lives saved need to be taken into 
consideration. A recent RCT in Sweden also reported on the quality-adjusted life years 
and found that the mindfulness group was more cost effective on all measurements of 
their study, including but not limited to medication costs and costs of the visits (Saha et 
al., 2020). Chisholm et al.’s (2016) global systematic review reported an 80% gap in 
anxiety treatment and prevention in high-income countries. Chisholm et al. and Saha et 
al. (2020) both reported on the societal perspective of costs saved from sick leave and 
income gained from increased productivity. Chisholm et al. (2016) reported use of 
conservative projection models from 2016-2030 at only 5% increase in work productivity 
and estimated that an average cost of $2 per person investment in anxiety prevention and 
treatment annually would result in a return on health value benefit at $50 billion.  
Given the cost of high utilization and specialty mental health care, research was 
needed to identify which treatment interventions were effective in both improving health 
outcomes and containing costs, especially for those who are uninsured and underinsured. 
Currently, ineffective treatments are costing individuals their mental stability and society 
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millions of dollars annually in lost output (Chisholm et al., 2016). Burnett-Zeigler et al. 
(2016) reported that the addition of mindfulness meditation practices as an adjunct or 
replacement in some cases to usual care (a control) needed to be investigated in powered 
sample sizes of low-income, diverse patients.   
Anxiety disorders are a growing population health concern, the prevalence of 
which has surpassed that of depression disorders, with women having twice the rate of 
men (NIH, 2017). Of note, according to the DSM-5, PTSD has been removed from 
anxiety disorders classification and is now classified under trauma-related disorders; 
however, the corresponding International Classification of Diseases (ICD) codes have not 
been reclassified (APA, 2013). In the DSM-5, anxiety disorders include primarily 
childhood separation anxiety disorder, selective mutism, and specific phobias, whereas in 
adulthood, there are higher percentages of panic disorder, agoraphobia, social anxiety 
disorder (SAD), general anxiety disorder (GAD, which makes up more than half of 
anxiety cases), substance/medication-induced anxiety disorder, and anxiety disorder due 
to a medical concern (APA, 2013; Alonso et al., 2018; Bandelow et al., 2017).  
In practice, PCPs commonly use GAD-7 and additional questions to diagnose 
anxiety. If the diagnosis is unclear, the diagnosis “unspecified anxiety disorder” is often 
utilized. In research, common instruments for measuring anxiety in participants include 
the Hamilton Anxiety Scale and GAD-7 (Sampaio et al., 2016; Spitzer et al., 2006; 
Webster et al., 2017). This study focused on low-income adults already diagnosed with 
any of the aforementioned adult anxiety disorders.  
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Anxiety is both psychic and somatic and often presents in somatic forms such as 
palpitations, shortness of breath, headaches, chest pain, digestive complaints, and 
sweating (Gates et al., 2016). Investigating the somatic complaints and ruling out organic 
illnesses often delay recognition and hence appropriate behavioral health care for patients 
with anxiety disorders. Patients’ awareness of their own somatic symptoms, such as 
shortness of breath or pain, results in self-referral for their symptoms and often results in 
overutilization of emergency services (Dark et al., 2017).  
Anxiety is a stress-induced psychosomatic disorder that has limited responses to 
pharmaceuticals like benzodiazepines and other anxiolytics (Ray et al., 2017). Multiple 
researchers have demonstrated that anxiety disorders respond well to nonpharmacological 
interventions including but not limited to yoga and meditation, cognitive behavioral 
therapy, and mindfulness-based stress reduction (MBSR; Adams et al., 2015; Daitch, 
2018; Kabat-Zinn et al., 1985; Ramos et al., 2017; Smith et al., 2015). Addressing and 
supporting people with anxiety disorders through an interdisciplinary approach in the 
community and using nonpharmacological methods fosters greater trust between diverse 
populations and their practitioners.  
Aside from limited access to cognitive behavioral therapy in behavioral health 
settings, yoga, mindfulness meditation, and MBSR are not yet considered reimbursable 
treatment approaches (Clarke et al., 2015; Johnson et al., 2019). Apart from select 
locations, these alternative modalities have not been integrated into the mainstream 
healthcare system, despite the evidence-based results of positive outcomes with the 
aforementioned modalities (Johnson et al., 2019).  
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Group Medical Visits 
The Agency for Health Research Quality (AHRQ) has recommended GMV to 
address patient access to care, increase patient and practitioner satisfaction in care 
delivered, and decrease high-cost health care utilization, including ED and specialty visits 
(AHRQ, 2018; Shaw et al., 2014). GMVs are shared medical appointments (SMAs) with 
a group of patients being seen simultaneously, lasting from 1-2 hours with a range in 
attendance from five to 16 patients with some common diagnoses and/or common interest 
in receiving an intervention (AHRQ, 2018).  
Ornish et al. (1990) and Noffsinger (2012) laid the groundwork for building 
practice models that assist the individual provider in managing monthly chronic care 
group visits that group patients by diagnosis or utilization behavior (Noffsinger, 2012). 
There are various GMV types, which include drop-in groups, disease-based group visits, 
and intervention-based groups (AHRQ, 2018), all of which are done either in person or 
virtually. GMVs combine biomedical care and consultation with health education and 
peer support. For example, a group of patients may be coming to the group because they 
all have chronic pain and simultaneously would like to receive acupuncture for their 
chronic pain condition. Other chronic pain groups may focus on acceptance of pain or 
mindfulness techniques to cope with pain and participate in activities to uncover their 
source of pain (i.e., contributors of pain via nutrition, work or home life activities) and 
share experiences and community resources (Gardiner et al., 2014).  
Significant positive health outcomes that have been documented in systematic 
reviews include increased patient satisfaction, increased patient knowledge, increased 
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healthy eating habits, transdiagnostic reduced symptom severity, and reduced weight 
(Parikh et al., 2019). There is evidence that GMV participants (diabetes patients and 
elders) had lower ED utilization and hospitalizations while active in groups (Edelman et 
al., 2012; Shaw et al., 2014). 
Group medical visits (GMV) that include nonpharmacological practices like 
mindfulness meditation are called integrative group medical visits (IGMV). In this 
context, mindfulness meditation is a nonpharmacological intervention that may take place 
in a PCMH that practices IBH. IGMVs have been implemented in response to interest in 
complementary and integrative health, which remains inaccessible to many people due to 
limited insurance coverage and high out-of-pocket cost. IMGVs may contribute to 
improving patient experience, improving population health, reducing costs, and 
increasing practitioner satisfaction (Cornelio-Flores et al., 2018; Dresner et al., 2016; 
Gardiner et al., 2017, Gardiner et al., 2019; Gareau et al., 2016; Geller et al., 2015; Mehl-
Madrona et al., 2016; Rowley et al., 2016; Shaw et al., 2014; Strickland et al., 2016).  
Devoid of side effects, mindfulness meditation has been found to have a variety of 
health benefits, including but not limited to reduction of somatic symptoms that may 
accompany anxiety, as well as a perceived reduction in emotions often found within the 
definition of anxiety such as distress, worry, nervousness, sleeplessness, and irritability 
(Bottaccioli et al., 2014). In a systematic review of psychoneuroimmunology (PNI)-based 
interventions, Moraes et al. (2018) found evidence of decreased levels of cortisol, 
epinephrine and norepinephrine, and pro-inflammatory cytokines [e.g., interleukin (IL)-
1α and β, tumor necrosis factor (TNF-α), and IL-6] in mindfulness interventions. In 
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Spain, a nurse-led mindfulness program reduced anxiolytic use by 54% in 3 months 
(Izaguirre-Riesgo et al., 2020).  
Another study from Spain was the first to examine a mindfulness-based 
intervention specifically focused on patients with GAD diagnosis from three different 
primary care practices. While the PCP referred eligible patients, they were not included 
in the intervention. The intervention did result in statistically significant reductions in 
anxiety symptoms, improvements in emotional regulation and awareness in both in-
person and virtual assistant aspects of the study (Navarro-Haro et al., 2019).  
Conceptual Framework 
The theoretical basis for understanding the phenomena occurring with low-
income racially/ethnically diverse patients in the context of the current U.S. health system 
was a combination of the Quadruple Aim Framework (QAF) with intersectionality theory 
and the theory of mental accounting. This combination in thought has not been utilized in 
previous research. The new framework is called integrative health equity in primary care 
framework. 
The QAF is an expansion of the Triple Aim developed by leaders at the Institute 
of Healthcare Improvement. The Quadruple Aim includes an improved patient 
experience, improved health outcomes or population health, reduced costs (Berwick et 
al., 2008), and then adds higher practitioner satisfaction or care team wellbeing. The final 
aim was first described by Spinelli (2013) as the ‘phantom limb’ and later formalized as 
an important consideration in reducing burnout of practitioners (Bodenheimer & Sinsky, 
2013). While all four aims of IGMVs have been researched, the aims of focus in this 
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study may be categorized under the right side of Figure 1, improved health outcomes and 
reducing costs, but should still be seen in the context of the four leaves of the QAF, as 
patient experience and care team well-being also affect the other aims indirectly or 
directly. In addition, the use of complimentary and integrative health modalities in the 
context of this framework influences the whole in delivering whole person integrated 
care.  
Figure 1 
Quadruple Aim Framework 
 
Note. Quadruple Aim (n.d.). 
Crenshaw coined the concept of intersectionality to view the intersection of race 
and gender as it relates to the marginalization of black women (Crenshaw, 1989). The 
intersectionality theory has been adopted in the health professions to explain the complex 
way in which the social determinants of health like economic stability, education level, 
environment, access to food and health care, and social networks or lack thereof, interact 
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with different aspects of a person’s identity to shape the discriminatory experiences that 
some marginalized groups may face within health systems (Gkiouleka et al., 2018). 
Intersectionality theory provides a lens in which to look at the QAF keeping in mind that 
safety-net hospital patients have different outcomes and for this study, specifically those 
who are low-income and have an anxiety diagnosis.  
Another area which enlightened this conceptual framework, is that of behavioral 
economics. Elbel et al. (2014) concluded that low-income patients are particularly 
understudied when it comes to their health care choices and that vulnerable populations 
would benefit from assistance in making better health care choices. They draw on 
Thaler’s (2016) notion of nudges to suggest that nudges are key in assisting patients make 
better choices.  
Thaler (2016) re-inserted human psychology and behavior into the field of 
economics; reemphasizing the work of 18th century economist Smith to bring back the 
notion of the human drivers to economic choices (Barberis, 2018). The reasons more 
low-income patients than middle to higher income patients go to the ED for nonemergent 
reasons that include mental health care may include factors such as transportation issues, 
custom of going to hospitals versus outpatient in their countries of origin, proximity of 
ED versus outpatient primary care office, and/or lack of a PCP or insurance. Thaler’s 
theory of mental accounting helps to explain why people make some of the choices they 
make, some of which may be rational, but more often are not rational, are reactive and 
based on emotion, pain, anxiety level and what is important at the present moment not 
53 
 
long term. He recommended that health care practitioners provide choice architecture to 
patients so that they may make more informed and better choices for their health.  
Utilizing the theories of intersectionality and mental accounting to frame the 
research question provided insight into the interaction of these concepts together as they 
relate to the two aims of health outcomes and cost reduction. These are concepts and 
theories steeped in the context of the capitalist system, which, by definition, do not 
support the underserved, low-income racially/ethnically diverse patients. However, the 
accessibility of the expensive and expansive hospital systems and their EDs allow anyone 
to choose this location for their care (Stone et al., 2012), regardless of its utility to meet 
the needs presented.  
Combining these lenses together opens a new way of viewing the current 
healthcare system and addressing the inequities in care within this contextual framework. 
Choice architecture combined with integrative and appropriate care has to be 
communicated with appropriate nudges and in culturally and diverse spaces where 
patients may feel safety, trust and access to the care that is needed to address health 
equitably.  Integration of the IGMV as a space that promotes choices and appropriate 
nudges frames the utility of IGMV for increasing mental health access and health equity 
for low-income racially/ethnically diverse patients may result in what is displayed below 




Integrative Health Equity in Primary Care Framework 
 
Original Contribution 
The original contribution of this study was viewing IGMV as an intersectional 
institutional intervention for the promotion of IBH in PC for low-income diverse persons. 
The potential diffusion of IGMV by safety-net institutions could influence access to 
integrative mental health care. Whether in-person or via telehealth groups, IGMV have 
been integrated into primary care. The potential positive social change impact would be 
greater access to integrative mental health care for the underserved, improved mental 
health outcomes and reduction of nonemergent use of the hospital.   
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The results of this study contributed to the body of knowledge on integrative 
mental health care and the underserved because results provide more information on the 
effectiveness of IGMVs in this population. Secondly, IGMV could be integrated further 
into multidisciplinary team education at both the preservice and inservice levels of 
education. Lastly, the new framework provided a lens in which to view health equity 
from a system, community and personal perspective nestled within the current health 
system quadruple aims framework.  
Relevant Scholarship 
In a qualitative review of earlier GMV research (1974-2004), Jaber et al. (2006), 
along with other findings, reported a decrease in high-cost utilization including specialty 
care, urgent care and ED utilization illuminating improved management by both the team 
and the patient. These were statistically significant primarily on elders, those with 
headaches and diabetes, but not specifically low-income patients. In the past 10 years 
there has been a surge of research in GMV, including IGMV research on the diverse low-
income populations. Gardiner et al. (2019) have focused on chronic pain and depression, 
which has highlighted outcomes, related to utilization, patient satisfaction, and health 
outcomes in low-income diverse patients in the primary care/PCMH context.  
ED utilization has been the primary reported cost measure because it is the most 
expensive (Ernst et al., 2015) as it is a patient driven versus provider driven cost. ED 
utilization in patients with chronic pain and depression utilizing IMGV (MBSR-based 
IGMV) did reduce and was statistically significant at 9 weeks compared to the control but 
not at 21 weeks (Gardiner et al., 2019). While Gardiner et al. (2019) mentioned the cost 
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savings via decreased opioid use and reduced ED utilization; the costs were not 
quantified. Gardiner et al. (2019) and Mehl-Madrona et al. (2016) specifically 
recommended more emphasis on cost reduction research.  
While there have been a variety of programmatic types of IGMV in practice 
(Thompson-Lastad, 2019), the majority of published IGMV research has been on 
depression and chronic pain, inclusive of emphasis on opioid use. Reducing opioid 
consumption, considering the opioid crisis, has been shown to be associated with IGMV 
in a recent RCT (Gardiner et al., 2019). While anxiety disorders have been listed as 
comorbidities (Chao et al., 2019; Gardiner et al., 2019) there has not been a focus on 
people with anxiety disorders.  
Research Question and Design 
What effect does IGMV have on number of nonemergent visits to the ED in 1 
year in low-income adult patients with anxiety disorders versus low-income adult patients 
with anxiety disorders receiving usual care?  
Secondary clinical data on Medicaid patients from 2017-2018 was available from 
a U.S. safety-net health system database. I conducted a quantitative retrospective, 
repeated-measures comparative analysis of ED visits from the year prior and then from 
the year post IGMV to compare ED utilization for these low-income adult patients with 
anxiety disorders who received IGMV and low-income adult patients with anxiety 





The IGMV participants of this retrospective study were 43 low-income adults 
ages 18-64 with an anxiety diagnosis that had participated in IGMV in a PCMH with 
IBH. The control group (usual care) were 42 low-income adults ages 18-64 with an 
anxiety diagnosis from the same PCMH that had not participated in IGMV but who were 
seeing their PCP for management of their anxiety and had access to colocated IBH.  
Sample and Power 
For this study, 85 subjects were de-identified from historical records from two 
groups, IGMV and usual care with 43 and 42 subjects, respectively in each group. The 
power of the tests was higher since the correlation coefficient between repeated measures 
was higher than 0.3. I used G*power computer software (Version 3.0) to calculate the 
sample size for the ANOVA repeated measures procedures to determine the required 
sample size (Faul et al., 2009).     
For a repeated measures model, statistical power was addressed separately for 
main (within and between subjects) effects and interaction (within-subject-by-between-
subject) effects. In the repeated measures design with 2 groups, each subject was 
measured at 2 time points, a level of significance of 0.05, a medium effect size of 0.25, 
and a correlation coefficient of at least 0.3 between repeated measures, and a statistical 
power of 0.80 required 46 subjects for within-factor (time) effects, 84 subjects for 
between-factor (group) effects, and 46 subjects for within-between factor interaction.   
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Variables/Sources of Data 
The independent variable was the type of mental health service patients with an 
anxiety diagnosis received (usual versus IGMV) at the outpatient safety-net health care 
facility. The dependent variable was ED utilization prior and after participation in the 
IGMV.  ED utilization was defined as nonemergent visits to the ED, which did not 
require hospitalization. The sources of the data were de-identified safety-net hospital 
records from the electronic medical record which was the same for both the hospital and 
the outpatient setting. IGMV participants were selected if they had an anxiety diagnosis 
and attendance of at least four IGMV sessions during the year. Usual care patients were 
filtered by anxiety diagnosis from the chronic pain registry from the same time period. 
Then the number of ED visits with anxiety related diagnoses was calculated, excluding 
any that resulted in hospitalization. Health center staff filtered the data by inclusion 
criteria, de-identified the data by removing unique identifiers and downloaded into excel 
spreadsheets, which were sent to me.  
Instrumentation or Measures 
The type of data that I received was patient demographics which included 
patients’ psychiatric disorder diagnoses, IGMV attendance, and the number of 
nonemergent visits to ED for anxiety disorders just prior to starting group and the end of 
the year.  
Design and Analysis 
The design was a quantitative retrospective, repeated-measures comparative 
analysis research design using data from the years 2017-2018. I used single stage 
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sampling from two points in time, first at the end of 2017 for 2017 cumulative 
nonemergent ED visits and then from the end of 2018 for the 2018 cumulative 
nonemergent ED visits. I compared the nonemergent ED visits for low-income adult 
patients with anxiety disorders who received IGMV versus usual care the year prior and 
post intervention for both the IGMV group and usual care for the same time frame. Usual 
care was defined as patients that were having their anxiety managed one on one by their 
PCP but also had access to psychotherapy groups. Patients spend on average six to nine 
months in a group cohort (Balasubramanian et al., 2017) and patients also complete 
annual surveys therefore pre and post years was selected for review. 
The comparison group was the group of patients with an anxiety disorder that 
attended five or more IGMV sessions. The rationale for this design was that the 
effectiveness of IGMVs in the context of an RCT, Gardiner et al. (2019) found 
statistically significant differences in health outcomes with those attending five or more 
IGMV sessions versus four or less. The control group were those patients with anxiety 
disorders receiving usual care.  
In order to protect human subjects, the institution sent de-identified data for 
analyses and was aware that the clinical site information would remain anonymous. The 
site contact person who sent the data was not involved in the intervention or usual care of 
the patients for this study. The inclusion criteria for the data were: all patients included in 
the study had a diagnosis of anxiety disorder, low-income status, and received care from 
the same institution. Exclusion criteria were patients with active psychosis, 
schizophrenia, and bipolar diagnoses or cancer diagnoses.  
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The principal contact person was a doctorally-prepared psychologist and 
researcher. The site’s team had not analyzed their IGMVs with the proposed research 
questions. However, they were interested in uncovering this type of data to plan for future 
IBH in primary care based on evidence. The psychologist voluntarily participated to run 
reports that filtered the information needed from historical patient records of those with 
anxiety who obtained usual care and those that were participating in the PCP led IGMVs 
during the 2017-2018 calendar years. 
Differences in the outcomes associated with the two groups were evaluated using 
repeated measures ANOVA. Both groups had similar socioeconomic status as they were 
all Medicaid recipients and therefore low-income. Individual patient incomes were not 
available.  
Data analysis began with preparatory activities such as the treatment of missing 
data, identification of outliers and other such data cleaning tasks. A detailed descriptive 
analysis of all quantitative data was performed. Overall, statistical assumptions were not 
violated and will be discussed in the results section below.  
The first phase of the analysis consisted of using descriptive statistics in 
computing the summary measures (mean, median, standard deviation, and range) for the 
variables measured on interval or ratio scales and frequency distributions (absolute 
frequency and percent) for the variables measured on nominal or ordinal scales.  
Significance level was set at a p-value equal to or less than 0.05. All statistical analyses 
were carried out using SPSS (Version 27). Repeated-measures ANOVA was used to 
determine a decrease in ED utilization within subjects, between groups, and within- 
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subjects-by-between-group interactions (i.e., the pattern of change in ED utilization 
between the two groups over time).   
Results 
Execution 
This quantitative, retrospective study was conducted with the proposed health 
center that has IBH in primary care and is situated in the western region of the U.S. The 
study was approved by the partner site’s IRB for data collection on April 1, 2021. 
Walden University IRB subsequently approved the study on May 3, 2021 (IRB approval 
number 05-03-21-0664376). The sample used for the study was 85 established patients 
with anxiety diagnoses that had colocated behavioral health care at their PCMH. The 
comparison group (IGMV group) was the alternative group care model that infused 
mindfulness meditation into the curriculum. The control group (usual care) was the 
standard model of IBH in primary care.  
The IGMV group was meant to be a mindfulness movement group in which the 
entire group was focused on the mind-body connection. However, there were not enough 
persons with an anxiety diagnosis established in these groups to support the proposed 
quantitative retrospective design plan. Hence, the data were collected from a pain and 
wellness group where mindfulness meditation was integrated at the beginning for 10 
minutes and at the end for 10 minutes. The retrospective data were collected in May 
2021. The premeasurement was cumulative ED visits for 2017. The postmeasurement 
was cumulative visits for 2018. The IGMV group were individuals who had existing 
anxiety disorder diagnoses and had attended four or more IGMV within the last year. The 
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sample included 85 cases (n=43 comparison and n=42 controls). The comparison group’s 
(IGMV) ED utilization was downloaded for one year prior and one year after IGMV. The 
comparison group was selected as 43 consecutive cases of individuals attending an 
IGMV who met inclusion criteria.  
The control group (usual care) was a sample of 42 individuals who were chosen 
as consecutive cases from the chronic pain registry who met the inclusion criteria, but did 
not attend any IGMV sessions. Usual care was defined as patients that were having their 
anxiety managed by their PCP, as participation in psychotherapy groups was controlled 
for by identifying that both intervention and control had access to usual individual or 
group psychotherapy and treatments.  
The IGMV sessions were not designated for patients with anxiety diagnoses only. 
The patients selected for the retrospective analysis were patients with an anxiety 
diagnosis who had attended the wellness groups in which all patients had a chronic pain 
diagnosis. Hence, both groups had a chronic pain diagnosis.  
All patients had access to IBH services which consisted of onsite therapists or 
psychiatrists who collaborated with the care team. The number of visits the sample had 
with these embedded therapists was also tracked. There were also external appointments 
with therapists or psychiatrists who were a part of a community network of providers or 
mental health clinics and these appointments were also tracked for the entire sample of 
patients.  
Regarding ED utilization, there was no missing data. Regarding ages, the range 
was changed from 18-65 to the actual pool that was between 19-75. Due to the strict 
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protection of patient identity, the age of each patient and income status were not included. 
Once coded as IGMV or control, the patients’ unique numerical identifiers were removed 
and patients were listed 1-85 only.  
Ethical considerations were at the forefront of the execution of this study. All the 
data were collected and stored electronically and used only in the manner proposed in the 
IRB application and by the requirements of both Walden University and the Institutions’ 
IRB. The data collected was de-identified immediately and the unique identifiers were 
discarded. I received the de-identified data in an Excel Spreadsheet. I screened for 
missing data, and when I saw that there was no missing data, I imported the data into 
SPSS version 27. I screened and coded the variables to prepare them for analysis. Then I 
performed descriptive statistics, frequencies and repeated measures ANOVA and saved 
the outputs.   
I also checked to see if the assumptions for repeated measures ANOVA were met: 
independence of observations, data were interval level, normal distribution, and 
homogeneity (Frankfort-Nachmias & Leon-Guerrero, 2016). The first assumption 
assumes that neither group had influence over the other and each observation was 
independent of the other. This assumption was met as these were retrospective data that 
were selected after groups were already completed. The second assumption that data 
were interval was true for the dependent variable because the number of ED visits while a 
scale measurement may be described by interval or ratio. The third assumption was the 
sample would be drawn from a population of normal distribution was violated since this 
was a purposeful sample. This violation did not interfere with the data analysis since 
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there was adequate power, but limited the generalizability of the results to the larger 
population (Schmider et al., 2010). The measurement points on the probability plot were 
distributed along the diagonal line confirming that the data were normal.  
Figure 3 
Normal P-P Plot for Emergency Department Visits 
 
The fourth assumption of homogeneity or populations variances being equal was 
also met. Levene’s test was not significant for pre or post measurements (p = 0.07, p = 
0.19) which confirmed equal variances. 
Descriptive Statistics 
I conducted a baseline descriptive analysis on the limited sociodemographic 
information available including gender, race/ethnicity, and stress-related chronic 
comorbidities.  The majority of the patients were female (65 of 85, 76%) and Caucasian 
(43 of 85, 48%). The ages of the participants were not shared as a part of the de-
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identification process, but the range was between 19-75 years of age, with majority 
between 19-65 (personal communication, M. Changaris, June 17, 2021). The number of 
females attending IGMV were 28 and male 15 versus the number of females in the 
control/usual care were 37 and male were five. The mean number of IGMV attended was 
21 while the median was 20, mode 6, min 4 and maximum 50 sessions. Table 1 displays 
the IGMV frequency statistics.  
Table 1 
Integrative Group Medical Visit Group Statistics  








Minimum 4  
Maximum 50 
 
Table 2 displays the frequencies and percentages for the sociodemographic 
information. There were six ethnic groups within the Nonwhite category and too few in 
each individual ethnic group to analyze by ethnic group. The largest race/ethnic subgroup 
was 17 patients who identified as Black. This was the only subgroup that had all seven 
patients of the IGMV group to have fewer postmeasurement ED visits than all other 
race/ethnic groups. There was one patient in each of Native American, Pacific Islanders, 
Other, and Declined groups, six Latinos and two Asian Americans who were in the 
intervention group. Forty-one of the 43 IGMV participants had either a decline or no 




Frequencies and Percentages for Sociodemographic Data (N = 85) 
Characteristics      N-IGMV  N-Usual care % 
Race/ethnic background 
1) Latino/a  
2) American Indian 
3) Asian American 
4) Black or African American 
5) Native Hawaiian/P. Islander  
6) White (Caucasian) 
7) Middle Eastern (Caucasian) 

































     Female 










Comorbidities    
     PTSD               25               21 54 
     Chronic pain               43               42 100 
     Depression               22               16 38 
 
Table 3 describes the ED utilization mean for 2017 and 2018, standard deviation 
and sample size of both comparison and control at the pre and post measurement 
intervals. Premean number of nonemergent ED visits for IGMV group was M = 2.74, SD 
= 3.774 while the control group, usual care, had M = 1.99, SD = 2.593 nonemergent ED 
visits during the year. Postmean number of ED visits for those who attended four or more 
IGMV sessions decreased to M = 1.53, SD = 1.894 while the control group’s 




Integrative Group Medical Visit and Control Emergency Department Utilization at Time 
1 and Time 2 
 Type of 
behavioral 
health service 




IGMV 2.74 3.774 43 
 Control 1.9 2.593 42 




IGMV 1.53 1.894 43 
 Control 2.12 3.094 42 
 Total 1.82 2.560 85 
 
Table 4 displays the tests of within-subjects contrasts and tests of between-
subjects effects. The within-subjects test shows the amount of change that occurred at the 
individual level of all patients, which means that the individuals measured against 
themselves did demonstrate change over time in ED utilization and but was not 
significant (p = 0.10). The between-subjects effects test shows that the differences 
between the two groups ED utilization over time was not significant (p = 0.82).  
Table 4  
Repeated Measures Analysis of Variance Test for Emergency Department Visits 




10.518 1 10.518 2.744 .101 
ED*type 21.530 1 21.530 5.618 .020 
Between 
groups 
.692 1 .692 .052 .820 
*ED utilization by either type of behavioral health service. 
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Figure 4 represents the estimated marginal means between the two points in time.  
This is the mean response for each group between the two measurements. There was a 
significant interaction in ED visits between IGMV and the control group (F = 5.62, p = 
0.02). The significance is the pattern of change in ED visits from Time 1 to Time 2 that 
went down in the IGMV group and up in the usual care group. The individual IGMV 
patients had a decrease in their utilization of the ED for mental health care.  
Figure 4 
Estimated Marginal Means of Emergency Department Visits by Type of Behavioral 
Health Service 
 
The ED utilization measurements were collected at two points in time for both 
groups. An independent t-test was run and both skewness and kurtosis were checked. The 
independent t-test produced the same results as the repeated-measures ANOVA and 
demonstrated that the patients in the IGMV group had a significant drop in ED utilization 
(p = 0.02), but that the difference between groups was not significant (p = 0.82). There 
was positive skewness and high kurtosis in both pre and post measurements of the control 
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group. The IGMV premeasurement was also positively skewed, but the postmeasurement 
was just over the threshold for skewness at 1.16. The IGMV premeasurement had excess 
kurtosis, but the postmeasurement Z-score for kurtosis was 0.71 and therefore not in 
excess. There are many unknown factors that might have attributed to the nonsignificant 
result between groups, but considering the data that were available and not controlling 
any other variables, the significance at postmeasurement of the IGMV group was worth 
further explanation.  
Mean scores are sensitive to extreme scores and result in skewness in one 
direction or the other (Franfort-Nachmias & Leon-Guerrero, 2015). Given the IGMV 
group postmeasurement was the only measurement with no extreme scores and ED 
utilization dropped, there was a normal distribution which explains the significant results.  
Standard IBH consists of access to individual and group psychotherapy sessions. 
Table 5 describes the IBH utilization mean, standard deviation and sample size of both 
comparison and control at the pre and postmeasurement intervals. The IGMV patients did 
access standard IBH more frequently than the control group with a M = 3.07, SD = 7.564, 
but their increase in utilization over the year was minimal with a M = 3.86, SD = 10.980. 
Whereas the usual care utilization of IBH remained the same over the both years with a 
M = 0.33, SD = 1.720 and SD = 0.816, respectively.  
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Table 5  
Integrative Group Medical Visit and Control Integrated Behavioral Health Utilization at 
Time 1 and Time 2 
IBH in PCMH Type of 
behavioral 
health service 
Mean Std deviation N 
IBH—Year 1 
(Time 1) 
IGMV 3.07 7.564 43 
 Control .33 1.720 42 
 Total 3.86 5.652 85 
IBH—Year 2 
(Time 2) 
IGMV 3.86 10.980 43 
 Control .33 .816 42 
 Total 2.12 7.984 85 
 
Quantitative Measures of Association 
While there was a wide range of ED use, the mean number of ED visits for the 
IGMV group decreased from 2.7 to 1.5 over one year. While the IGMV group had a drop 
from the year prior to study measurement versus post measurement, it cannot be stated 
with complete certainty that adults measured had never attended an IGMV session prior 
to this retrospective analysis. The analysis was based on the inclusion criteria of the 
number of visits was per year.  Because I could not identify each participant to examine 
ED visits per year, it was not possible to conclude that these participants had never had 
previous exposure (personal communication, M. Changaris, June 15, 2021). The mean 
number of ED visits for the usual care group increased from 1.9 to 2.1 over one year.  
The difference between the groups was not statistically significant and therefore I cannot 
conclude that the attendance of IGMVs versus other usual IBH services had a statistical 
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correlation. For the known comorbidities there were more patients with PTSD and 
Depression in the IGMV group than in the usual care group.  
Discussion 
Interpretation 
The results of this study corroborated this use of ED for mental health care and 
confirmed Iturralde et al. (2019) findings that patients with anxiety were independently 
associated with more ED utilization. Both the IGMV and usual care groups had equal 
access to IBH at their PCMH so the only known difference in their access to care was 
participation in IGMV groups which, getting exposure to mindfulness meditation. Even 
though the safety-net health system in this study provided the established strategy of IBH 
in primary care (Buche et al., 2017) and IGMV sessions, some patients still utilized the 
ED for nonemergent mental health care. Dark et al. (2017) explained utilization of the ED 
continues to occur because it is difficult to distinguish somatic feelings of anxiety from 
an organic crisis of the heart or lungs which results in overutilization of emergency 
services. However, there are other barriers low-income patients encounter (Agarwal et 
al., 2016; Martinez-Hume et al., 2017; Saluja et al., 2019; Whittaker et al., 2016).  
A multi-state study on factors associated with ED utilization, in Medicaid 
expanded states, confirmed that concerns best managed in an ambulatory setting are still 
being seen in the ED and that these are typically patients with chronic illness 
comorbidities (Agarwal et al., 2016). These results are in congruence with the findings of 
my study that even with Medicaid and IBH, the ED is being utilized for mental health 
care. The authors suggest multiple factors, including wait times, mental health illness, 
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polypharmacy, and chronic illnesses (Agarwal et al., 2016) for nonemergent ED 
utilization.    
Gardiner et al. (2019) examined ED utilization in an RCT with low-income 
patients who have chronic pain and depression. ED utilization dropped significantly at 9 
weeks, but not 21 weeks for the MBSR-based IGMV patients compared to control.  
While the current study was over one year with a purposeful sample of patients with an 
anxiety diagnosis and comorbidity of chronic pain, the lack of statistical significance of 
ED utilization at one year was similar to the findings at 21 weeks.  
The results of my study add to the knowledge that behavioral health interventions 
in primary care may reduce nonemergent use of the ED and increase some access to 
mental health care at the primary care versus tertiary care level, but that other factors 
need to be investigated to improve access and reduce further nonemergent ED utilization. 
I would suggest that this safety-net site established the capacity to offer integrative 
mental health access, incorporating mindfulness meditation with usual care, for low-
income patients and that this clinical site’s health system structure reflects the context of 
the conceptual framework. 
Conceptual Framework Context 
The conceptual framework was partially supported by the study. The conceptual 
framework was created to visualize a more integrated and equitable approach to the 
typical structural elements of the U.S. health care systems by inserting a blended 
approach to care. First, is that the structure is based on the QAF which is how health care 
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systems in the U.S. operate. At the population health level, the bottom right side of the 
diagram displays the nonemergent ED utilization were reduced.  
Figure 5  
Integrative Health Equity in Primary Care Framework Including Dependent Variables  
 
At the community level, a diverse low-income population was selected to report 
frequencies across race/ethnicity and gender. The baseline for selecting this health 
center’s data was that the site appeared to be offering choices in an integrative primary 
care center without gender, racial/ethnic barriers and with the option to attend groups in 
which mindfulness meditation was practiced at every session. Greater differences may 
have been observed in a setting where IBH services were not the standard of care and 
Medicaid had not been not expanded. The usual care subjects did not attend IGMV 




sessions but did have access to therapists and the options to choose other psychotherapy 
groups within the context of their PCMH.  
Mental accounting at the individual level, may be influenced by mindfulness 
meditation practice, but was not tested in this study. Other qualitative methods would 
need to be employed to uncover this mental process and how patients decide where to 
seek care. Theoretically, the knowledge of being able to attend a group visit versus 
waiting up to three months for an appointment aids the process of mental accounting 
when mental health care is needed. However, there are many factors affecting the mental 
accounting and the resultant choices patients make, including but not limited to lapse of 
insurance, comorbidities, and the proximity of the ED at the time of need versus and 
available appointment or group.  
This is the first longitudinal study to examine the patient’s ED utilization with an 
intersectional institutional lens. Life stressors, employment status, substance use, literacy 
level, homelessness status, loss of insurance at the time of utilizing the ED, and 
educational attainment were not collected, but all patients were low-income patients with 
co-occurring chronic pain.  
Limitations 
There were a few limitations to this study including sample size, design and 
reliability of the independent variable for comparison. First, the sample was drawn from 




Second, the design of the study was a quantitative retrospective analysis design 
with a purposeful sample. When observing ED utilization patterns, a random sampling of 
patients with all ICD 10 codes categorized under anxiety disorders (excluding PTSD) 
may have produced results in alignment with previous research that demonstrates 
reduction in ED utilization with GMV. Due to lack of information technology assistance, 
this type of data collection was not feasible. Additionally, in this design, all patients had 
access to individual and usual care psychotherapy groups. Perhaps only comparing 
IGMV versus usual care psychotherapy groups may have produced clearer and more 
significant differences. Of note, there were four more with PTSD and six more with 
Depression in the IGMV group compared to the usual care group which could have had 
an influence on the level of significance of the results.  
While the IGMV group had a drop from the year prior to study measurement 
versus post measurement, I could not be certain that participants in the comparison group 
had never attended an IGMV session prior to this retrospective analysis. Because I could 
not identify each participant to examine ED visits per year, it was not possible to 
conclude that participants had never had previous exposure (to IGMV) (personal 
communication, M. Changaris, June 15, 2021).  
Lastly, the type of behavioral health service was the independent variable. The 
IGMV were compared with usual care but these were multiple IGMV group sessions 
over time. While the practitioners who facilitated the IGMV and IBH groups were 
consistently and respectively the same, there would have been natural variability in which 
patients were present at each group session affecting group dynamics. However, 
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variations in group composition and group facilitators would be true in any real-world 
group, including the psychotherapy groups in the usual care.  
Implications 
Nursing Implications 
Nurses work in primary, secondary and tertiary settings. The main implication of 
this study for the discipline of nursing is to educate nurses at both the preservice and in-
service levels to recognize the population health impacts of appropriate care. In 
preservice, nursing students can learn the settings best positioned to deliver care and 
produce the best health outcomes for the patient, community and the health system 
(Jordan et al., 2021). In in-service, nurses may continue learning and working with other 
disciplines to assist patients remove barriers (Valaitis et al., 2020) to accessing the 
required level of mental health care in culturally appropriate ways.  
Empirical Implications 
All of the data came from two nurse practitioner (NP) coled groups with 
psychologists which cost less than physician coled groups with psychologists. NP coled 
groups could be a practice model that is replicated more widely for IBH in primary care 
(Housden et al., 2017). The average primary care physician in this region earns $200-
340,000 per year versus the average NP who earns $120-160,000 per year (Bureau of 
Labor Statistics, 2020). 
Utilizing retrospective data had the advantage of less bias entering the research 
process. The challenges presented in the proposed research translating into the actual data 
feasible for collection were part of the realistic protections necessary for human subjects 
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with mental health illness. The data and the analysis were also representative of the 
multiple factors that affect patients as they navigate the health system. Patients are not 
only part of one group but they are interacting with multiple team members at different 
levels.  
Theoretical Implications 
The conceptual framework was multidimensional, but the study utilized only the 
right side aims and the intersectional institutional approach. The integrative health equity 
in primary care framework provided a lens in which to view health equity from three 
levels, system, community and person, being mindful that the patients in this study were 
from a U.S. health system in the western region of the U.S. An intersectional institutional 
approach allowed us to contextualize the patients’ experience on these different levels 
and shift from focusing on socio-demographic attributes and their social determinants of 
health, but also to how they interface and translate into their social inclusion or exclusion 
and the power dynamics that express themselves as they navigate through the healthcare 
space (Gkiouleka et al., 2018).  
Reducing wait time for established low-income primary care patients by 
expanding the patients’ options at the primary care level (Agarwal et al., 2016; 
Wadsworth et al., 2019) provides opportunity for social connections, cocreating health 
plans (Thompson-Lastad, 2018) and potentially reduces structural discriminations 
(Gkiouleka et al., 2018; James, et al., 2010; Saluja et al., 2019) that may be experienced. 
Structural discriminations occur at many levels in the health care system, including but 
not limited, lack of transportation, to lack of translation use for language barriers, 
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understanding the concept of primary care (Saluja et al., 2019) instructions not explained 
or printed on medications or instructions at appropriate literacy levels, restricted day time 
hours of primary care (Whittaker et al., 2016), race/ethnic biases, as well as the stigma of 
having Medicaid as their insurance (Martinez-Hume et al., 2017). The known factors that 
contribute to delayed appointments and repeat visits to the ED.  
Social Change Implications 
The results of my study effect positive social change because the results provided 
new information when examining longitudinal ED utilization and access to integrative 
mental healthcare for a racially/ethnically diverse safety-net population. The state where 
this safety-net is located had expanded Medicaid. Thompson-Lastad and Rubin (2020) 
revealed that states that did not expand Medicaid have more limitations as it relates to 
low-income adults accessing primary care and IGMV programming.  
Recommendations 
Future Research 
 Follow up prospective qualitative or quantitative, or mixed methods studies could 
be conducted on more diverse patient populations with anxiety diagnosis, perhaps 
excluding or comparing those patients with and without a chronic pain diagnosis. A 
multisite investigation of utilization of IGMV in IBH in primary care compared to 
psychotherapy groups in diverse populations may provide a more robust understanding of 
the diversity of integrative mental health needs. Future research should also separate as 




Reviewing trends from 2008-2018, anxiety is on the rise for all race/ethnic groups 
(Goodwin, 2020). The results of this study added to the body of literature about access to 
integrative behavioral health care in primary care. Although this study did not reveal that 
IGMV was statistically significant from the usual IBH in primary care, the study did 
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Outlet for Manuscript 
Drug and Alcohol Dependence: This journal aligns with the content in the 
manuscript as it has other published articles on anxiety, benzodiazepine use, comorbid 
substance use disorder, and the use of tapers for benzodiazepines. There was also one 
article on ethnic differences in patterns of use. However, there has not been anything 
published on any of the aforementioned topics in this journal since 2018, nor on the use 
of meditation in conjunction with other tapers. The editors may be interested given the 
global burden of disease and especially during this year given rise and exacerbation of 





Background: The purpose of this retrospective quantitative comparative analysis was to 
determine whether low-income primary care patients with diagnoses of anxiety, who 
have participated in integrative medicine group visit (IGMV), have reduced use of 
benzodiazepine (BZD) compared to patients receiving care in individualized 
appointments and did not participate in IGMV.  
Methods: A purposeful sample of 85 low-income primary care adult patients ages 18-75 
with an anxiety disorder (43 IGMV, 42 usual care) were reviewed from existing 2017-
2018 clinical data. The data was analyzed using repeated-measures ANOVA.  
Results: BZD dose was reduced in the IGMV group compared to usual care, but the 
number of patients prescribed BZDs all year was nine of the 85 patients. The difference 
within the groups was not statistically significant (p = 0.05) and the difference between 
the groups was not statistically significant (p = 0.67). 
Conclusion: There was no statistically significant correlation that IGMV provides greater 
access to BZD tapering than usual care. Further research should survey the patients with 
anxiety disorders in the catchment area of this health system to estimate nonprescription 






Anxiety disorders are a growing population health concern and the prevalence has 
surpassed depression disorders with women having twice the rate of men (NIH, 2017). Of 
note, according to the DSM-5, posttraumatic stress disorder (PTSD) has been removed 
from anxiety disorders classification and is now classified under trauma related disorders 
(APA, 2013). The DSM-5 classification of anxiety disorders includes primarily in 
childhood separation anxiety disorder, selective mutism, and specific phobias whereas in 
adulthood higher percentages of panic disorder, agoraphobia, social anxiety disorder 
(SAD), general anxiety disorder (GAD-which makes up more than half of anxiety cases), 
substance/medication-induced anxiety disorder, and anxiety disorder due to a medical 
concern (APA, 2013; Alonso et al., 2018; Bandelow et al., 2017).   
In practice, PCPs commonly use GAD-7 and additional questions to diagnose 
anxiety. If the diagnosis is unclear, the diagnoses unspecified anxiety disorder is often 
utilized. In research, common instruments for measuring anxiety of participants include 
the Hamilton Anxiety Scale and GAD-7 (Sampaio et al., 2016; Spitzer et al., 2006; 
Webster et al., 2017).  
Benzodiazepines (BZDs) are modulators of the neurotransmitter gamma-
aminobutyric acid and act as tranquilizers and sedatives (Fluyau et al., 2018). BZDs were 
designed as a rescue medication primarily for panic attacks and sleep or preprocedural 
sedation, respectively (Fluyau et al., 2018) or as a bridge until SSRI, SNRI or other 
anxiolytic reached therapeutic levels (Blackwelder & Bragg, 2016). However, due to 
their rapid alleviation of symptoms, patients have come to appreciate BZD effects albeit 
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short lived. Repeated use often develops into dependency and places individuals at risk 
for addiction to BZDs (Vicens et al., 2011). Addiction to BZDs is a factor in high-cost 
utilization when supplies run out or alternatives to addressing anxiety are not available 
(Dark et al., 2017).  
Singularly or concurrently with opioids, BZD use and misuse is a population 
health and systemic concern. In a retrospective study of medical expenditure data from 
2011, 2013 and 2015, persons with anxiety had an almost ten-fold odds ratio for opioid 
BZD concurrent use (Vadiei & Bhattacharjee, 2020). As with opioids, efforts have also 
been underway to curb BZD use, which are often used concurrently with opioids and 
increase morbidity and mortality from overdose (Vadiei & Bhattacharjee, 2020).  
According to the 2018 National Survey on Drug Use and Health, an estimated 5 
million adults aged 18 and over misused BZDs (SAMHSA, 2019). For patients from 
other countries, or those that travel to other countries, BZDs (and other psychiatric 
medications) are available over the counter without a prescription from a licensed 
practitioner (Moreno et al., 2018). Online cryptomarkets are another portal for access to 
BZD that is difficult to investigate and were not included in this study, but are a known 
source for ongoing abuse of BZD (Van Hout & Hearne, 2017). Therefore, the 
aforementioned SAMHSA (2019) statistic was the only calculable figure. This study 
focused on a nonpharmacological intervention for the reduction of BZD use.  
In efforts to improve their mental health or due to wait times for a consultation, 
many patients may alone or in conjunction with prescribed meds, self-medicate with 
home remedies, teas, herbs, and nutritional supplements that they may not discuss with 
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their practitioner. More than half of patients report their primary care practitioner (PCP) 
has never asked them about their herb or supplement use (Pruitt et al., 2018). Allopathic 
practitioners receive little education on herbs, supplements and integrative approaches 
(Pruitt et al., 2018). While many are relatively safe, others have potentiating effects, 
interactions, or alternatively no evidence-based effect (Pruitt et al., 2018). Self-
medicating of both allopathic and nonallopathic substances may and has resulted in 
serious and/or fatal consequences (Alford et al., 2016; Fluyau et al., 2018).  
Creating a patient care environment for patients with support from their peers that 
increases options and trust (Lavoie et al., 2013; Thompson-Lastad, 2018) to disclose self-
treatments aids in the discovery of alternative coping mechanisms that are critical in 
addressing this mental health access problem. Group medical visits (GMV) may provide 
that environment. GMV are shared medical appointments with a group of patients being 
seen simultaneously with their PCP, lasting from 1-2 hours with a range in attendance 
from 5-16 patients with some common diagnoses and/or common interest in receiving an 
intervention (AHRQ, 2018).  
Significance/Importance 
Kabat-Zinn et al (1985) laid the groundwork for the use of mindfulness with 
patients while Ornish et al (1990) and Noffsinger (2012) laid the groundwork for building 
practice models that assist the individual provider to manage monthly chronic care group 
visits that group patients by diagnosis or utilization behavior (Noffsinger, 2012). In the 
past 20 years, practitioners serving low-income adults have offered GMV in the context 
of primary care that is often deemed a patient centered medical home (PCMH). PCMHs 
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include private and government community clinics, national health service (NHS) and 
federally qualified health centers ([FQHCs]Wadsworth et al., 2019). PCMH certification 
requires that there is a health care team for each patient coordinating care to ensure that 
there are no care gaps and addressing different aspects of their health, including social 
determinants of health (SDH) (Linman et al., 2019).  
With the utilization of GMV in PCMH, researchers have noted that efficiency of 
care increases as care team members work together with multiple patients at a time, 
creating access and peer support simultaneously (Lavoie et al., 2013; Parikh et al., 2019). 
Earlier GMVs focused on diabetes (Vaughan et al., 2019), pregnancy and parenting 
(Wadsworth et al., 2019), and cancer (Reed et al., 2014). Since 1990, different models 
including transdiagnostic groups focused on stress reduction, teaching kitchens [low-cost 
nutrition instruction] (Kakareka et al., 2019), and integrative pain management programs 
(Chao et al., 2019; Gardiner et al., 2019) have burgeoned. Research on the effectiveness 
of these and other GMV models have also been employed with a surge noted after 2014 
(Parikh et al., 2019).    
A survey of PCMH found that less than half of the patients have on-site access to 
a behaviorist, social worker, or psychologist on the care team (Kessler et al., 2014). For 
those that have integration of behavioral health (IBH) at the PCMH, there is improved 
adherence to treatment plans and improved health outcomes (Balasubramanian et al., 
2017). Zeiss and Karlin (2008) found that patients preferred IBH at the location they 
received their primary care (colocated care). Access to GMV has increased IBH in 
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primary care and allowed patients the convenience of having their primary and mental 
health care in one location (colocation). 
In a U.S. national health statistics report of over 88,000 adults, patients reported 
more interest in complementary and integrative health (CIH) practices to manage their 
health, with yoga being the most prevalent CIH practice (Clarke et al., 2015). Integrative 
Group Medical Visits (IGMV) builds on the growing use of GMV for chronic care. 
IGMVs have been implemented in response to interest in CIH, which remains 
inaccessible to many people due to limited insurance coverage and high out-of-pocket 
cost. IGMVs contribute to improving patient experience, improving population health, 
reducing costs, and increasing practitioner satisfaction (Cornelio-Flores et al., 2018; 
Dresner et al., 2016; Gardiner et al., 2017, Gardiner et al., 2019; Gareau et al., 2016; 
Geller et al., 2015; Mehl-Madrona et al., 2016; Rowley et al., 2016; Shaw et al., 2014; 
Strickland et al, 2016).  
Conceptual Framework 
The theoretical basis for understanding the phenomena occurring with low-
income racially/ethnically diverse patients in the context of the current health system 
would be a combination of the Quadruple Aim Framework (QAF) with intersectionality 
theory and the theory of mental accounting. This combination in thought has not been 
utilized in previous research. The new framework is called integrative health equity in 
primary care framework. 
The QAF is an expansion of the Triple Aim developed by leaders at the Institute 
of Healthcare Improvement. The Quadruple Aim includes an improved patient 
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experience, improved health outcomes or population health, reduced costs (Berwick et al, 
2008), and then added higher practitioner satisfaction or care team wellbeing. The final 
aim was first described by William Spinelli (2013) as the “phantom limb” and later 
formalized as an important consideration in reducing burnout of practitioners 
(Bodenheimer & Sinsky, 2013).  
While all four aims of IGMVs have been researched, the aims of focus in this 
study may be categorized under the right side of Figure 1, improved health outcomes and 
reducing costs, but should still be seen in the context of the four aims of the Quadruple 
Aim Framework (QAF), as patient experience and care team well-being also affect the 
other aims indirectly or directly. In addition, the use of CIH modalities in the context of 
this framework influences the whole in delivering whole person integrated care.  
Figure 1 
Quadruple Aim Framework 
 
Note. Quadruple Aim (n.d.). 
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Crenshaw coined the concept of intersectionality to view the intersection of race 
and gender as it relates to the marginalization of black women (Crenshaw, 1989). The 
intersectionality theory has been adopted in the health professions to explain the complex 
way in which the social determinants of health like economic stability, education level, 
environment, access to food and health care and social networks or lack thereof, interact 
with different aspects of a person’s identity to shape the discriminatory experiences that 
some marginalized groups may face within health systems (Gkiouleka et al., 2018). 
Intersectionality theory provided a lens in which to look at the QAF keeping in mind that 
safety-net hospital patients have different outcomes—for this study, specifically those 
who are underserved and have an anxiety diagnosis. 
Another area which enlightens this conceptual framework, is that of behavioral 
economics. Elbel et al. (2014) concluded that low-income patients are particularly 
understudied when it comes to their health care choices and that vulnerable populations 
would benefit from assistance in making better health care choices. They draw on 
Thaler’s (2016) notion of nudges to suggest that nudges are key in assisting patients make 
better choices.  
Thaler (2016) reinserts human psychology and behavior into the field of 
economics; reemphasizing the work of 18th century economist Smith to bring back the 
notion of the human drivers to economic choices (Barberis, 2018). The reasons more 
low-income patients than middle to higher income patients go to the ED for nonemergent 
reasons that include mental health care may include factors such as transportation issues, 
custom of going to hospitals versus outpatient in their countries of origin, and/or lack of a 
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PCP or insurance. Thaler’s (2016) theory of mental accounting helps to explain why 
people make some of the choices they make, some of which may be rational, but more 
often are not rational, are reactive and based on emotion, pain, anxiety level and what is 
important at the present moment not long term. He recommends that health care 
practitioners provide choice architecture to patients so that they may make more informed 
and better choices for their health.  
Utilizing the theories of intersectionality and mental accounting to frame the 
research question provides insight into the interaction of these concepts together as they 
relate to the two aims of health outcomes and cost reduction. These are concepts and 
theories steeped in the context of the capitalist system, which, by definition, does not 
support the underserved, low-income racially/ethnically diverse patients. However, the 
accessibility of the expensive and expansive hospital systems and their emergency 
departments lend any and all to choose this location for their care (Stone et al., 2012), 
regardless of its utility to meet the needs presented.  
Combining these lenses together opened a new way of viewing the current 
healthcare system and addressing the inequities in care within this contextual framework. 
Choice architecture combined with integrative and appropriate care may be 
communicated with appropriate nudges and in culturally and diverse spaces where 
patients may feel safety, trust and access to the care that is needed to address access and 
equity.  Integration of the IGMV as a space that promotes choices and coaching frames 
the utility of IGMV for increasing mental health access and health equity for low-income 




Integrative Health Equity in Primary Care Framework 
 
Original Contribution 
The original contribution of this study was viewing IGMV as an intersectional 
institutional intervention for the promotion of IBH in PC for low-income diverse persons. 
The potential diffusion of IGMV by safety-net institutions could influence access to 
integrative mental health care. Framing IGMV in the context of the existing healthcare 
system allows decision-makers to conceptualize how IGMV contribute to the system’s 
healthcare priorities (Figure 2).  
While limited, in-person and telehealth IGMVs groups are being integrated into 
primary care. The potential positive social change impact of scaling up could be greater 
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access to integrative mental health care for the underserved, improved mental health 
outcomes and reduction of nonemergent use of the hospital. This inquiry has contributed 
to the body of knowledge on integrative mental health care and the underserved. 
Additionally, with the known evidence, this intervention could be integrated further into 
multidisciplinary team education at both the preservice and inservice levels of education. 
The purpose of this repeated-measures retrospective quantitative comparative 
analysis was to determine whether patients with diagnoses of anxiety, who have 
participated in IGMV, in the context of the PCMH, have reduced use of BZD compared 
to patients receiving usual care, who did not participate in IGMV. This analysis was set 
in the context of a study that researched two other related questions.  
Usual care was defined as patients that were having their anxiety managed by 
their primary care provider, as participation in psychotherapy groups was controlled for. 
Utilizing the right side aims (reduction of costs and improved health outcomes) of the 
QAF allowed analysis of how these constructs were interrelated.  
Relevant Scholarship 
The current standard of care for patients with anxiety disorders is to prescribe 
selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine 
reuptake inhibitors (SNRIs) along with nonpharmacological interventions, including but 
not limited to cognitive behavioral therapy (Blackwelder & Bragg, 2016; Driot et al., 
2017). Some people with anxiety disorders use prescribed (and not prescribed) BZD. The 
risks of BZD include side effects (i.e., dizziness, falls, confusion, impaired memory, 
depression, etc.), dependence, and death from overdose potential (Furbish et al., 2017). 
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Likewise, some patients use both BZDs and other medications. Multiple studies have 
been completed to investigate the best taper method for discontinuation of BZDs. Results 
of a meta-analysis reviewing these studies found very little evidence that anything is 
better than placebo, respectively (Welsh et al., 2018).  
The results point most favorably to paroxetine and imipramine, which were both 
found to be helpful in tapering and while mixed reviews suggest the use of melatonin, 
given insomnia is a frequently co-occurring diagnosis and it has a low side effect profile 
(Welsh et al., 3018). Propranolol had mixed outcomes also, but investigators report that it 
could be used on a trial basis since the options are limited. Buspirone had worse taper 
outcome than placebo (Welsh et al., 2018). Mindfulness meditation was not included in 
this meta-analysis. Yoga, with an emphasis on meditation and controlled breath was the 
only intervention better than placebo with greater outcomes with increased frequency 
(Saeed et al., 2019).  
The problem is use of BZD for anxiety versus access to nonpharmacological 
integrative health interventions that could potentially reduce the use of these BZD in low-
income diverse populations in a safety-net community. Due to the lack of professionals in 
the community PCPs are unable to refer out to psychologists (Driot et al., 2019). Patients 
are often referred out (Stussman et al., 2019) to interventions (like counseling, meditation 
and yoga classes) that they are unable to afford so they resort to medications from their 
PCP that are cheaper alternatives than accessing CIH in the community. IGMVs provide 
access to CIH that otherwise would not be accessible.  
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Aside from psychiatric medication use, other aspects of mental and emotional 
health have been documented in IGMV research with statistically significant 
improvements in mental health quality of life measured by the SF-36 with reductions in 
depression and loneliness (Gardiner, et al., 2019; Geller et al., 2011) and a decrease in 
pain medication usage (Gardiner, et al., 2019). IGMVs have taken on favorable roles in 
creating more access to CIH in the mainstream primary care setting. Bukar et al (2019) 
also found similar results in an in-patient psychiatric setting with significant reductions in 
anxiety lasting up to one day, which resulted in hiring of a yoga instructor as a staff 
member. Bukar et al (2019) noted that BZD use was reduced, but since not measured 
directly suggested that further research be conducted on how yoga and meditation affect 
the reduction of BZD use.  
The progression of both qualitative and quantitative research has illuminated a 
need for describing the phenomenon of groups in primary care, the inclusion effect 
(Geller, 2019), or the access to CIH with the guidance of their PCP or the 
interdisciplinary nature that empowers patients to behavior change and accessing 
knowledge and resources. For example, in a qualitative study conducted in Canada, 
Lavoie et al. (2013), both practitioners and patients expressed the benefits of having 
GMV in a PCMH. Themes extracted from the interviews were increased self-
management, improved information sharing, an increased trust of providers, less isolation 
and peer support.  
Research results have shown an increase in patient satisfaction with the use of 
IGMV, exposing patients to other community members, increasing coping and 
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empowerment, reducing loneliness and having an opportunity to share experiences and 
community resources with each other (Dresner et. al., 2016, Geller et al., 2011, 2015; 
Housden et al., 2017; Lestoquoy et al., 2017; Thompson-Lastad, 2018). Housden et al. 
(2017) found that NP-led GMVs encouraged interprofessional practice and served to 
deconstruct some of the traditional primary care hierarchies between clinicians and 
between clinicians and patients. Orzechowski (2016) also found that there were decreased 
wait times for appointments from three months to one month in a feasibility study 
examining mindfulness groups for patients with fibromyalgia. Addressing and supporting 
people with anxiety disorders through an interdisciplinary approach at the primary care 
level integrating nonpharmacological methods may foster greater trust between diverse 
populations and their practitioners.  
Research Question 
What is the effect of IGMV on benzodiazepine dose in 1 year in low-income adult 
patients with anxiety disorders compared to low-income adult patients with anxiety 
disorders receiving usual care? 
Methods 
Participants 
The IGMV participants of this retrospective study were 43 low-income adults 
ages 18-64 with an anxiety diagnosis that had participated in IGMV in a PCMH with 
IBH. The control group (usual care) were 42 low-income adults ages 18-64 with an 
anxiety diagnosis from the same PCMH that had not participated in IGMV but who were 
seeing their PCP for management of their anxiety and had access to colocated IBH. 
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Sample and Power 
For this study, 85 subjects were de-identified from historical records from two 
groups, IGMV and usual care with 43 and 42, respectively in each group. The power of 
the tests was higher since the correlation coefficient between repeated measures was 
higher than 0.3. The ANOVA repeated-measures procedures in G*power computer 
software (Version 3.0) was used to calculate the required sample size (Faul et al., 2009).   
For a repeated measure model, statistical power was addressed separately for 
main (within and between subjects) effects and interaction (within-subject-by-between-
subject) effects. In a repeated measures design with 2 groups, each subject was measured 
at 2 time points, a level of significance of 0.05, a medium effect size of 0.25, and a 
correlation coefficient of at least 0.3 between repeated measures, and a statistical power 
of 0.80 required 46 subjects for within-factor (time) effects, 84 subjects for between-
factor (group) effects, and 46 subjects for within-between factor interaction.   
Variables/Sources of Data 
The independent variable was the type of mental health service patients with an 
anxiety diagnosis received (usual versus IGMV) at the outpatient safety-net health care 
facility. The dependent variable was BZD prescription dose prior and after participation 
in the IGMV. BZD dose was defined as the strength of the medication in milligrams that 
was being prescribed. The sources of the data were de-identified safety-net hospital 
records from the electronic medical record which was the same for both the hospital and 
the outpatient setting. IGMV participants were selected if they had an anxiety diagnosis 
and attendance of at least four IGMV sessions during the year. Usual care patients were 
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filtered by anxiety diagnosis from the chronic pain registry from the same time period. 
Then the last reported dose of BZD was recorded for patients with anxiety related 
diagnoses at the two points in time. Health center staff filtered the data by inclusion 
criteria, de-identified the data by removing unique identifiers and downloaded into excel 
spreadsheets, which were sent to me.  
Instrumentation or Measures 
The type of data I received was patient demographics, such as gender, SES, 
patient’s psychiatric disorder diagnoses, IGMV attendance, reported dose of BZD just 
prior and at the end of the year.  
Design and Analysis 
The design was a quantitative retrospective, comparative analysis research design. 
Secondary clinical data on Medicaid patients from 2017-2018 was available from a U.S. 
safety-net health system database. I used single stage sampling from two points in time, 
first at the end of 2017 for the BZD dose recorded prior to the start of IGMV sessions for 
2018 and then from the end of 2018 for the last recorded dose of BZD. I compared 
reported BZD prescription dose for low-income adult patients with anxiety disorders who 
received IGMV versus BZD prescription dose for low-income adult patients with anxiety 
disorders who received usual care just prior and at the end of the year. Usual care was 
defined as patients that had their anxiety managed by their PCP but also had access to 
psychotherapy groups.  
The comparison group was the group of patients with anxiety disorder that 
attended five or more IGMVs. The rationale for this design is that Gardiner et al. (2019) 
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found statistically significant differences in health outcomes with those attending five 
more IGMV sessions versus four or less in their RCT. The control group were those 
patients with anxiety disorders receiving usual care. The results revealed whether IGMV 
in the primary care environment was correlated with any significant changes in BZD 
prescription dose at this particular safety-net PCMH.  
In order to protect human subjects, the institution agreed to send de-identified 
data for analyses and is aware that their site information will remain anonymous. The site 
contact person who sent the reports was not involved in the intervention or usual care of 
the patients for this study. The inclusion criteria for the data were: all patients included in 
the study had a diagnosis of anxiety disorder, low-income status, and received care from 
the same institution. Exclusion criteria were patients with insomnia and no comorbid 
anxiety diagnosis (excluding non-benzodiazepine hypnotics from analysis), active 
psychosis, schizophrenia, and bipolar diagnoses, or cancer diagnoses.  
The principal contact person was a doctorally prepared psychologist and 
researcher. The site’s team has not analyzed their IGMVs with the proposed questions, 
but they were interested in this type of data to plan for future IBH in primary care based 
on evidence. The psychologist voluntarily participated to have reports run that would 
filter the information needed from historical patient records of those with anxiety who 
obtained usual care and those that were participating in the PCP and psychologist coled 
IGMVs during the year 2018.  
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Differences in outcomes associated with the two groups were evaluated using 
repeated measures ANOVA. All patients were low-income adult Medicaid recipients, but 
individual incomes were not available.  
Data analysis began with preparatory activities such as the treatment of missing 
data, identification of outliers and other such data cleaning tasks. A detailed descriptive 
analysis of all quantitative data was performed. Overall, statistical assumptions were not 
violated and are discussed in the results section below.  
The first phase of the analysis consisted of using descriptive statistics in 
computing the summary measures (mean, median, standard deviation, and range) for the 
variables measured on interval or ratio scales and frequency distributions (absolute 
frequency and percent) for the variables measured on nominal or ordinal scales.  
Significance level was set at a p-value equal to or less than 0.05.  All statistical analyses 
were carried out using SPSS (Version 27).  Repeated-measures ANOVA was used to 
determine a decrease in BZD dose within subjects, between groups, within- subjects-by-
between-group interactions (i.e., the pattern of change in BZD dose between the two 
groups over time).  
Results 
Execution 
This quantitative, retrospective study was conducted with the proposed health 
center that has IBH in primary care and is situated in the western region of the U.S. The 
study was approved by the partner site’s IRB for data collection on April 1, 2021. 
Walden University IRB subsequently approved the study on May 3, 2021 (IRB approval 
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number 05-03-21-0664376). The sample used for the study was a purposeful sample of 
85 established patients with anxiety diagnoses that had colocated mental health care at 
their PCMH. The comparison group (IGMV group) was the alternative group care model 
that infused mindfulness meditation into the IGMV sessions. The control group (usual 
care) was the standard model of IBH in primary care.  
The IGMV group was meant to be a mindfulness movement group in which the 
entire group was focused on the mind-body connection. However, there were not enough 
persons with an anxiety diagnosis established in these groups to support the proposed 
quantitative retrospective design plan. Hence, the data was rather collected from a pain 
and wellness group where mindfulness meditation was integrated at the beginning for 10 
minutes and at the end for 10 minutes. The premeasurement BZD dose was from the end 
of 2017. The postmeasurement BZD dose was from the end of 2018.  
The comparison group were individuals who had an existing anxiety disorder 
diagnosis and had attended four or more IGMV within the last year. The sample included 
85 cases (n=43 comparison and n=42 controls). The comparison group’s (IGMV) BZD 
dose level prior to the measurement of IGMV attendance was recorded (Time 1) and then 
recorded again at one year after (Time 2). The number of refills were proposed to be 
collected, but the site was unable to deliver this measure. Refills are typically monthly, 
but the dose represents the tapering and behavior change in administration of BZDs 
(personal communication, M. Changaris, June 17, 2021). The location of the BZD 
prescription ED versus PCMH was also anticipated, but was not available. The 
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comparison group was selected as 43 consecutive cases of individuals attending an 
IGMV who met inclusion criteria.  
The control group (usual care) was a sample of 42 individuals who were chosen 
as consecutive cases who met the inclusion criteria, but did not attend any IGMV 
sessions. Usual care was defined as patients that were having their anxiety managed by 
their PCP, as participation in psychotherapy groups was controlled for by identifying that 
both comparison and control had access to usual individual or group psychotherapy and 
treatments.  
The IGMV sessions were not designated for patients with anxiety diagnoses only. 
The patients selected for the retrospective analysis were patients with an anxiety 
diagnosis who had attended the wellness groups in which all patients also had a chronic 
pain diagnosis. Hence, both groups had a chronic pain diagnosis.  
All patients had access to IBH services which consist of on-site therapists or 
psychiatrists who collaborate with the care team. The number of visits the sample had 
with these embedded therapists was also tracked. There were also external appointments 
with therapists or psychiatrists who are a part of a community network of providers or 
mental health clinics and these appointments were also tracked for the entire sample of 
patients.  
Only nine patients in the sample of 85 patients were still prescribed BZDs; there 
was no missing data. How many were prescribed BZDs prior to this study time 
collections were not available. Regarding ages, the range was changed from 18-65 to the 
actual pool that was between 19-75. Due to the strict protection of patient identity, the 
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age of each patient and income level were not included. Once coded as IGMV or control, 
the patients’ unique numerical identifiers were removed and patients were listed as 1-85 
only.  
Ethical considerations were at the forefront of the execution of this study. All the 
data were collected and stored electronically and used only in the manner proposed in the 
IRB application and by the requirements of both Walden University and the Health 
System’s IRBs. The data collected was de-identified and unique identifiers were 
discarded. I received the de-identified data in an Excel Spreadsheet. I screened for 
missing data, and when I saw that there was no missing data, I imported the data into 
SPSS version 27. I screened and coded the variables to prepare them for analysis. Then I 
performed descriptive statistics, frequencies and repeated measures ANOVA and saved 
the outputs.   
I also checked to see if the assumptions for repeated measures ANOVA were met: 
independence of observations, data were interval level, normal distribution, and 
homogeneity (Frankfort-Nachmias & Leon-Guerrero, 2016). The first assumption 
assumes that neither group had influence over the other and each observation was 
independent of the other. This assumption was met as these were retrospective data that 
were selected after groups were already completed. The second assumption that data 
were interval was true for the dependent variable because the BZD dose while a scale 
measurement may be described by interval or ratio. The third assumption was the sample 
would be drawn from a population of normal distribution was violated since this was a 
purposeful sample. This violation did not interfere with the data analysis since there was 
118 
 
adequate power, but limited the generalizability of the results to the larger population 
(Schmider et al., 2010). The measurement points on the probability plot were mostly 
distributed along the diagonal line confirming that the data were normal. 
Figure 3 
Normal P-P Plot of Benzodiazepine Dose 
 
The fourth assumption of homogeneity or populations variances being equal was 
also met. Levene’s test was not significant for pre or post measurements (p = 0.82, p = 
0.10) which confirmed equal variances. 
Descriptive Statistics 
I conducted a baseline descriptive analysis on the limited sociodemographic 
information available including gender, race/ethnicity, and stress-related chronic 
comorbidities. The majority of the patients were female (65 of 85, 76%), Caucasian (43 
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of 85, 48%). The ages of the participants were not shared as a part of the de-identification 
process, but the range was between 19-75 years of age, with majority between 19-65 
(personal communication, M. Changaris, June 17, 2021). The number of females 
attending IGMV were 28 and male 15 versus the number of females in the control/usual 
care were 37 and male were five. The mean number of IGMV attended was 21 while the 
median was 20, mode 6, min 4 and maximum 50 sessions. The table below displays the 
IGMV frequency statistics.  
Table 1  
Integrative Group Medical Visit Group Statistics  








Minimum 4  
Maximum 50 
 
Table 2 displays the frequencies and percentages of the aforementioned 
sociodemographic information.  
Table 2 
Frequencies and Percentages for Sociodemographic Data (N = 85) 
Characteristics      N-IGMV  N-Usual care % 
Race/ethnic background 
1) Latino/a  
2) American Indian 
3) Asian American 
4) Black or African American 
5) Native Hawaiian/P. Islander  
























7) Middle Eastern (Caucasian) 












     Female 










Comorbidities    
     PTSD               25               21 54 
     Chronic pain               43               42 100 
     Depression               22               16 38 
 
Table 3 describes the BZD dose mean, standard deviation and sample size of both 
IGMV and usual care at the pre and post measurement intervals. Premean number of 
BZD dose for IGMV group was M = 0.27, SD = 1.070 while the control group, usual 
care, had BZD dose M = 0.29, SD = 1.019. Both postmean BZD dose for those who 
attended four or more IGMV sessions decreased to M = 0.023, SD = 0.1065 and for the 
control group who did not attend any IGMV sessions to M = 0.12, SD = 0.4528. Of note 
the majority of patients had never had BZD prescribed or were already at zero milligrams 
of BZD use. Previous BZD use, external prescriptions or nonprescriptions were 
unknown.  
Table 3  
Integrative Group Medical Visit and Control Benzodiazepine Dose at Time 1 and Time 2 
 Type of 
behavioral 
health service 




IGMV .2674 1.070 43 
 Control .2857 1.019 42 




IGMV .0233 .1065 43 
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 Control .1190 .4528 42 
 
 Total .071 .035 85 
 
Table 4 below displays the tests of within-subjects contrasts and tests of between-
subjects effects. The within-subjects test shows the amount of change that occurred at the 
individual level of all patients, which means that the individuals measured against 
themselves did demonstrate change over time in BZD dose, but was not significant (p = 
0.05). The between-subjects effects test shows that the differences between the two 
groups BZD dose over time was not significant (p = 0.67). Therefore, the null hypothesis 
was retained. 
Table 4 
Repeated Measures Analysis of Variance Test for Benzodiazepine Dose 








1.793 1 1.793 3.890 .052 
BZD*type .064 1 .064 .138 .711 
Between 
subjects 
.138 1 .138 .187 .667 
*BZD dose by either type of behavioral health service. 
The figure below represents the estimated marginal means between the two points 
in time, which is the mean response for each group between the two measurements. Both 
groups’ BZD dose declined sharply at Time 2, however the decline in the IGMV group 
was larger than control group (Figure 4) which represents a greater change in the tapering 




Estimated Marginal Means of Benzodiazepine Dose by Type of Behavioral Health 
Service 
 
Both IGMV and usual care had equal access so the only known difference in their 
care was the exposure to the mindfulness meditation in the IGMV groups. Table 5 
describes the IBH utilization mean, standard deviation and sample size of both 
comparison and control at the pre and post measurement intervals. The IGMV patients 
did access IBH more frequently, but their increase in utilization of IBH over the year was 
minimal. The IBH utilization in the usual care group remained the same over the year.  
123 
 
Table 5  
Integrative Group Medical Visit and Control Integrated Behavioral Health Utilization at 
Time 1 and Time 2 
IBH in PCMH Type of behavioral 
health service 
Mean Std deviation N 
IBH—Year 1 
(Time 1) 
IGMV 3.07 7.564 43 
 Control .33 1.720 42 
 Total 3.86 5.652 85 
IBH—Year 2 
(Time 2) 
IGMV 3.86 10.980 43 
 Control .33 .816 42 
 Total 2.12 7.984 85 
 
The prescribing of BZDs at this facility has been on the decline for over a decade, 
but since mandated in 2017, has declined more sharply (personal communication, M. 
Changaris, June 17, 2021). Most patients have been transitioned over to the medications 
that are evidence-based and safe for longer term use, including SSRIs, SNRIs, atypicals, 
essentials oils, teas, and supplements and mindfulness meditation.  
Quantitative Measures of Association 
BZD use tracked by BZD prescription dose was limited and this may be due to 
the state and health care system limiting prescribers, along with decrease in opioid 
prescribing mandated since 2017 (personal communication, M. Changaris, June 17, 
2021). BZD refill data (number of actual refills of medication) were anticipated for both 
ED and outpatient events, but was not available as planned. The only BZD data available 
were collected on the BZD dose in milligrams over the year. The dose tapering data were 
provided for the 9 subjects that were still taking BZDs, representing only10% of the 
current sample refilling BZDs over the study timeframe. The site contact reported that 
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refills were typically monthly with administration frequency of 1-2 times per day over the 
course of the year (personal communication, M. Changaris, June 17, 2021). One-time 
prescriptions were excluded (i.e., sedation for a procedure, or time ED BZD prescription 
that was never refilled).  
Discussion 
Interpretation 
My results show that those patients with exposure to IGMV did have some 
reduction in BZD use, but IGMV was not superior to usual care with IBH. The results 
raise more questions that need to be investigated given the known estimates of BZD 
misuse and abuse (SAMHSA, 2019; Van Hout & Hearne, 2017).  
The only practice known to statistically reduce BZD use in previous studies was 
yoga with an emphasis on meditation and controlled breathing and was the only 
intervention better than placebo (Saeed et al., 2019). The current study cannot be directly 
compared since it was not a yoga program. The findings also highlight that this safety-net 
site established the capacity to offer integrative mental health access to low-income 
patients and that their health system structure that reflects the conceptual framework that 
was proposed. 
Conceptual Framework Context 
The conceptual framework was partially supported by the study. The conceptual 
framework was created to visualize a more integrated and equitable approach to the 
typical structural elements of the U.S. health care systems by inserting a blended 
approach to care. First, is that the structure is based on the Quadruple Aim Framework 
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which is how health care systems in the U.S. operate. At the population health level, the 
right side of the diagram displays the change in BZD use. Tapering of BZD dose prevents 
potential morbidity and mortality from respiratory depression, dependency or overdose 
and associated costs.  
Figure 5  
Integrative Health Equity in Primary Care Framework Including Dependent Variables  
 
 
At the community level, a diverse low-income population was selected to reports 
frequencies across race/ethnicity and gender. The reason for selecting this health center’s 
data was that the site appeared to be offering choices in an integrative primary care center 
to a diverse population without gender, racial/ethnic barriers and with the option to attend 
groups in which mindfulness meditation was practiced at every session. Greater 




differences may have been seen in a setting where IBH services were not the standard of 
care and Medicaid was not expanded. The usual care subjects did not attend IGMV 
sessions but did have access to therapists and other psychotherapy groups within the 
context of their PCMH.  
While the U.S. government recommends IBH in primary care, sites like the one in 
this study reflect the proposed framework because they offer more options for access to 
care such as having the IGMV to reduce the wait time for appointments. Although not 
statistically significant, overall BZD use was less and allowed patients options for the 
way in which they realize their care.  
Mental accounting at the individual level was not tested in this study. However, in 
a recent study researchers found that patients are willing to taper off BZDs if they trust 
their prescriber (Oldenhof et al., 2021) and group visits have been shown to increase this 
level of trust (Lavoie et al., 2013; Thompson-Lastad, 2018).  
This is the first study to retrospectively compare two groups’ BZD tapering in the 
context of PCMH with an intersectional institutional lens. In a systematic review of 
RCTs, Lynch et al (2020) did find eight studies where brief interventions targeted at 
assisting patients to taper off BZDs who were seen in the primary care setting were more 
effective than usual care.  
Limitations 
There were a few limitations to this study including sample size, data inclusion, 
and site restrictions. First, the sample size was not large enough to capture a larger subset 
of patients still utilizing BZDs. The data were collected at one point in time, de-identified 
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and sent. Therefore, it was not possible to extract more patients using BZD as this may 
have resulted in duplicate cases.  
Second, recent studies in Europe have been assessing BZD along with hypnotics 
since both are utilized for anxiety and/or insomnia or both (Landolt, 2021; Rasmussen et 
al., 2021). Hypnotics, also known as Z-drugs, are being prescribed in multiple countries 
to reduce the use of BZDs (Lynch et al., 2020). Hypnotics were not tracked in this study 
which could be seen as a limitation and while they are also a controlled substance, they 
are technically a different medication class. Including hypnotics may have altered the 
results in either direction. The use of SSRIs, SNRIs, hypnotics, atypicals, and muscle 
relaxants were also not collected. Muscle relaxants and hypnotics also have the risk of 
respiratory depression (APA, 2013). Data on patients’ use of herbs, supplements and teas 
were also not available and may have some similar side effects as SSRIs, SNRIs, 
hypnotics, atypicals, and muscle relaxants.  
Compared to MBSR groups, like those in the Gardiner et al (2019) RCT, the 
mindfulness meditation component of this study comprised only 20 minutes of the 
IGMV. This was an unexpected limitation of this study. Despite this limitation, the 
effects of brief mindfulness were noted to be protective.  
The data were not directly acquired from the site but sent electronically from on-
site staff. I was dependent the on-site staff availability and capacity to collect the 
proposed data necessary. The site researcher was aware of the research questions, was 
knowledgeable about institutional IGMV programs and the data that were potentially 
available. However, until collecting the data with administrative restrictions, the 
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robustness of the data was unknown. The de-identified collection methods prohibited 
collecting more available data once it was noted that more cases were needed. Collecting 
secondary data from a clinical site versus directly from publicly available data had 
multiple challenges, including but not limited to clinical level approvals, site IRB 
approval, and reliance on staff to collect and send the data based on the study design.   
Implications 
Nursing Implications 
Implications for the discipline of nursing would be at primary, secondary and 
tertiary levels of prevention. At the primary prevention level, nurses have the capacity to 
identify symptoms of anxiety and make nonpharmacological recommendations for 
anxiety management along with teaching on the risks and avoidance of use of BZDs, 
prescribed or not prescribed (Moreno et al., 2018; Platt et al., 2016). In secondary 
prevention, nurses may work with other team members to identify length of BZD use, 
discuss risks, including risk of respiratory depression and unintentional overdose in 
combination with opioids (Bouvier et al., 2018) and lack of evidence related to long-term 
use. Nurses may also encourage patients to discuss other pharmacological or support for 
nonpharmacological options with the patient’s PCP (Welsh et al., 2018). Additionally, if 
IBH is available, nurses can ensure that patients are connected to linguistically and 
culturally appropriate counselors and groups to address anxiety triggers, manage 
symptoms, and prevent relapse. In tertiary prevention, nurses can also work with 
practitioners to encourage tapering and prescribing alternatives to BZDs once an SSRI or 
SNRI has reached effectiveness (Blackwelder & Bragg, 2016; Furbish et al., 2017; Welsh 
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et al., 2018) and ensure if prescribed that education has been done and that patient’s 
repeat back their understanding of the information.  
Empirical Implications 
The dearth of BZD data may indicate that state legislation did curtail some of the 
provider-initiated prescriptions through policy and institutional norms. In this sample 
Latinos and Whites were the only race/ethnic groups still using BZDs and the use of 
BZDs in both groups was tapering down over the year, suggesting efforts of prescribers 
to reduce prescribing.  
Despite state and system mandates to avoid prescribing BZDs, some patients were 
still prescribed BZDs on a routine basis at the time of this study. There may be several 
reasons for this. Tapering BZD use is important as abrupt discontinuation can result in 
withdrawal symptoms (Fluyau et al., 2018). Wait times for appointments may also be a 
contributing factor as same day appointments, individual or group, may be limited. While 
access to IGMV and IBH were available, access to other integrative modalities and 
nonpharmacological options could also be factors given the cost of accessing those 
resources in the community.  
It is unknown whether these patients were consuming non-prescribed BZDs. For 
example, it is not known how many patients acquire BZDs through cryptomarkets or 
purchasing from other countries where BZDs are available over the counter. The data I 
obtained was a reflection of a health system change where most patients appear to have 




I created an integrative conceptual framework to examine how an alternative 
model was incorporated into a mainstream U.S. health system. The integrative health 
equity in primary care framework provided a new lens in which to view health equity 
from three levels, system, community and person. The system being the health care 
institution with quadruple aim priorities, the community being the group context with 
practitioners and peers at the center, and the person being the patient accessing the 
services.  
From the system perspective, this health system had made efforts to reduce BZD 
prescribing through policy enforcements. Simultaneously, they expanded access at both 
the individual and group levels. Mixing the allopathic model with integrative approaches 
may have contributed to BZD tapering. At the community or group level, there was an 
emphasis of IBH with non-prescribing practitioners (psychologists). At the individual 
level, patients were provided with choice architecture and an opportunity to have visits 
with practitioners and peers. In this sample, few were still prescribed BZDs, but the 
majority were utilizing IBH and other methods to manage their anxiety.   
Social Change Implications 
The results of my study effect positive social change because the results provided 
new information on BZD prescribing and tapering for a racially/ethnically diverse safety-
net population. From a health system perspective, the state where this safety-net is 
located had expanded Medicaid, making coverage of individual and GMV feasible within 
a capitated insurance model. This health system does not serve uninsured and 
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undocumented patients (personal communication, M. Changaris, August 2, 2020). 
Thompson-Lastad and Rubin (2020) revealed that states that did not expand Medicaid 
have more limitations as it relates to low-income adults accessing primary care and 
IGMV programming.   
From a societal perspective, the potential economic output and lives saved need to 
be taken into consideration. A recent RCT in Sweden also reported on the quality 
adjusted life years and found that the mindfulness group was more cost effective on all 
measurements of their study, including but not limited to medication or visit costs (Saha 
et al., 2020). Chisholm et al. (2016) global systematic review reported an 80% gap in 
anxiety treatment and prevention in high-income countries. Chisholm et al. (2016) and 
Saha et al. (2020) both report on the societal perspective of costs saved from sick leave 
and income gained from increased productivity. Chisholm et al. (2016) report use of 
conservative projection models from 2016-2030 at only five percent increase in work 
productivity and estimated that an average cost of $2 per person investment on anxiety 




The use and misuse of BZDs continues to be a public health issue (SAMHSA, 
2019). The magnitude of trafficking of BZDs from other countries is still unknown. 
Online anonymous surveys could also potentially reveal more information about 
acquisition of BZDs from the cryptomarket.  
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Many U.S. health care systems are adopting a capitated system like the health 
system in this study. As alternative practices are incorporated into these health systems, 
research is needed to investigate the efficacy of these mixed models of care.  
Conclusion 
The benefits of IBH in primary care at the PCMH had statistically nonsignificant 
reduction in BZD use at this health system over one year. IGMV with mindfulness 
meditation was not superior to standard IBH. Reviewing trends from 2008-2018, anxiety 
is on the rise for all race/ethnic groups, highest in women and low-income adults between 
ages 18-25 (Goodwin, 2020) with an increase in BZD use (Sarangi, 2021). Supporting 
low-income diverse populations to taper off BZDs to other pharmacological and 
nonpharmacological interventions is warranted and may save lives. The results of this 
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Outlet for Manuscript 
The Journal of Holistic Nursing: This journal aligns with the content in the 
manuscript as it has other published articles on within the past five years on mental 
health, mindfulness meditation, within prenatal and veteran populations, covering various 
different chronic diseases such as HIV, cancer, chronic kidney disease, PTSD, chronic 
pain and depression. The last article in this research journal on the impact of mindfulness 
meditation on anxiety was published in 2015 with a recommendation for more articles 
including advanced practice nurses utilizing mindfulness meditation in the context of 
individual and group medical appointments. The editors may be interested in this 
manuscript given the rise of global burden of anxiety disorders and the need for research 
on group visit interventions that have the potential to increase the participation of nurses 
at the primary care level to address mental health in a holistic way. By definition, PCMH 
have to have nurses on the team to both coordinate and provide both pharmacologic and 





Purpose: To compare the integrative medicine group visit (IGMV) patients’ anxiety 
symptom severity to usual care patients.  
Design: Retrospective quantitative comparative analysis with a purposeful sample of 85 
low-income adult patients with an anxiety disorder (43 IGMV, 42 usual care) from a 
primary care health center.  
Methods: A purposeful sample of 85 patients with an anxiety disorder (43 IGMV, 42 
usual care) were reviewed from existing 2017-2018 clinical data. Anxiety levels were 
extracted from pre and post annual wellness surveys. The data were analyzed using 
repeated-measures ANOVA.  
Findings: Anxiety symptom severity decreased in the IGMV group and increased in 
usual care. The difference within groups and between groups was not significant (p = 
0.50, p = 0.89). Seventy-seven subjects completed both pre and post survey 
measurements prompting a post hoc analysis. The post hoc analysis revealed a power of 
.96 within factors and a power of .77 for between factors confirming that a Type II error 
was averted.  
Conclusion: This study provided a framework for contextualizing how patients with 
anxiety could have access to nonpharmacological behavioral health care at the primary 
care level. Future research could focus on prospective research with rigorous study 







One in every five Americans has been diagnosed with a mood disorder (NIH, 
2017). Anxiety disorders, often comorbid with mood disorders have the highest global 
burden of disease, currently at about 7% both nationally and globally with a 3-month 
prevalence of up to 10% and one-third of Americans experiencing an anxiety disorder in 
their lifetime (Alonso et al., 2018; Chisholm et al., 2016; NIH, 2017). The prevalence has 
surpassed depression disorders with women having twice the rate of men (NIH, 2017).  
The DSM-5 classification of anxiety disorders includes primarily in childhood 
separation anxiety disorder, selective mutism, and specific phobias whereas in adulthood 
includes higher percentages of panic disorder, agoraphobia, social anxiety disorder 
(SAD), general anxiety disorder (GAD-which makes up more than half of anxiety cases), 
substance/medication-induced anxiety disorder, and anxiety disorder due to a medical 
concern (APA, 2013; Alonso et al., 2018; Bandelow et al., 2017).   
In practice, PCPs commonly use GAD-7 and additional questions to diagnose 
anxiety. If the diagnosis is unclear, the diagnoses unspecified anxiety disorder is often 
utilized. In research, common instruments for measuring anxiety of participants include 
the Hamilton Anxiety Scale and GAD-7 (Sampaio et al., 2016; Spitzer et al., 2006; 
Webster et al., 2017). This paper (part of a larger study) focuses on an integrative health 
approach, initiated by primary care providers (PCP), for reducing symptoms in low-
income patients with currently diagnosed anxiety disorders.  
Anxiety often presents in somatic forms, such as palpitations, shortness of breath, 
headaches, chest pain, digestive complaints, and sweating but often does not get 
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diagnosed as anxiety (Gates et al., 2016). Investigating somatic complaints often delays 
recognition and hence appropriate mental health care for anxiety disorders. Hill et al 
(2019) found, in a population of Latino day workers, that greater severity of anxiety 
symptoms was associated with being single, housing insecurity, acculturation stress, 
discrimination and marijuana use. Patients’ awareness of their own somatic symptoms, 
like shortness of breath or pain, results in a self-referral for their symptoms and often 
result in overutilization of the emergency services (Dark et al 2017) where 
benzodiazepines (BZDs) are commonly prescribed.  
The current standard of care for anxiety disorders is a combination of the use of 
BZDs, SSRIs or SNRI and CBT or other psychotherapy (Blackwelder & Bragg, 2016; 
Driot et al., 2017). Benzodiazepines were theoretically and practically prescribed as a 
rescue medication and bridge until other non-controlled substance anxiolytics reached 
therapeutic levels (Blackwelder & Bragg, 2016). However, due to their rapid alleviation 
of symptoms, practitioners and patients have come to appreciate their effects, albeit short 
lived due to their short half-life. Repeated use often develops into dependency and places 
individuals at risk for addiction to BZDs (Furbish et al., 2017). 
In many cases, patients prefer their PCP manage their mental health care (Buche 
et al, 2017). The integration of primary care and behavioral health (via a team-based care 
model) as integrated behavioral health (IBH) has been established as a strategy for social 
change and improving health outcomes and reducing high-cost utilization (Buche et al, 
2017). Once care is established, group medical visits (GMV) with a PCP are spaces, 
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whether virtual or in person, that have been created in some health systems to allow 
patients increased access to their patient-centered medical home (PCMH).     
The Agency for Health Research Quality (AHRQ) has recommended GMV to 
address patient access to care, increase patient and practitioner satisfaction in care 
delivered, and decrease high-cost health care utilization including ED and specialty visits 
(AHRQ, 2018; Gardiner et al., 2019; Shaw et al., 2014). GMV are shared medical 
appointments with a group of patients being seen simultaneously with their PCP and/or 
collaboratively with a psychologist or other team member, lasting from 1-2 hours with an 
average of 5-16 patients with some common diagnoses and/or common interest in 
receiving an intervention (AHRQ, 2018). Ornish et al (1990) and Noffsinger (2012) laid 
the groundwork for building practice models that assist the individual provider to manage 
their panel with monthly chronic care group visits that group patients by diagnosis or 
utilization behavior. 
There are various GMV types, which include drop-in groups, disease-based group 
visits, and intervention-based groups (AHRQ, 2018) all of which are done either in 
person or virtually. GMV combine biomedical care and consultation with health 
education and peer support. For example, chronic pain groups may focus on acceptance 
of pain or mindfulness techniques to cope with pain and participate in activities to 
uncover their source of pain (i.e., contributors of pain via nutrition, work or home life 
activities) and share experiences and community resources (Gardiner et al., 2014).  
Significant positive health outcomes that have been documented in systematic 
reviews include increased patient satisfaction, increased patient knowledge, reduction in 
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symptom severity, weight reduction and increased healthy eating habits (Parikh, et al, 
2019). There is evidence that GMV participants (diabetes and elders) have lower ED 
utilization and hospitalizations while active in groups (Edelman et al., 2012; Gardiner et 
al., 2019; Shaw et al., 2014). Cornelio-Flores (2018) reported a drop in anxiety for 
Spanish-speaking low-income patients with chronic pain utilizing a Spanish adaptation of 
Gardiner’s intervention with mindfulness-based stress reduction (MBSR). The change 
was not statistically significant, but it is unclear if all had an anxiety diagnosis and there 
were only 19 participants in this pilot. 
Significance/Importance 
In the past 20 years, practitioners serving low-income patients have offered GMV 
in the context of a primary care that is deemed a PCMH. PCMHs include private and 
government community clinics, national health service (NHS) and federally qualified 
health centers ([FQHCs]Wadsworth et al., 2019). PCMH certification requires that there 
is a health care team, including nurses, for each patient. The team addresses different 
aspects of their health and coordinate the patient’s care to ensure that there are no gaps in 
their care (Linman et al., 2019).  
With the utilization of GMV in PCMH, researchers noted that efficiency of care 
increases as care team members work together with multiple patients at a time, creating 
access and peer support simultaneously (Parikh et al., 2019). Due to the lack of 
professionals in the community PCPs are unable to refer out to psychologists (Driot et al., 
2019) when patients prefer talk therapy or a group approach versus medication. A survey 
of PCMH found that less than half of the patients have on-site access to a behaviorist, 
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social worker, or psychologist on the care team (Kessler et al., 2014). Zeiss and Karlin 
(2008) found that patients preferred IBH at the location they received their primary care 
(colocated care). Access to GMV has increased IBH in primary care and allowed patients 
the convenience of having their primary and mental health care in one location 
(colocation). 
While not colocated care, two psychiatrists in Canada decided to increase access 
to their practice with GMV. They decided to conduct their follow up appointments only 
as GMV (Remick & Remick, 2014). They interviewed patients to see if they had a 
preference and statistically there was no difference. However, the authors did note that 
the sample was their own patients and that the patients did express reduced stigma while 
getting support from other patients while in the group (Remick & Remick, 2014).  
Integrative Group Medical Visits (IGMV) builds on the growing use of GMV for 
chronic care. IGMVs have been implemented in response to interest in complementary 
and integrative health (CIH), which remains inaccessible to many people due to limited 
insurance coverage and high out-of-pocket cost. IGMVs may contribute to improving 
patient experience, improving population health, reducing costs, and increasing 
practitioner satisfaction (Cornelio-Flores et al., 2018; Dresner et al., 2016; Gardiner et al., 
2017, Gardiner et al., 2019; Gareau et al., 2016; Geller et al., 2015; Kakareka et al., 2019; 
Mehl-Madrona et al., 2016; Rowley et al., 2016; Shaw et al., 2014; Strickland et al., 
2016).  
The relevant literature for the field of IBH in primary care draws from various 
disciplines, which highlights the interdisciplinary nature of this inquiry. Some of the key 
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literature for this inquiry, from the pioneers of infusing integrative health into GMV, was 
published between 2011-2014 while the majority of the literature synthesized was 
primarily within the last 5 years. Hence, I have included some key literature from 
previous years to explain the progression of this research. The fields of nursing, health 
psychology, primary care, CIH, behavioral medicine, behavioral economics, health care 
utilization, and public health were explored for relevant scholarship on the IBH in 
primary care by way of GMV to address anxiety disorders and improve health outcomes 
in predominantly low-income adults.  
The main focus of IGMV research has been on depression and chronic pain, 
inclusive of emphasis on opioid use (Parikh et al., 2019). Reducing opioid consumption, 
considering the opioid crisis, has been shown to be associated with IGMV in a recent 
randomized controlled trial (Gardiner et al., 2019). Aside from psychiatric medication 
use, other aspects of mental and emotional health have been documented in IGMV 
research with statistically significant improvements in mental health quality of life 
measured by the SF-36 with reductions in depression and loneliness (Gardiner, et al., 
2019; Geller et al., 2011) and a decrease in pain medication usage (Gardiner, et al., 
2019). While anxiety disorders have been listed as comorbidities (Gardiner et al., 2019) 
there has not been a focus on people with anxiety disorders. Hence there has been a gap 
in knowledge whether participation in IGMV affect anxiety symptom severity in low-
income patients in primary care/PCMH.  
Components of yoga practice, like mindfulness meditation and meditative 
movements, are often included in IGMVs and IGMV research (Chao et al., 2015; Chao et 
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al., 2019; Gardiner et al., 2019; Saper et al., 2017; Thompson-Lastad et al., 2019). The 
ancient practice of yoga began approximately 5,000 years ago in India with meditation 
and breath work or pranayama (Wimberly et al., 2018), but over time the postures 
(asanas) were added. Meditative breath work has been observed to increase 
parasympathetic activity while reducing sympathetic activity (Kuppusamy et al., 2020). 
Modern yoga is the union of breath work with an intentional sequence of meditative 
movements.  
IGMVs have taken on favorable roles in creating more access to CIH in the 
mainstream primary care setting. Several studies have demonstrated a reduction in 
anxiety with the utilization of yoga (Adams et al., 2015; Bukar et al., 2019; Kuppusamy 
et al., 2020). Bukar et al (2019) also found similar results in an inpatient psychiatric 
setting with significant reductions in anxiety lasting up to one day, which resulted in 
hiring of a yoga instructor as a staff member.  
The progression of both qualitative and quantitative research has illuminated a 
need for describing the phenomenon of groups in primary care, the inclusion effect 
(Geller, 2019), or the access to CIH with the guidance of their PCP, or the 
interdisciplinary nature that motivates patients to behavior change. For example, in a 
sentinel qualitative study conducted in Canada, Lavoie et al. (2013) reported both 
practitioners and patients expressed the benefits of having GMV in a PCMH. Themes 
extracted from the interviews were increased self-management, improved information 
sharing, an increased trust of providers, less isolation, and peer support.  
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Research has already been strongly in favor of the increase in patient satisfaction 
with the use of IGMV, exposing patients to other community members, increasing coping 
and empowerment, reducing loneliness, and having an opportunity to share experiences 
and community resources with each other (Dresner et al., 2016, Geller et al., 2011, 2015; 
Housden, et al., 2017; Lestoquoy et al., 2017; Thompson-Lastad, 2018). Housden et al. 
(2017) found that nurse practitioner (NP) led GMVs encouraged interprofessional 
practice and served to deconstruct some of the traditional primary care hierarchies 
between practitioners and between practitioners and patients. Orzechowski (2016) also 
found that there were decreased wait times for appointments from three months to one 
month in a feasibility study examining mindfulness groups for patients with fibromyalgia.  
Conceptual Framework 
The theoretical basis for understanding the phenomena occurring with low-
income racially/ethnically diverse patients in the context of the current health system 
would be a combination of the Quadruple Aim Framework (QAF) with intersectionality 
theory and the theory of mental accounting. This combination in thought has not been 
utilized in previous research. The new framework is called integrative health equity in 
primary care framework. 
The QAF is an expansion of the Triple Aim developed by leaders at the Institute 
of Healthcare Improvement. The Quadruple Aim includes an improved patient 
experience, improved health outcomes or population health, reduced costs (Berwick, et 
al., 2008), and then adds higher practitioner satisfaction or care team wellbeing. The final 
aim was first described by William Spinelli (2013) as the “phantom limb” and later 
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formalized as an important consideration in reducing burnout of practitioners 
(Bodenheimer & Sinsky, 2013).  
The aims of focus in this study were categorized under the right side of Figure 1, 
improved health outcomes and reducing costs, but should still be seen in the context of 
the four aims of the Quadruple Aim Framework (QAF), as patient experience and care 
team well-being also affect the other aims indirectly or directly. In addition, the use of 
CIH modalities in the context of this framework influences the whole in delivering whole 
person integrated care.  
Figure 1 
Quadruple Aim Framework 
 
Note. Quadruple Aim (n.d.). 
Crenshaw coined the concept of intersectionality to view the intersection of race 
and gender as it relates to the marginalization of black women (Crenshaw, 1989). The 
intersectionality theory has been adopted in the health professions to explain the complex 
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way in which the social determinants of health like economic stability, education level, 
environment, access to food and health care, and social networks or lack thereof, interact 
with different aspects of a person’s identity to shape the discriminatory experiences that 
some marginalized groups may face within health systems (Gkiouleka et al., 2018). 
Intersectionality theory provided a lens in which to look at the QAF keeping in mind that 
safety-net hospital patients have different outcomes—for this study, specifically those 
who are underserved and have an anxiety diagnosis. 
Another area which enlightened this conceptual framework, is that of behavioral 
economics. Elbel et al. (2014) concluded that low-income patients are particularly 
understudied when it comes to their health care choices and that vulnerable populations 
would benefit from assistance in making better health care choices. They draw on 
Thaler’s (2016) notion of nudges to suggest that nudges are key in assisting patients make 
better choices.  
Thaler (2016) reinserts human psychology and behavior into the field of 
economics; reemphasizing the work of 18th century economist Smith to bring back the 
notion of the human drivers to economic choices (Barberis, 2018). Thaler’s theory of 
mental accounting helps to explain why people make some of the choices they make, 
some of which may be rational, but more often are not rational, are based on emotion, 
pain, anxiety level, and what is important at the present moment not long term. He 
recommends that health care practitioners provide choice architecture to patients so that 
they may make more informed and better choices for their health.  
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Utilizing the theories of intersectionality and mental accounting to frame the 
research question provided insight into the interaction of these concepts together as they 
relate to the two aims of health outcomes and cost reduction. These are concepts and 
theories steeped in the context of the capitalist system, which, by definition, do not 
support the underserved, low-income racially/ethnically diverse patients.  
Combining these lenses together opened a new way of viewing the current 
healthcare system and addressing the inequities in care within this contextual framework. 
Choice architecture combined with integrative and appropriate care has to be 
communicated with nudges and in culturally and diverse spaces where patients may feel 
safety, trust, and access to the care that is needed to address access and equity. Integration 
of the IGMV as a space that promotes choices and appropriate nudges frames the utility 
of IGMV for increasing mental health access and health equity for low-income 




Integrative Health Equity in Primary Care Framework 
 
Original Contribution 
The original contribution of this study was viewing IGMV as an intersectional 
institutional intervention for the promotion of IBH in PC for low-income diverse persons. 
The potential diffusion of IGMV by safety-net institutions could influence access to 
integrative mental health care. Framing IGMV in the context of the existing healthcare 
system allows decision-makers to conceptualize how IGMV contribute to the system’s 
healthcare priorities (Figure 2).  
Whether in-person or via telehealth groups, IGMVs are being integrated into 
primary care. The potential positive social change impact would be greater access to 
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integrative mental health care for low-income patients, improved mental health outcomes, 
and reduction of nonemergent use of the hospital. This inquiry has contributed to the 
body of knowledge on integrative mental health care and the underserved. Additionally, 
with the known evidence, this intervention could be integrated further into 
multidisciplinary team education at both the preservice and inservice levels of education. 
The purpose of this retrospective quantitative comparative analysis was to 
determine whether patients with a diagnosis of anxiety, who have participated in IGMV, 
in the context of the PCMH, had a reduction in symptom severity for patients diagnosed 
with anxiety compared to patients receiving usual care who did not participate in IGMV.   
Usual care was defined as patients that are had their anxiety managed by their 
PCP, as participation in psychotherapy groups was controlled for. Utilizing the right side 
aims (reduction of costs and improved health outcomes) of the QAF allowed analysis of 
how these constructs were interrelated. Patient felt symptoms falls under the improved 
health outcomes aim.  
The chosen research site reported implementation of the tool Stay 
Healthy/Screening, Brief Intervention and Referral to Treatment that is a combination of 
two validated tools that have been merged into one screening system. Screening, Brief 
Intervention and Referral to Treatment tool is utilized in primary care to identify patients 
needing timely interventions and referrals to relevant resources for substance use disorder 
and psychiatric disorders (Hargraves et al., 2017). Both tools have been through interrater 
and interscreener reliability checks. Internal testing and survey fatigue in combining the 
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tools was also completed between 2016-2017 and all patients are mandated by the state to 
take the assessment annually (personal communication, M. Changaris, August 2, 2020).  
The Stay Healthy Assessment is an individual health education and behavioral 
assessment that was developed by the Department of Health Care Services in 1999 and 
updated in 2013 and is available in 10 languages (DHCS, 2019). The questions related to 
anxiety were analyzed for the anxiety status of the participants before and after 
participation in IGMV groups.  
Relevant Scholarship 
The current standard of care for patients with anxiety disorders is to prescribe 
selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine 
reuptake inhibitors (SNRIs) along with nonpharmacological interventions, including but 
not limited to cognitive behavioral therapy.  
Mindfulness meditation is the constant integrative modality that is thread through 
the IGMV sessions and is defined as observing thoughts in a nonjudgmental and 
nonreactive way to bring a sense of heightened awareness to the present state of emotions 
and sensations (Barnby et al., 2015; Jayatilake, 2017; Kabat-Zinn et al., 1985). Barnby et 
al (2015) found that mindfulness meditation, through neuroimaging, reduced both anxiety 
and ruminating thoughts by inhibiting activity in the posterior regions and increasing 
activity in the prefrontal and frontal regions of the brain.  
In a systematic review and meta-analysis, Goyal et al. (2014) found a moderate 
improvement in anxiety at eight weeks, but concluded that mindfulness meditation 
programs were no better than other therapies. However, they did recommend that 
163 
 
stronger study designs would need to be employed to determine the effects on health 
outcomes (Goyal et al., 2014). Alternatively, in a retrospective review of diverse inner-
city patients’ PCMH data, Smith, et al. (2015) found an open abbreviated four-week 
MBSR/yoga program (not attached to GMV) for their patients resulted in statistically 
significantly lower anxiety, but the study was limited in that it did not have a control 
group.  
In neuroscience studies, evidence supports that mindfulness meditation modulates 
reactivity to inner thoughts, perceptions and the wandering mind (Brandmeyer & 
Delorme, 2020). In as little as 3 months, Lutz et al (2018) found that subjects had 
increased focus and decreased emotional reactivity (Lutz et al., 2018) whereas 
Brandmeyer and Delorme (2017) found similar results within 8 sessions.  
Slowing down emotional reactivity is a critical outcome for those with acute or 
chronic anxiety symptoms (Tolin et al., 2021). Travis et al. (2018) reported in their RCT 
on meditation an increase in brain integration and reduced distress. Likewise, reducing 
distress and stress reduces cortisol release, glucose and blood pressure. Similar to other 
chronic diseases, if anxiety symptoms, root causes and alternative coping skills are made 
aware and addressed, the stress on the mind and body may result in other health related 
consequences such as shorter telomeres (Wang et al., 2017), loss of memory, high blood 
pressure, or elevated glucose. Apart from chronic pain and depression, anxiety is also 
often found as a comorbid condition with diabetes and hypertension (Ogle et al., 2018).  
The problem is chronic uncontrolled anxiety in low-income adults in a safety-net 
community. Patients have on average 10 visits before they receive an anxiety diagnosis 
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(Alonso et al., 2018) resulting in a delay in appropriate mental health treatment. More 
than half of persons with depression have the comorbidity of anxiety affecting 
approximately 40 million people in the US (ADAA, 2020). Patients are often referred out 
(Stussman et al., 2019) to interventions (like counseling, meditation and yoga classes) 
that they are unable to afford so they resort to medications from their PCP that are 
cheaper alternatives rather than accessing CIH in the community. IGMVs provide access 
to integrative healthcare that otherwise would not be accessible.  
While there is a plethora of literature on mindfulness practices for mental health 
for White persons, researchers reported a need for research focused on the use of 
mindfulness practices in low-income racially/ethnically diverse persons (Burnett-Zeigler 
et al.2016; Ryan et al., 2018) with anxiety. Given the cost of specialty mental health care, 
additional research was needed to identify which treatment interventions were effective 
in both improving health outcomes and containing costs especially in those who are 
uninsured and underinsured. Currently, the cost of ineffective treatments is costing 
individuals their mental stability and society millions of dollars annually in lost economic 
output (Chisholm et al., 2016). Burnett-Zeigler et al. (2016) recommended the addition of 
mindfulness meditation practices as an adjunct or replacement in some cases to usual 
mental health care needed to be investigated in larger sample sizes of low-income diverse 
adult patients.  
Addressing and supporting people with anxiety disorders through an 
interdisciplinary approach at the primary care level integrating nonpharmacological 
methods may foster greater trust between racially/ethnically diverse populations and their 
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practitioners. I reviewed retrospectively how patients may have benefited from such 
interventions over time and contributed to not only addressing the gap in the literature, 
but also offer recommendations based on the findings for coordinated and cost-effective 
care to community care of those with anxiety disorders.  
I chose the research site where I collected my data because there were data on my 
topic, this healthcare facility used an IBH model within a PCMH model and utilized a 
PCP and psychologist as coleads for the IGMV.  The participants at the study site 
followed a curriculum that assisted them in building awareness and mindfulness into the 
choices that they make through mindful meditation exercises, progressive relaxation, and 
discussions about behavior change, self-care and other nonpharmacological resources. 
Given that almost two-thirds of the IGMVs studied included a mindfulness meditation 
component (Thompson-Lastad, 2019), this study focused on how IGMVs with 
mindfulness meditation compared to usual care in reducing symptoms of anxiety. 
Research Question 
What is the effect of IGMV on anxiety disorder symptom severity reduction in 1 
year compared to usual care groups in low-income adult patients with anxiety disorders? 
Methods 
Participants 
The IGMV participants of this retrospective study were 43 low-income adults 
ages 18-64 with an anxiety diagnosis that had participated in IGMV in a PCMH with 
IBH. The control group (usual care) were 42 low-income adults ages 18-64 with an 
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anxiety diagnosis from the same PCMH that had not participated in IGMV but who were 
seeing their PCP for management of their anxiety and had access to colocated IBH. 
Sample and Power 
For this study, 85 subjects were de-identified from historical records from two 
groups, IGMV and usual care and there were 43 and 42 in each group, respectively. The 
power of the tests was higher if the correlation coefficient between repeated measures 
was higher than 0.3. I used G*power computer software (Version 3.0) to calculate the 
sample size for the repeated-measures ANOVA procedures to determine the required 
sample size (Faul et al., 2009).     
For a repeated measure model, statistical power was addressed separately for 
main (within and between subjects) effects and interaction (within-subject-by-between-
subject) effects. In a repeated measures design with 2 groups, each participant was 
measured at 2 time points. Using a level of significance of 0.05, a medium effect size of 
0.25, and a correlation coefficient of at least 0.3 between repeated measures, and a 
statistical power of 0.80 required a sample size of 46 subjects for within-factor (time) 
effects, 84 subjects for between-factor (group) effects, and 46 subjects for within-
between factor interaction.   
Variables/Sources of Data 
The independent variable was the type of mental health service patients with an 
anxiety diagnosis received (usual versus IGMV) at the outpatient safety-net health care 
facility. The dependent variable was symptom severity prior and after participation in the 
IGMV. The sources of the data were de-identified safety-net hospital records and 
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associated outpatient records provided by the PCMH on survey results. Health center 
staff filtered the data by the inclusion criteria and downloaded the data into excel 
spreadsheets, which were sent to me. 
Instrumentation or Measures 
The type of data that I gathered was patient socio-demographics, such as gender, 
patient’s psychiatric disorders diagnoses, IGMV attendance, and anxiety symptom 
severity scores just prior and at the end of the year.  
Design and Analysis 
The design was a repeated-measures retrospective, comparative analysis research 
design. The data that included was from the years 2017- 2018. I used single stage 
sampling from two points in time, first the annual wellness survey anxiety related score 
in 2017 prior to starting IGMV sessions in 2018 and then the annual wellness survey 
anxiety related score post participation. I compared reported symptom severity score 
between the two groups just prior to IGMV and at the end of the year. Usual care was 
defined as patients that were having their anxiety managed one on one by their PCP only, 
with access to standard IBH.  
The comparison group was the group of patients with anxiety disorder that 
attended five or more IGMVs. The rationale for this design was that Gardiner et al. 
(2019) found statistically significant differences in health outcomes with those attending 
five or more IGMV sessions versus four or less in their RCT. The control group was 
those patients with anxiety disorders receiving usual care during the same time frame. 
The rationale for looking over the course of a year was patients spend on average six to 
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nine months in a group cohort (Balasubramanian et al., 2017) and patients also complete 
annual surveys therefore pre and post years were selected for review. 
In order to protect human subjects, the institution agreed to send de-identified 
data for analyses and was aware that their site information would remain anonymous. The 
site contact person who sent the reports was not involved in the intervention or usual care 
of the patients for this study. The inclusion criteria for the data were: all patients included 
in the study had a diagnosis of anxiety disorder, low-income status, and received care 
from the same institution. Exclusion criteria were patients with insomnia and no 
comorbid anxiety diagnosis (excluding non-benzodiazepine hypnotics from analysis), 
active psychosis, schizophrenia, and bipolar diagnoses, or cancer diagnoses.  
The principal contact person is a doctorally prepared psychologist and researcher. 
The site’s team had not analyzed their IGMV with the proposed questions. However, they 
were interested in uncovering this type of data to plan for future IBH in primary care 
based on evidence. The psychologist voluntarily participated to run reports that filtered 
the information needed from historical patient records of those with anxiety who obtained 
usual care and those that were participating in the PCP and psychologist coled IGMVs 
during the 2018 calendar year.  
Differences in the outcomes associated with the two groups were evaluated using 
repeated-measures ANOVA. Both groups had similar socioeconomic status as they were 




Data analysis began with preparatory activities such as the treatment of missing 
data, identification of outliers, and other such data cleaning tasks. A detailed descriptive 
analysis of all quantitative data was performed, involving the summarization of available 
socio-demographic data.  
The first phase of the analysis consisted of using descriptive statistics in 
computing the summary measures (mean, median, standard deviation, and range) for the 
variables measured on interval or ratio scales and frequency distributions (absolute 
frequency and percent) for the variables measured on nominal or ordinal scales.  
Significance level was set at a p-value equal to or less than 0.05. All statistical analyses 
were carried out using SPSS (Version 27). Repeated-measures ANOVA was used to 
determine a decrease in symptom severity within subjects, between groups, within- 
subjects-by-between-group interactions (i.e., the pattern of change in symptom severity 
between the two groups over time).   
Results 
Execution 
This repeated-measures retrospective comparative analysis was conducted with 
the proposed health center that had IBH in primary care and was situated in the western 
region of the U.S. The study was approved by the partner site’s IRB for data collection on 
April 1, 2021. Walden University IRB subsequently approved the study on May 3, 2021 
(IRB approval number 05-03-21-0664376). The sample used for the study was a 
purposeful sample of 85 established patients with anxiety diagnosis that had colocated 
mental health care at their PCMH. The comparison group (IGMV group) was the 
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alternative group care model that infused mindfulness meditation into the IGMV. The 
control group (usual care) was the standard model of IBH in primary care.  
The IGMV group was intended to be a mindfulness movement group in which the 
entire group visit was focused on the mind-body connection. However, there were not 
enough persons with an established anxiety diagnosis in these groups to support the 
proposed quantitative retrospective design plan. Hence, the data were rather collected 
from a pain and wellness group where mindfulness meditation and progressive muscle 
relaxation was integrated at the beginning for 10 minutes and at the end for 10 minutes. 
The premeasurement year was from 1/1/2017–12/31/2017 (+/- four months) if 
measurement date for screener was close to start of next year but no other appropriately 
timed measures existed). The postmeasurement year 1/1/2018-12/31/2018 (+/- four 
months) if measurement date for screener was close to start of next year but no other 
appropriately timed measures existed). The comparison group were individuals who had 
an existing anxiety disorder diagnosis and had attended four or more IGMV within the 
last year. The sample included 85 cases (n=43 comparison and n=42 controls). The 
comparison group was selected as 43 consecutive cases of individuals attending an 
IGMV who met inclusion criteria.  
The control group (usual care) was a purposeful sample of 42 individuals who 
were chosen as consecutive cases who meet the inclusion criteria, but did not attend any 
IGMV sessions. Usual care was defined as patients that were having their anxiety 
managed by their PCP, as participation in psychotherapy groups was controlled for by 
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identifying that both intervention and control had access to usual individual or group 
psychotherapy and treatments.  
The IGMV sessions were not designated for patients with anxiety diagnoses only. 
The patients selected for the retrospective analysis were patients with an anxiety 
diagnosis who had attended the wellness groups in which all patients had a chronic pain 
diagnosis. Hence, both groups had a chronic pain diagnosis.  
All patients had access to IBH services which consisted of on-site therapists or 
psychiatrists who collaborate with the care team. The number of visits the sample had 
with these embedded therapists was also tracked. There were also external appointments 
with therapists or psychiatrists who were a part of a community network of providers or 
mental health clinics and these appointments were also tracked for the entire sample of 
patients.  
Regarding wellness surveys, there were 8 missing surveys from the IGMV group, 
but usual care wellness surveys were all completed. Regarding ages, the range was 
changed from 18-65 to the actual pool that was between 19-75. Due to the strict 
protection of patient identity, the age of each patient and income status were not included. 
Once coded as IGMV or control, the patients’ unique numerical identifiers were removed 
and patients were listed 1-85 only.  
Ethical considerations were at the forefront of the execution of this study. All the 
data were collected and stored electronically and used only in the manner proposed in the 
IRB application and by the requirements of both Walden University and the Institutions’ 
IRB. I received the de-identified data in an Excel Spreadsheet. I excluded the missing 
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data and imported the completed scores into SPSS version 27. I screened and coded the 
variables to prepare them for analysis. Then I performed descriptive statistics, 
frequencies and repeated-measures ANOVA and saved the outputs.   
I also checked to see if the assumptions for repeated-measures ANOVA were met: 
independence of observations, data were interval level, normal distribution, and 
homogeneity (Frankfort-Nachmias & Leon-Guerrero, 2016). The first assumption 
assumes that neither group had influence over the other and each observation was 
independent of the other. This assumption was met as these were retrospective data that 
were selected after groups were already completed. The second assumption that data 
were interval was true for the dependent variable because the anxiety severity scores 
while a scale measurement may be described by interval or ratio. The third assumption 
was the sample would be drawn from a population of normal distribution was violated 
since this was a purposeful sample. This violation did not interfere with the data analysis 
since there was adequate power, but limited the generalizability of the results to the larger 
population (Schmider et al., 2010). The measurement points on the probability plot were 




Normal P-P Plot for Anxiety Symptom Severity Scores 
 
The fourth assumption of homogeneity or populations variances being equal was 
also met. Levene’s test was not significant for pre or post measurements (p = 0.38, p = 
0.88) which confirmed equal variances. 
Descriptive Statistics 
I conducted a baseline descriptive analysis on the limited sociodemographic 
information available including gender, race/ethnicity, and stress-related chronic 
comorbidities.  The majority of the patients were female (65 of 85, 76%), Caucasian (43 
of 85, 48%). The ages of the participants were not shared as a part of the de-identification 
process, but the range was said between 19-75 years of age, with majority between 19-65 
years of age (personal communication, M. Changaris, June 17, 2021). The number of 
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females attending IGMV were 28 and male 15 versus the number of females in the 
control/usual care were 37 and male were five. The mean number of IGMV attended was 
21 while the median was 20, mode 6, min 4 and maximum 50 sessions. Table 1 below 
displays the IGMV frequency statistics.  
Table 1  
Integrative Group Medical Visit Group Statistics  








Minimum 4  
Maximum 50 
 
Table 2 displays the frequencies and percentages for the aforementioned 
sociodemographic information and comorbidities.  
Table 2 
Frequencies and Percentages for Sociodemographic Data (N = 85) 
Characteristics      N-IGMV  N-Usual care % 
Race/ethnic background 
1) Latino/a  
2) American Indian 
3) Asian American 
4) Black or African American 
5) Native Hawaiian/P. Islander  
6) White (Caucasian) 
7) Middle Eastern (Caucasian) 

































     Female 










Comorbidities    
     PTSD               25               21 54 
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     Chronic pain               43               42 100 
     Depression               22               16 38 
 
There were 77 surveys completed at the intervals pre and post designated time 
frame around participation in the IGMVs. The comparison group of IGMV subjects 
received IGMV for one year before and after their annual surveys were collected. The 
second assessment was reported to be up a year and four months after depending on when 
they took their next assessment post IGMV involvement. They were selected as 43 
consecutive cases of individuals attending IGMV who met inclusion criteria and 
premeasurement years ranged from 2016 through 2018 and postmeasurement years from 
2018 through 2019, of which 35 completed pre and post annual survey. In contrast, all of 
the 42 subjects from the control group completed their surveys.  
The total possible score for anxiety symptom severity was six. The mean score for 
the IGMV group was 3.63 at premeasurement and dropped to 3.14 for postmeasurement. 
The control group’s anxiety symptom severity increased from the mean score 
premeasurement of 3.26 and went up to 3.4 for post measurement. However, the overall 
difference was not statistically significant.  
Table 3 describes the anxiety symptom severity mean, standard deviation and 
sample size of both comparison and control at the pre and post measurement intervals. 
Premean score for anxiety symptom severity for the IGMV group was M = 3.63, SD = 
1.800 while the control group, usual care, had M = 3.26, SD = 2.013. Postmean score for 
anxiety symptom severity for those who attended four or more IGMV sessions decreased 
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to M = 3.14, SD = 1.987 while the control group who did not attend any IGMV sessions 
anxiety symptom severity score increased to M = 3.40, SD = 1.951.  
Table 3 
Integrative Group Medical Visit and Control Anxiety Symptom Severity at Time 1 and 
Time 2 
 Type of 
behavioral 
health service 






IGMV 3.63 1.800 35 
 Control 3.26 2.013 42 






IGMV 3.14 1.987 43 
 Control 3.40 1.951 42 
 Total 3.29 1.959 77 
 
Table 4 displays the tests of within-subjects contrasts and tests of between-
subjects effects. The within-subjects test shows the amount of change that occurred at the 
individual level of all patients, which means that the individuals measured against 
themselves did not demonstrate a significant change over time in anxiety symptom 
severity with (p = 0.50). The between-subjects effects test shows that the differences 




Table 4  
Repeated Measures Analysis of Variance Test for Anxiety Symptom Severity 
 Sum of 
squares 










3.771 1 3.771 1.529 .220 
Between 
groups  
.105 1 .105 .021 .886 
*Anxiety symptom severity by either type of behavioral health service. 
The figure below represents the estimated marginal means between the two points 
in time, which is the mean response for each group between the two measurements.  
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Figure 3  
Estimated Marginal Means of Anxiety Symptom Severity by Type of Behavioral Health 
Service 
 
There was an interaction in anxiety symptom severity between IGMV and the 
control group (F = 1.53, p = 0.22) signifying that there was a pattern of change in anxiety 
symptom severity from Time 1 to Time 2.  Anxiety symptom severity decreased in the 
IGMV group and increased in the usual care group, but the change in anxiety symptom 
severity was not statistically significant nor was the difference in the endpoint 
measurements at Time 2 since usual care Time 1 was lower than IGMV Time 1.  
Only 77 subjects completed both pre and post survey measurements prompting a 
post hoc analysis. The post hoc analysis was revealed a power of .96 within factors and a 
power of .77 for between factors confirming that a Type II error was averted.  
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Both IGMV and usual care had equal access so the only difference in their care 
was the exposure to the mindfulness meditation in the IGMV groups. There was no 
statistical significance in the frequency in which patients utilized other IBH services or 
the external behavioral health network. Table 5 describes the IBH utilization mean, 
standard deviation and sample size of both comparison and control at the pre and post 
measurement intervals. The IGMV patients did access IBH more frequently, but their 
increase in utilization over the year was minimal whereas the usual care utilization 
remained the same over the year.  
Table 5 
Integrative Group Medical Visit and Control Integrated Behavioral Health Utilization at 
Time 1 and Time 2 
IBH in PCMH Type of 
behavioral 
health service 
Mean Std deviation N 
IBH—Year 1 
(Time 1) 
IGMV 3.07 7.564 43 
 Control .33 1.720 42 
 Total 3.86 5.652 85 
IBH—Year 2 
(Time 2) 
IGMV 3.86 10.980 43 
 Control .33 .816 42 
 Total 2.12 7.984 85 
 
There were several types of anxiety disorder with the most common being anxiety 
unspecified/NOS (51 out of 85, 60%), PTSD also and then in combination with GAD or 
anxiety unspecified (24 out of 85, 28%), and then in descending order GAD (8 out of 85, 
9%, panic disorder (4 out of 85, 5%), and health anxiety (1 out 85, 1%). Table 6 displays 




Frequencies of Types of Anxiety Disorder 
 Frequency- N 
IGMV          Usual care 
Percentage-% 
IGMV          Usual care 
Anxiety NOS 33                 20 39                 24 
PTSD 10                 14 12                 16 
GAD 3                    5 4                    6 
Panic disorder 0                    4 0                     5 
Health anxiety 1                    0 1                     0 
 
Quantitative Measures of Association 
Anxiety symptom severity change is important, but variable. Even though the 
symptom severity went down in the IGMV group, the patients have different types of 
anxiety disorders which may have affected the results. The difference between the groups 
was not statistically significant. Unspecified anxiety disorder was the most common 
disorder of the subjects in this study. The number of patients with PTSD alone or 
comorbid PTSD was the second most common and fairly uniform across the groups, 
because the current clinical classification of ICD codes is still operationalized under 
anxiety disorders.  
Discussion 
Interpretation 
The results of this study did corroborate the existing research that anxiety is 
common in low-income adult patients, but that more research is needed on 
racially/ethnically diverse populations (Bucay-Harari et al., 2020; Camacho et al., 2015; 
Guo et al., 2015; Nelson et al., 2020). The most common diagnosis of unspecified anxiety 
may affect receiving the appropriate treatment and counseling in a timely manner. 
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Practitioners often delay a specific diagnosis when the symptoms are unclear, they have 
not had enough time with the patient, or the patient lacks sufficient awareness to describe 
their symptoms. In a review of qualitative evidence with GAD in primary care, Toledo-
Chavarri (2020) reported the aforementioned PCP challenges as well as the high relapse 
rate of chronic uncontrolled anxiety as difficulties in managing patients with chronic 
anxiety disorders.  
The results added to the literature on how low-income patients in primary care in 
PCMH context that have anxiety disorders access mental health care and how their 
anxiety symptom severity scores change over time. Parikh et al. (2019) demonstrated that 
there was clinical importance and improvement in health outcomes change when 
professionals were working with multiple patients together versus one-on-one calls and 
visits. Group care increased time with patients and provided the practitioners an 
opportunity to observe patients’ behavior in a group setting. However, group care may or 
may not reduce anxiety depending on group cohesion, dynamics of the group and the 
facilitator. Roth et al. (2021) described a process of implementation mapping that may be 
useful for PCMH that does not have an IGMV program but are interested on how to 
implement an IGMV program. The findings of the current study also highlight that this 
safety-net site established the capacity to offer integrative mental health access to low-




Conceptual Framework Context 
The conceptual framework was partially supported by the study. The conceptual 
framework was created to visualize a more integrated and equitable approach to the 
typical structural elements of the U.S. health care systems by inserting a blended 
approach to care. First, is that the structure was based on the Quadruple Aim Framework 
which is how health care systems in the U.S. operate. At the population health level, the 
right side of the diagram displays the health outcomes of anxiety symptom severity.  
Figure 4 
Integrative Health Equity in Primary Care Framework Including Dependent Variables  
 
At the community level, patients accessed care in both individual and group 






not attend IGMV sessions but did have access to therapists and other psychotherapy 
groups within the context of their PCMH. In a metanalysis of countries with universal 
health care, Parker et al. (2021) concluded that the most effective care for patients with 
anxiety was when a behaviorist was integrated at the primary care level.  
Thaler’s (2016) theory on mental accounting emphasized that patients usually 
make irrational decisions based on anxiety, pain, and emotions. Increasing access and 
time with peers and practitioners with IGMV may allow the space to influence patients’ 
mental accounting with appropriate nudges from other peers and practitioners. The 
relationships, knowledge, influence and support (Lavoie et al., 2013; Parikh et al., 2019) 
those patients may benefit from in the group setting has the potential to reduce the 
severity of anxiety symptoms. 
This is the first longitudinal study to examine the patient’s anxiety symptom 
severity in the context of attending an IGMV with an integrative health equity in primary 
care framework. All of the patients were low-income patients with co-occurring chronic 
pain from a diverse pool of adults utilizing public insurance to receive their health care 
services. While comorbid depression was also known, some of their social determinants 
of health were unknown, which would have been useful descriptive statistics on the 
population and will be described in the limitations.  
Limitations 
There were a several limitations in this study. Life stressors, employment status, 
substance use, literacy level, homelessness status, and educational attainment were not 
collected. Life stressors and homelessness status would have been harder to collect in a 
184 
 
quantitative manner, but the other socio-demographic data was expected to be collected 
and was not sent.   
While the survey tool as a whole was assessed for validity and reliability, 
assessing only the questions related to anxiety versus a tool specifically for anxiety 
assessment was not ideal. The four questions related to anxiety on the annual wellness 
survey were the only available measure to assess pre and post anxiety severity scores for 
patients with anxiety disorders and they were not assessed separately for validity and 
reliability. No other anxiety assessments were taken apart from GAD, which may be 
limiting since not all patients are diagnosed with GAD. This was a limitation of 
conducting a retrospective analysis, as measurements recorded are the only ones feasible 
to analyze and may have affected the levels of significance seen in the outcomes.  
The design of the study was a quantitative retrospective comparative analysis 
design with a purposeful sample. Compared to MBSR IMGV groups like those in the 
Gardiner et al. (2019) RCT, the mindfulness meditation component comprised only 20 
minutes of the IGMV. The mindful movement IGMV was the IGMV type that was 
proposed for this study, but there were not enough participants with a diagnosed anxiety 
disorder in these sessions (personal communication, M. Changaris, May 19, 2020). This 
was an unexpected limitation of this doctoral project.  
The sampling of these IGMV may have also affected the significance of the 
results since they were purposefully sampled from a chronic pain and wellness group 
instead of the intended mindfulness movement group. While muscle tension and pain are 
common anxiety symptoms (APA, 2013; Bruns et al., 2019), not all persons with an 
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anxiety disorder have chronic pain. Of note, there were also more patients with a 
diagnosis of depression in the IGMV group which may have added additional challenges 
and affected the results of the study.  
Implications 
Nursing Implications 
Implications for the discipline of nursing would be for nurses to participate in the 
active engagement of IBH in primary care whether through leadership, management, 
education, or policy. As an interdisciplinary profession, nurses working collaboratively 
with patients, psychologists, health coaches, and care coordinators may be more effective 
working as a team with patients in the PCMH setting (Farber et al., 2017). In value-based 
settings, community nurses could be trained to facilitate groups which has been found to 
be effective in decreasing anxiety and medication (Izaguirre-Riesgo et al., 2019). 
As leaders, nurses have the opportunity to identify patients’ barriers and needs, 
remove barriers and implement improved patient care. Burnett-Zeigler et al. (2019) found 
comparable positive outcomes between the experienced mindfulness instructor and the 
novice instructor facilitating mindfulness with racially/ethnically diverse low-income 
women with depressive symptoms and suggested nurses and other health care workers be 
trained to facilitate mindfulness groups. As managers, nurses have the opportunity to 
facilitate care coordination with other team members and facilitate group visits.  
As educators, nurses have the opportunity to meet individually or in groups with 
patients to share knowledge and resources in safe spaces for patients and to coach them to 
optimize their health. Williams et al. (2015) reviewed different ways in which nurses can 
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get training in mindfulness and incorporate mindfulness approaches into their practice. 
By training, nurses focus on nonpharmacological approaches and have reported higher 
levels of trust with patients.  
As advocates, nurses have opportunities to advise local representatives and health 
centers on the AHRQ recommendations to offer group visits and to assure policies and 
procedures are in place to actualize these spaces for patients. In the field of perinatal 
health, the group health care model has been expanded by nurse-led organizations 
partnering with health centers across the country (Rising & Quimby, 2017). Lastly, nurse 
researchers also have the opportunity to advance interdisciplinary programs through 
application of research results and further research on resultant health outcomes.  
Empirical Implications 
Uncontrolled chronic anxiety fluctuated over time. Black IGMV patients had 
reduced anxiety symptoms versus usual care patients. This was not anticipated and while 
the sample was too small to make any conclusions, it does raise an area of potential 
further investigation. Additionally, Nonwhites had a drop in anxiety symptom severity 
regardless of intervention type, while Whites had an increase in anxiety symptom 
severity regardless of intervention type.  
IGMV may result in some anxiety symptom reduction but the results and existing 
literature imply that other factors and challenges low-income adults encounter need to be 
taken into consideration and efforts made to reduce those barriers to behavioral health 
care. For example, Latino day workers had higher levels of anxiety with housing issues, 
experiences of discrimination, and feelings of acculturation stress (Hill et al., 2019). Less 
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acculturated immigrants have been found to access mental health services less (Hill et al., 
2019; Burnett-Zeigler et al., 2019).  
Mindfulness meditation increases processing of stressful events from the sensory 
cortex via the hippocampus to the amygdala and slows emotional reactivity versus 
directly from the thalamus to the amygdala which prompts a more rapid response 
(Breedlove & Watson, 2018) which is helpful when faced with challenging situations. 
Mindfulness meditation reduces distress and reactivity, increasing parasympathetic 
activity and decreasing sympathetic activity, increasing neuroplasticity, and reducing 
cortical thinning (Barnby et al., 2015; Brandmeyer & Delorme, 2020; Kuppusamy et al., 
2020; Lutz et al., 2018; Travis et al., 2018). 
Theoretical Implications 
The integrative health equity in primary care framework provided a new lens in 
which to view mental health equity from three levels, system, community and person. 
The system being the health care institution with a quadruple aim, the community being 
the group context with practitioners and peers, and the person being the patient accessing 
the services. Anxiety symptom severity is experienced at the person level, but can be 
alleviated or aggravated by stressful or negative interactions within groups as well as by 
difficulty navigating the health system.  
An intersectional institutional approach allowed the contextualization of the 
patients’ experience at the system, community and person level and shifted the focus 
from socio-demographic attributes and their social determinants of health alone to how 
patients interface with an institution. These interactions may translate into their social 
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inclusion or exclusion as they encounter different power dynamics as they navigate 
through the healthcare space (Gkiouleka et al., 2018). These interactions directly 
influence the upper right side of the framework’s (Figure 4) health outcomes.  
The inclusion of group care in this conceptual framework provided a guide on 
how to reframe mental health as usual by incorporating the circular space that situates 
each individual to be in equal proximity to the other with equal level of importance and 
agency as they interact with health center staff and their peers. Framing health systems in 
this manner emphasizes health equity at the primary care level for diverse and vulnerable 
populations. Reframing mental health also helps patients to destigmatize the need for 
seeking mental health care and connecting with others that are having diagnosed or 
undiagnosed mental health challenges (Remick & Remick, 2014).  
Social Change Implications 
The results of my study effect positive social change because the results provided 
new longitudinal data on behavioral health access for racially/ethnically diverse publicly 
insured safety-net population with anxiety disorders. These patients were beneficiaries of 
Medicaid expansion. Thompson-Lastad and Rubin (2020) revealed that states that did not 
expand Medicaid have more limitations as it relates to low-income adults accessing 
primary care and IGMV programming.  
Infusing the basic aspects of the ancient indigenous practice of yoga, specifically 
breath work and mindfulness meditation into the system of basic primary health care is 
part of reframing, prioritizing, and ensuring that diverse communities are having care 
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models that reflect group culture and priorities of communal versus individual care. 
IGMV or group visits in general are not for everyone so having options is also important.  
Geller (2019) named the “group inclusion effect” as a concept that needed more 
exploration. I suggest that being in a group or circle versus belonging to a specific group 
enhanced or promoted change since patients may have been exposed to different peers in 
the group sessions they attended and may attend a group session based on their 
convenience so not always the same group. The implications for more colocated group 
care or hybrid groups with the option to remote in could increase the choice architecture 
at more PCMH locations around the country and increase flexibility for those with 
transportation or job constraints. 
Recommendations 
Future Research 
Follow up prospective qualitative or quantitative, or mixed methods studies could 
be conducted on patients from the system with anxiety diagnosis. If feasible it would be 
interesting to conduct interviews with the NPs and psychologists who coled these groups 
to obtain their perspectives on care team well-being, which is another research gap. 
Additionally, a quantitative analysis comparing them with physician coled groups for cost 
and health outcomes differences could inform future policy and programming. 
Prospective studies are needed to compare IGMV patients’ different health outcomes 
using by tracking the different amounts of mindfulness effect on the consumption of all 
anxiety medications, including but not limited to controlled substances like BZDs or 
hypnotics with a measurement scale focused on anxiety only such as the Hamilton 
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Anxiety Rating Scale (Hamilton, 1959) or the patient reported outcomes measurement 
information system (PROMIS®) Adult Anxiety Short Form version 1.0 short form 8a 
which consists of a 7-item questionnaire from the 29 item bank (Pilkonis et al., 2011). 
Other research could compare nonallopathic practitioners, nurses, social workers or 
health coaches leading the groups with the PCP referral only. Online anonymous surveys 
could also potentially reveal more information about acquisition of BZDs from the 
cryptomarket. Lastly, noting the latest research showing yoga was superior to non-
mindful exercise in reducing anxiety (So et al., 2020), a study on yoga or mindful 
movement in primary care would be informative.  
As many systems adopt value-based care, there is a need to investigate further the 
definition of group visits and perhaps the decreased reliance on having an allopathic 
medical practitioner present to be considered a clinical, billable care event. Future group 
visit studies could include measuring biofeedback and mindfulness training with the 
newer brain-sensing headband technology that is now available. Observing more 
longitudinal data is important given the long-term consequences and effects on quality 
adjusted life years and lost economic output (Chisholm et al. 2016; Saha et al. 2020).  
Conclusion 
The benefits of IGMV with mindfulness meditation was not statistically 
significant, but did demonstrate clinical changes at both the system and person level 
versus usual IBH care. Reviewing trends from 2008-2018, anxiety is on the rise for all 
race/ethnic groups. The trends also show that anxiety is highest women and low-income 
adults between ages 18-25 (Goodwin, 2020).  
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The results of this study demonstrated reduction in anxiety symptom severity over 
time with IGMV and an increase in anxiety symptoms with those in usual BH care, but 
the significance of that change was lacking. It is unclear if the reduction seen in IGMV 
patients would be sufficient enough to sustain reductions over time. The groups were 
mixed gender, ages, and race/ethnic groups and it is unclear if this was a protective or 
harmful factor. This study provided a framework for contextualizing how patients with 
anxiety could have options for behavioral health care and a potential additional access 
point to assist patients in how they respond to these stressors. The results of this study 
prompt prospective research with stricter study designs and larger sample size to uncover 
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Part 3: Summary 
Integration of the Studies 
The findings from the three studies are related and show promise for investigating 
aspects of ED utilization, BZD tapering, and anxiety symptom severity in patients with 
anxiety disorders in more depth in future studies. The preceding literature supports the 
use of IGMV in patients with cancer, chronic pain, and depression (Chao et al., 2019; 
Charlot et al., 2019; Gardiner et al., 2019; Thompson-Lastad, 2019) and a reduction in 
wait times for appointments (Orzechowski, 2016). Many of these patients also have co-
occurring anxiety, and a subset of them still use controlled substances for pain, anxiety, 
and sometimes both (Bruns et al., 2019; Vadiei & Battacharjee, 2020). While EDs are not 
equipped with mental health care services, patients continue to use the ED for mental 
health care for their uncontrolled anxiety (Dark et al., 2017) as delays in accessing IBH in 
primary care persist for low-income diverse populations (Acevedo, 2015; James et al., 
2010; Saluja et al., 2019). In this study, I investigated an integrative model of care that 
may increase behavioral health access for low-income patients with anxiety within the 
context of their PCMH. The findings reduced the gap but also raised more potential 
research questions as well as appropriate research methods.  
The findings revealed lower ED utilization, reduced BZD use, and reduction in 
anxiety symptom severity in patients who participated in IGMV, but compared to usual 
care, these results were not statistically significant. These results may still be clinically 
significant and prompt the need for further research with stricter study designs. Because 
this was the first study focusing on anxiety disorders in the context of IGMV in the 
212 
 
PCMH, there is no direct comparison with any of the existing literature. However, the 
protective effect of mindfulness meditation and the benefits of previous RCTs on both 
GMV and IGMV prompt further investigation.  
Alignment With Theoretical Framework 
The findings aligned with this new conceptual framework, which blends an 
integrative group approach within the PCMH to promote greater access for low-income 
patients to IBH in primary care. The integrative health equity in primary care framework 
encompasses advancing system priorities but incorporates a focus on IGMV, recognizing 
that intersectionality, mental accounting, and choice architecture should be taken into 
consideration. The framework promotes the inclusion of nonpharmacological integrative 
approaches such as mindfulness meditation for individual or group behavioral integration 
at the primary care level to meet both their primary and behavioral health needs in one 
location to reduce barriers to care, including but not limited to transportation to multiple 
locations.  
At the center of the conceptual framework, patients have access to both their PCP 
and behaviorist for longer periods of time, and the practitioners likewise have the 
opportunity to observe and coach patients in both individual and group settings. Peers 
also have the opportunity to learn, support, encourage, and meditate in a group together. 
The contextual framework may be clinically useful because the current health systems 
that use IGMV do not have a known documented framework for contextualizing IGMVs 




All Black IGMV subjects demonstrated a reduction in ED utilization and reduced 
anxiety symptoms versus usual care. This was not anticipated, and while the sample was 
too small to make any comparisons or conclusions with other racial/ethnic groups, it does 
raise an area of potential further investigation. Additionally, all non-Whites had a drop in 
anxiety symptom severity regardless of type of mental health service, while Whites had 
an increase in anxiety symptom severity regardless of type of mental health service. 
Another unexpected finding was that only 10% of the sample was still consuming 
prescribed BZDs, with a tapering trend. This raises questions about nonprescribed use. 
Lastly, it was interesting to note that patients who attended IGMV were using usual care 
as well, increasing their interaction with their PCMH.  
Positive Social Change 
The results of my study effect positive social change because the results provide 
new information on longitudinal ED utilization, BZD tapering, and anxiety symptom 
severity changes for patients with an anxiety disorder. Despite the rise of anxiety over the 
past decade, there has been limited research on patients with anxiety in primary care. 
Creating a framework in this dissertation also gave a lens on integrative mental 
healthcare for a racially/ethnically diverse safety-net population that does not currently 
exist. The potential positive social change impact would be greater access to integrative 
mental health care for low-income adults, improved behavioral health outcomes, and 
reduction of nonemergent use of the ED. 
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Areas of Future Research 
Regarding ED utilization, a prospective study on the implementation of a yoga-
based IGMV to investigate whether adding the movement component to mindfulness 
meditation would improve health and cost outcomes would be informative to this area of 
research. Regarding BZD use, a national online anonymous survey in English and 
Spanish to assess nonprescription BZD use would contribute to data needed to address 
the magnitude of undocumented use and abuse of BZDs. Additionally, a prospective 
quantitative or mixed method study of IGMV comparing cost and health outcomes of 
three different dyad cofacilitators (with psychologists)—physicians versus nurse 
practitioners versus nonallopathic practitioners for patients with anxiety—would guide 
implementation for health systems exploring incorporation of the IGMV model.  
Lessons Learned 
Lessons learned were three-fold. First, it is important to find a research partner. 
Often, retrospective analysis is completed on an existing dataset and not at a clinical site. 
Conducting a retrospective analysis of existing protected data at a remote site requires a 
dedicated onsite champion who has time, effort, and understanding of the research 
problem. I was fortunate to find such a person. The reality is that research is not done 
alone. Your committee, your mentors, and family are all there to support you in different 
ways.  
Another lesson was to expect the unexpected. Every institution and its IRB have 
their own protocols and clearances. Multiple roadblocks, red tape, and compromises 
should be expected. Even if they approve collection of data that answers your questions 
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and understand the kind of data that is needed, there may be local processes in place that 
block getting the specific data required to answer the questions.  
Finally, the process, not the outcome, is what is most important. While a certain 
outcome might be anticipated, the results may not support the theories or hypotheses. 
Good research reveals what is there and also illuminates concerns with study design. 
There may be temptations to change a question, collect more data than proposed, or 
present data that are not related to the research question, but this is not proper or ethical 
research. 
Conclusion 
The journey of research into real-world patient experiences via their personal 
health history data was exciting and overwhelming. Entering into a world of numbers and 
labels, without names and faces, was daunting but at the same time reduced bias and 
assumptions. Research on a diverse sample revealed how different racial/ethnic low-
income adults access the system and benefit from behavioral health integration in primary 
care, added to the evidence base, and raised additional questions around couching 
integrative health approaches in primary care to advance health equity and behavioral 
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Appendix A: Well-Being Screening—Adult Part I 
Questions from the form are listed below. Asterisks (*) are notated on the 
questions related to this study for which data will be analyzed pre and post involvement 
in IGMV for the established year of the study. Responses to the first two questions are 
not at all, rarely, somewhat, and often. The remainder responses are yes and no.  
1. In the past month, I have been unable to work or carry out my normal 
activities due to my physical health? 
2. In the past month, I have been unable to work or carry out my normal 
activities due to sadness, anxiety, or stress? * 
3. In the past year you have had 5 or more alcoholic drinks in one day (men) 
or 4 or more alcoholic drinks in one day (women)?  
4. In the past year, have you used a recreational drug or used a prescription 
medication for nonmedical reasons?  
5. Over the last 2 weeks, have you been bothered by little interest or pleasure 
in doing things? 
6. Over the last 2 weeks, have you been bothered by feeling down, 
depressed, or hopeless? 
7. Over the last 2 weeks, have you been bothered by feeling nervous, anxious 
or on edge? * 
8. In the past month, have you been bothered by repeated, disturbing 
memories, thoughts, or images of a stressful experience from the past?* 
9. Do you often have trouble sleeping? * 
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Appendix B: Sociodemographic and Stress-Related Chronic Comorbidities 
 IGMV Usual Care 
Gender Female 28, Male 15 Female 37, Male 5 
Race/ethnicity: 1) 
Latino/a/x 2) 
American Indian or 
Alaskan Native 3) 
Asian American 
4) Black or African 
American 
5) Native Hawaiian 
or Pacific Islander 
6) White 7) Middle 
























PTSD 25 21 
Chronic Pain 43 42 
Depression 22 16 
 
